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ABSTRACT 
 
THE INFLUENCE OF MATERNAL CONTEXTS ON INFANT OUTCOMES, 
 SECONDARY ANALYSIS OF WPCR DATA 2000-2010 
 
by 
Mary R. Butler 
The University of Wisconsin-Milwaukee, 2014 
Under the Supervision of Professor Dr. Kathleen Sawin 
 
Congenital heart defects (CHD) are the most prevalent birth defect in the world and occur 
in approximately 6-8 of every 1,000 live births (Hoffman & Kaplan, 2002).  CHD 
continues to be one of the leading causes of infant morbidity and mortality today.  Five to 
ten percent of all cases of CHD can be attributed to a chromosomal abnormality, 3%-5% 
are linked to single gene defects, and approximately 2% are a result of known 
environmental factors (Clark, 2001).  With only 10%-15% of the causes of CHD are 
understood, the remaining 85%-90% of all CHD cases, the etiologies remain unknown.  
The purpose of this study was to examine the relationships of select maternal variables to 
the type of CHD (simple vs. complex), birth weight and gestational age in infants born 
with CHD participating in the Wisconsin Pediatric Cardiac Registry (WPCR).  This study 
was a secondary analysis of 1,687 parent/child questionnaires using the data within the 
WPCR database from 2000-2010.  A life course perspective was used to organize the 
maternal context variables and illustrate the relationships to the birth outcomes of the 
infants with CHD. The findings in this study included two maternal variables as risk 
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factors for having a child with complex CHD. Personal maternal history of CHD (OR: 
2.382; 95 % CI: 1.424-3.984) and history of serious health condition (OR: 1.537; CI: 
1.085-2.178) increased the risk for complex CHD in these infants.  The predictors of birth 
weight included; maternal history of hypertension, serious health condition six months 
prior/during pregnancy, CHD, obesity and income (R² = 0.049, p < 0.05).  The predictors 
of gestational age included; maternal history of hypertension, flu, and serious health 
conditions 6 months prior/during pregnancy, and type of housing (R² = 0.045, p < 0.05). 
Nurses and healthcare providers can identify risk factors prior to pregnancy and provide 
education to women and their partners in anticipation for a future pregnancy to reduce 
risk of complex CHD in their infant. This study reinforces the multifaceted nature of 
CHD and need for further investigation of maternal and paternal exposures to help 
identify other risk factors for complex CHD.  
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CHAPTER ONE 
The Influence of Maternal Contexts on Infant Outcomes  
 Congenital heart defects (CHD) are the most prevalent birth defect in the world 
and occur in approximately 6-8 of every 1,000 live births (Hoffman & Kaplan, 2002).  
CHD continues to be one of the leading causes of infant morbidity and mortality today.  
Five percent to ten percent of all cases of CHD can be attributed to a chromosomal 
abnormality. And another 3%-5% are linked to single gene defects, and approximately 
2% are a result of known environmental factors (Clark, 2001).  With only 10%-15% of 
the causes of CHD are understood, the remaining 85%-90% of all CHD cases, the 
etiologies remain unknown.   
CHD is the most common birth defect in the United States in children and adults 
with approximately 1,040,106 new patients are diagnosed each year (Gibson, Burns, 
Walker, Cross, & Leslie, 2010). Understanding and identifying the risk factors associated 
with CHD is critical in reducing the financial and social constraints placed on the 
individual and society and the individual (Jacobs, Wernovsky, & Elliot, 2007) and 
decreasing the prevalence of CHD.  There are many types of CHD, with many being 
simple such as an atrial septal defect (ASD) to the very complex, hypoplastic left heart 
syndrome (HLHS).  As children with complex CHD survive into adulthood as a result of 
advances in treatment and diagnosis respectively the numbers of adults with complex 
CHD are increasing twofold as well.  It is estimated a lifetime cost for children in the 
U.S. with complex CHD can be in excess of $1.2 billion (CDC, 2010).  In 2004 it was 
estimated that hospital care for all patients with CHD, children and adults, exceeded $2.6 
billion (AHA, 2009). As the adult CHD population grows, researchers predict that 
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numbers of adults with CHD will surpass the number of children with CHD in the next 
decade.  The cost of care for complex CHD produces significant financial strains on 
families, healthcare systems and society that have been recognized as a public health 
problem. These issues have led researchers to gain greater understanding of the etiology 
of CHD development in the fetus thus try to decrease the prevalence.   
Although treatment for CHD has evolved dramatically over the years, it’s etiology 
continues to be elusive. In the past, children born with cyanotic heart disease (causing 
low blood oxygen levels) were treated only with palliative measures with most children 
dying early in infancy.  Of those children who survived, most had significantly shorter 
life spans before diagnostic and surgical technologies were available. Cardiac 
angiography was the first diagnostic tool developed in the 1930’s to visualize cardiac 
malformations.  Shortly after catheterizations, surgical ductus ligation, surgical 
correction, and palliative surgical techniques followed for treatment of cyanotic heart 
defects with great success in the 1940’s (Emmanouilides, 2001).  The first 
cardiopulmonary bypass procedure was successfully performed in 1953.  This novel 
procedure was one of the first doors to be opened for surgical care and treatment of 
congenital heart disease.  These ground breaking diagnostic and surgical techniques 
created a new group of complicated children and adults with a chronic health condition to 
care for in our society (Emmanouilides, 2001).   
 Over the last 75 years, successful advances in the identification of the many 
structural forms of CHD, methods for surgical correction, and palliative procedures have 
dramatically decreased mortality from 50% to almost 15% (Emmanouilides, 2001).  
Although many milestones have been accomplished in the diagnosis and treatment of 
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CHD, the etiology remains elusive.  Epigenetics, the study of the biological processes in 
which heritable genetic changes not found in DNA sequencing influence gene function at 
various stages of development is a growing area of interest in the study of CHD.  The 
environmental exposures incurred over generations and the genetic predispositions to 
specific health conditions such as CHD are areas of great interest for research.  
Identification of biologic, physical and social risk factors for giving birth to an infant 
with CHD in women of childbearing are goals of many researchers and clinicians.   
Through use of animal models and the recent ability to sequence the human 
genome, a greater understanding of the molecular and genetic influences during fetal 
development of the heart has allowed researchers and clinicians the ability to identify 
critical times of vulnerability and target potential interventions.  Pre- and inter-conception 
timeframes are now understood as critical times to focus in the mother’s exposures and 
their influence during fetal cardiac development (Sartiani et al, 2009).  The epigenetic 
factors influencing the activation or inactivation of cardio-specific genes during cardiac 
development are being studied and are better understood.  Therefore the environmental 
exposures that are potentially triggering these cellular processes are of great interest for 
researchers and clinicians due to the multifactorial nature of CHD.  
 Although the exact mechanism of CHD development during pregnancy when a 
women are exposed to some medications, vitamins, alcohol or tobacco use, and some 
environmental toxins is not well understood, there has been an observed risk for CHD 
development in the fetus from these agents (Brent, 2004).  Due to the heterogeneity of 
CHDs in humans and ethical considerations in human studies, understanding the exact 
mechanisms in cardiac formation and CHD development have been complicated.  Several 
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cardio specific genes (GATA, Nkx, Hand, EGFR, Wnt5a), transcription factors (ZIC3, 
NKX2.5, TNX5, GATA4, TFAP2B, TBX1 and FOG2) (Clark, Yutzey & Benson, 2006) 
and epigenetic processes (histone modifications, RNA modifications, and DNA 
methylation) are known to be essential in normal cardiac development.  Researchers have 
identified errors occurring in several genes, transcription factors, chromosomes, and 
single nucleotide polymorphisms that are responsible for specific CHDs in both animal 
models and humans (Bentham & Bhattacharya, 2008; Hinton, Yutzey, & Benson, 2005; 
Huang, Liu, & Lv, 2010; McFadden & Olson, 2002; Reamon-Buettner, Spanel-Borowski, 
& Borlak, 2005).   
Cardiac development is a complicated process of cell proliferation, 
differentiation, migration and morphogenesis creating the potential for disruption of one 
or many of the multiple pathways.  The gene-environmental interaction theory (Nora, 
1968) and its influence of CHD development is complex due to the multifactorial nature 
complicating identification of specific etiological sources of CHD. Researchers and 
clinicians cannot underestimate the various exposures a woman encounters throughout 
her lifetime and the potential impact it may have on her developing infant. As further 
genetic and environmental research is conducted, greater understanding of these complex 
processes may provide nurses and clinicians recommendations for treatments promoting 
preventative prenatal health care practice guidelines for the reduction of CHD and the 
costs associated with its care. 
Specific biologic, physical, and social variables during various times of pre-and 
inter-conception and pregnancy are areas for researchers and practitioners alike to 
intervene and study. The Centers for Disease Control and Prevention have published 
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routine updates on the Public Health Action Plan to Prevent Heart Disease and Stroke 
including investigation of the environmental causes of CHD and cardiovascular disease 
(CVD) (CDC, 2011).  The National Heart, Lung, and Blood Institute (NHLBI) created a 
task force in 2001 specifically focusing on pediatric cardiovascular disease identifying 
research priorities, and scientific opportunities to address the growing public health 
problem of CHD in children and adults (NHLBI, 2002).   
Etiological and epidemiological research are important when trying to identify 
causal sources of CHD.  This type of research has implications for prenatal, pediatric, and 
adult care in counseling and identification of risk factors associated with CHD in these 
groups.  However, this research is also instrumental when transitioning these children 
with CHD into a healthy adulthood.  Health care providers (HCPs) need to provide 
adequate counseling for their reproductive health as some forms of CHD are familial.  
Continued epidemiologic, environmental, and genetic CHD research will assist in the 
identification of the risk factors and causal factors associated with CHD to significantly 
decrease or eliminate CHD in humans (Weinhold, 2004). 
Study Problem and Purpose  
During the review of literature several reviews of maternal risk factors for CHD 
were discovered. These investigators identified specific maternal risk factors for CHD 
but, none of which contained all of the maternal contexts of interest in one study (Gorini, 
Chiappa, Gargani, & Picano, 2013; Luteijn, Brown, & Dolk, 2013; Patel & Burns, 2013; 
Stothard, Tennant, Bell & Rankin, 2009; Jenkins at al., 2007; Thulstrup & Bonde, 2006; 
Watson, Jacobson, Williams, Howard & DeSesso, 2006; Lin & Ardinger, 2005).  The 
genetic research was extensive; however the understanding between environmental risk 
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factors and genetic risk factors remains unknown. The Baltimore Washington Infant 
Study (BWIS) was the only study identified which separated the type of CHD into 
categories of severity and evaluated biologic and environmental risk factors (Ferencz, 
Loffredo, Correa-Villaseñor & Wilson, 1997). 
Pediatric cardiologists around the state of Wisconsin became aware of the 
increasing number of infants born with single ventricle physiology in the late 1990’s. 
After much discussion and review, these cardiologists, and a large interdisciplinary team, 
created the Wisconsin Pediatric Cardiac Registry (WPCR) in 2000.  This database, 
modeled after the BWIS (Ferencz et al., 1997), was created to help identify and track data 
associated with CHD in infants born in Wisconsin.  The goal for creation of this 
comprehensive database was to gain a greater understanding of the influences of maternal 
and paternal exposures before and during the pregnancy that might increase the risk of 
CHD development in the infant. This database includes the temporal, epidemiological, 
and demographic variables that may reflect risk factors for the birth of an infant with 
CHD.  The WPCR project has collected environmental exposure history, family history 
and genetic data for analyzing to aid in understanding the etiology of CHD.   
The WPCR was the first large heart defect database-registry to collect subjective 
and genetic information from histories of mothers, fathers, and infants born in Wisconsin 
with various forms of CHD (Hanson-Morris, Pelech, 2006).  The WPCR was created 
with three overarching goals (Harris et al., 2011): 
1.  Ascertain all families with an infant/child born with a congenital heart 
defect in the state of Wisconsin and provide a detailed phenotypic 
description of the anomaly.    
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2. Obtain both DNA samples and complete questionnaires from all 
ascertained families and also a control group. 
3. Initiate and promote collaborative research into genetic and environmental 
etiologies of CHDs, utilizing data and specimens from the WPCR (p. 24). 
Over the last 15 years several publications using the data from the WPCR have 
been presented.  An overview of the structure of the WPCR and goals for the collection 
of the data and potential for studies using the data within the WPCR were published by 
Cronk et al. (2003), Hanson-Morris and Pelech (2006), and Harris et al. (2011). In Cronk 
et al’s two studies (2004, 2011) geographical distribution of several types of CHD were 
explored in Wisconsin using data from the WPCR database. Presently, there are no 
published studies using the maternal data from the WPCR.   
The first goal of the WPCR was most pertinent to this study. It is estimated that 
CHD prevalence is 0.5%-0.8%, or approximately 400-600 new cases each year occur in 
Wisconsin (Hanson-Morris & Pelech, 2006). In this study the completed questionnaire 
data were used to evaluate relationships between maternal demographics and exposures 
prior to and during the pregnancy and the type of CHD of their infants.  There have been 
no published results from 2000-2010 using WPCR data examining maternal factors for 
risk of type of CHD. In the literature the majority of studies have identified maternal risk 
factors for CHD development for the general population. Few studies have identified risk 
factors associated with the type of CHD.  
 The BWIS was the first large population based study to examine the risk factors 
of CHD development in the general population.  This study also examined the 
relationships between the genetic and environmental risk factors and the various CHD 
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phenotypes (Ferencz et al., 1997). The BWIS found evidence of increased risk with 
certain types of CHD and hypothesized that certain risk factors may be more prevalent 
during particular times of cardiac formation. The BWIS demonstrated an increased risk 
for laterality/looping defects (OR 8.3, 95% CI 3.0-23.0), atrioventricular septal defects, 
nonchromosomal (OR 10.6, CI 3.7-30.6), and cardiomyopathy (OR 11.5, CI 4.4-29.8) 
when maternal diabetes was present (Ferencz et al., 1997). They also found increased risk 
for specific types of CHD when several other maternal variable were present including 
history of fever, influenza, family history of CHD, maternal age > 30years, and use of 
diazepam. 
The current study examined maternal risk factors related to complex CHD in 
these infants as this question has not been examined to date. A power analysis based on 
the work of Peduzzi et al. (1996) was performed to determine adequacy of size of the 
sample.  Using the formula of N=10k/p (k=number of covariates) (p=the smalls of the 
proportion of negative or positive cases) N=10(15)/.3, N= 500; 500 cases were required 
for this study.  With 1,687 completed questionnaires available adequate power to 
determine relationships among the variables was present. Hypotheses were derived from 
a review of literature and review of the information collected by the WPCR. This study 
may provide identifiable and modifiable risk factors for women with history of an infant 
with CHD to decrease the risk for having a subsequent pregnancy affected by CHD.  
Maternal health and exposures have also been associated other birth outcomes 
including birth weight and gestational age. Low birth weight and early gestational age 
have been associated with certain maternal risk factors such as chronic health conditions 
(Palmer, Bonzini, Harris et al., 2013), history of smoking (Ashford et al.,  2010; Rogers, 
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2009) , and socioeconomic status (Blumenshine, Egerter, Barclay, Cubbin, & Braveman, 
2010; Jansen et al., 2008; Messer et al.,  2008). In this group of infants with various types 
of CHD, it is hypothesized that these maternal risk factors are also associated with the 
infants’ birth weight and gestational age as well as type of CHD.  It is important for 
women to optimize their health prior to and during pregnancy to decrease the risk for low 
birth weight and premature birth.  Infants with complex CHD were also believed to be at 
greater risk for low birth weight and prematurity due to the complexity of CHD diagnosis 
(Williams et al., 2010; Malik, Cleves, Zhao, Hobbs, & NBDS, 2007).  
The same questionnaire was used consistently from 2000-2010, thus providing 
large amounts of data to be explored.  In 2006 a control group was initiated to provide 
comparisons of children without CHD. However, there were never enough control 
subjects to meet the goal of the registry.  The majority of the comparison groups were 
older children or teenagers found to have normal cardiac structures on echocardiography, 
with approximately 270 controls available. There were approximately 50 controls who 
completed a questionnaire that was an abbreviated version if over the age of two years.  
These children were older therefore their parents were less likely able to complete the 
questionnaire accurately, due to recall issues. Therefore in this study the control group 
was not used.  The genetic information collected was not used for this study. 
 A secondary analysis of the maternal context variables in the WPCR was 
completed using this large data set collected over the last 10 years.  Through 
identification of the relationships between these maternal context variables and the 
outcome or type of CHD nurses and researchers may be provided with new evidence of 
risk factors in this population.  From a critical review of literature of the contextual and 
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genetic maternal risk factors for CHD development, a specific aim was developed with 
two hypotheses to be tested and one exploratory research questions to be posed.  The 
specific aim of this study was to examine the relationships of select maternal context 
variables to the type of CHD (simple or complex), birth weight and gestational age in 
infants born with CHD participating in the WPCR.   
Theoretical Framework  
 The central tenets of nursing include person, environment, health, and nursing 
(Flaskerud & Halloran, 1980; Yura & Torres, 1975).   Nursing has a goal to provide a 
holistic model of healthcare delivery incorporating research findings to guide practice.  
Both nursing and the life course theory have a goal of improving health and 
understanding disease processes.  Therefore a life course perspective on health was 
chosen as a theoretical model to guide this study as this theory conceptualizes health as a 
reflection of an underlying developmental trajectory.  The goal of the life course 
perspective is to understand, explain, and improve health and disease patterns across 
various populations (Halfon & Hochstein, 2002).  The key concepts of the life course 
theory include:  
 Timeline – health is cumulative and longitudinal, i.e., developed over a lifetime. 
 Timing - health and health trajectories are particularly affected during 
critical/sensitive periods. 
 Environment – the broader environment (biologic, physical, and social) affects 
health and development. 
 Equity – health inequality reflects more than genetics and personal choice. (Fine 
& Kotelchuck, 2010). 
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 The life course perspective uses a multidimensional approach incorporating 
biological, psychological, behavioral, and social contexts to explain health and disease 
processes allowing for intervention and education identifying risk and protective factors 
(Fine & Kotelchuck, 2010).  This perspective acknowledges throughout the 
developmental trajectory, that some contexts are fixed or hard wired, and others contexts 
are highly flexible or plastic and amenable to change.  The life course perspective fits 
well in the study of CHD as many of the contexts are both fixed and plastic occurring 
along a developmental trajectory. Although this study was cross sectional, the data 
provided various points in the periconceptual timeframe and throughout the pregnancy to 
evaluate the relationships to CHD.   The life course model recognizes the epigenetic 
nature of diseases and appreciates how today’s experiences and exposures determines 
tomorrow’s health.   Those health trajectories are particularly affected during critical or 
sensitive periods (timing) and the broader environment - biologic, physical, and social 
contexts – significantly affects the ability to be healthy (environment) (Kotelchuck, 
2011). 
 A brief description of the proposed life course perspective is presented to explain 
the complex and overlapping relationships of maternal contexts to infant birth outcomes 
through the developmental trajectory of periconception to birth (Figure 1).   The maternal 
contexts are divided into three contexts; biologic (known genetic causes associated with 
CHD, age, race, chronic health conditions (CHC), family history of CHD), physical 
(obesity, ETOH/drug use, cigarette use, medication/vitamin use, type of water 
consumed), and social contexts (socioeconomic status (SES), occupation, education 
level).  The maternal contexts include fixed and modifiable factors of the maternal 
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environment or context both in the periconceptual phase and throughout pregnancy. It is 
understood that some contexts are unable to be changed such as the genetic contexts, and 
some contexts are amenable to change directly by choice of the mother such as the 
behavioral contexts.  The social contexts have some ability for change in this model.   
However, some of the variables are influenced by a combination of maternal choices and 
a community level influence as well.   The purpose of this study was to explore the 
relationships of select maternal variables to the type of CHD, birth weight and gestational 
age in infants born with CHD participating in the WPCR using a life course perspective.  
The hypotheses evaluated were: 
Hypotheses 
Hypotheses 1:  Multiple maternal risk factors of  biologic (known genetic causes 
associated with CHD, age, race, chronic health conditions, family history of CHD), 
physical (history of obesity, use of alcohol, drugs, cigarettes, medication/vitamin use, and 
type of water consumed), and social variables (SES, occupation, education level) 
influence the risk of complex CHD. 
Hypothesis 2: Multiple maternal risk factors (biologic, physical, social) influence the 
risk of low birth weight or early gestational age in the infants born with CHDs. 
Definition of Terms 
Maternal Contexts   
 Maternal contextual factors are the biologic, physical and social contexts specific 
to the mothers of infants born with CHD. Maternal biologic context variables studied 
include:  known genetic causes associated with CHD, maternal age, race, history of 
chronic health conditions, and family history of CHD. 
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Biologic:  Biologic maternal context variables are the maternal variables which are 
inherent only to the mother and are not modifiable prior to or during the pregnancy.  The 
biologic variables being studied include:  Known genetic causes associated with CHD, 
maternal age, race, history of chronic health conditions, and family history of CHD.  
 Known Genetic Causes Associated with CHD:  There is a higher prevalence of 
CHD associated with specific syndromes or genetic abnormalities.  In these 
syndromes the type of CHD is sporadic if present, degree of severity, and is 
related to the heterogeneous nature of CHD (Huang, Liu, Sun, Lv, Du, & Fan, 
2010).   
Age:   Age is the part of life from birth to a given time. An individual's development 
measured in terms of the years requisite for like development of an average individual 
(Merriam-Webster Medical Dictionary, 2012).   
 Race:  Race is based on the premise of physical and biological differences, 
whereas ethnicity is based upon behavioral and cultural differences of groups with 
no biological underpinnings and can be sometimes mistakenly used 
interchangeably.  Race is defined as a self-identification data item in which 
respondents choose the race or races with which they most closely identify 
(Federal Office of Management and Budget, 2000).  
 Chronic health conditions:  A chronic health conditions lasts longer than 3 - 6 
months, is biologically based, has a significant impact on the life of a person, and 
requires more than usual access to healthcare services for support (The Council 
for Children and Adolescents with Chronic Health Conditions, 2005). Maternal 
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hypertension, diabetes, and epilepsy and mood disorders have been associated 
with greater risk for CHD (Liu et al., 2013).   
 Family history of CHD:  Having a first degree relative with a structural form of 
CHD increases risk for CHD in offspring (Bentham & Bhattacharya, 2008; Clark, 
1996).  Maternal history of CHD was significant risk factors for CHD in their 
infants (Liu et al., 2013). 
Physical:  Maternal physical context variables are variables which are modifiable 
behaviors of the mother prior to or during the pregnancy.  The maternal physical 
variables studied include:  History of obesity, ETOH and /or drug use, cigarette use, 
medication and/or vitamin use, and type of water consumed. 
 Obesity:  Obesity is a condition that is characterized by excessive accumulation 
and storage of fat in the body and is indicated by a body mass index of 30 or 
greater (CDC, 2012) A normal range for BMI is 18.5-24.9 (NIH, 2014).  
 Drug/alcohol use: Alcohol and drug use is defined as consumption of alcoholic 
beverages including beer, wine, and spirits and/or illicit drugs on a weekly basis 
(Strandberg-Larson at al., 2011).   
 Cigarette use:  Cigarette or tobacco use is defined as smoking/using of 
cigarettes/tobacco products on a daily basis (Karatza et al., 2011). 
 Medication/vitamin use:  According to the Food, Drug, and Cosmetic Act (2002) 
a drug is a substance recognized in an official pharmacopoeia or formulary; or a 
substance intended for use in the diagnosis, cure, mitigation, treatment, or 
prevention of disease; a substance other than food intended to affect the structure 
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Figure 1. Life course Conceptual Framework 
 
16 
 
 
 
or function of the body; or a substance intended for use as a component of a 
medicine but not a device or a component, part, or accessory of a device.   
 Type of water consumed: Ingesting contaminated drinking water has been 
associated with increased risks for birth defects (Watson, Jacobson, Williams, 
Howard & DeSesso, 2006).   Contaminated drinking water is a growing concern 
in many industrialized and industrializing nations due to increased population 
demands for products.   
 Social:  Social maternal context variables are the social influences or immediate 
community variables of the mother.  The social contexts can be influenced by maternal 
choice and/or sociological influences of the immediate community surrounding these 
mothers.  The social maternal variables studied include:  maternal socioeconomic status, 
occupation, and education level. 
 Socioeconomic Status:  Socioeconomic status is a combination of income level, 
educational level, and community income level (Luo, Wilkins, Kramer, & 
FIHSG, 2006).  
 Occupation:  Occupation can include paid and unpaid work history, job tasks, 
type of industry, and materials handled or machinery used (Shaw, Nelson, 
Iovannisci, Finnell, & Lammer, 2003).   
 Educational Level:  Educational level is the amount of school achieved/ 
completed by the mother (Alverson, Strickland, Gilboa, & Correa, 2011).  
Infant Outcomes:   Infant outcomes are the birth outcomes of the infant born 
with CHD.   Infant birth outcomes being studied include: type of CHD either simple or 
complex, birth weight, and gestational age. It was believed that the more complex the 
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CHD the greater the risk for prematurity and low birth weight would be observed.  In the 
literature, CHD has been associated with small for gestational age and lower birth 
weights (Malik, Cleves, Zhao, Hobbs & NBDS, 2007). 
 Type of CHD (simple or complex): CHD can be classified in many different 
methods including anatomical classifications or cyanotic heart disease (Kornosky 
& Salihu, 2008; Mitchell, Korones, & Berendes, 1971),  pathogenic 
classifications (Botto & Correa, 2003; Ferencz et al., 1997; Clark, 1996; Marelli, 
Mackie, Ionescu-Ittu, Rahme & Pilote, 2007), structurally significant verses 
insignificant (Ferencz et al., 1997; Grech 1999; Pradat, Francannet, Harris & 
Robert, 2003; Teun van der Bom et al., 2011), with or without genetic mutation 
(Lin & Ardinger, 2005; Pradat, Francannet, Harris & Robert, 2003) or surgical 
classifications (Jacobs et. al. 2007).  In this study CHD was separated into either 
simple or complex and was identified from ICD-9 codes. Simple CHD consisted 
of single diagnoses of CHD, and/or did not cause significant cyanosis, and/or did 
not require immediate hospitalization or surgical intervention within the first year 
of life. Complex CHD consisted of multiple CHD diagnoses, and/or were 
cyanotic lesions, and/or required hospitalization or surgical intervention within 
the first year of life. Based upon  past research simple CHD consists of isolated 
CHD including; atrial septal defect (ASD), ventricular septal defect (VSD), 
pulmonary stenosis (PS), aortic stenosis (AS), bicuspid aortic valve (BAV), 
coarctation of the aorta (COA) and mitral valve (MV) disease.  Complex CHD 
consists of single or multiple diagnosis including; Tetralogy of Fallot (TET), 
atrioventriculoseptal defect (AVSD), transposition of the great arteries (TGA), 
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pulmonary atresia (PA), hypoplastic left heart syndrome (HLHS), and 
univentricular heart disease or variants including multiple lesions. 
 Birth Weight:  Weight at birth is defined as pounds and ounces or kilograms.  
Birth weight can be categorized into very low (<1500g), moderately low (1500-
2499g), and normal birth weight (2500g+) (Nembhard, Salemi, Loscalzo, Wang, 
& Hauser, 2009).  
 Gestational Age:  Gestational age is defined as the time from conception until 
birth or the number of weeks from the first day of the mother's last menstrual 
period (LMP) until the birth (Engle, 2004).  Gestational ages are assessed by the 
date of the LMP and by physical exam using the Dubowitz/Ballard examination 
score (Engle, 2004).  By definition, moderate to late preterm is considered < 37 
weeks gestation, very preterm (28 to < 32 week) and extremely preterm (< 28 
weeks) (WHO, 2013).   
Time:  The trajectory of time includes the periods of periconception and includes all time 
up until the birth of the child with CHD. 
Methods 
 This study was an exploratory secondary analysis of the maternal biologic, 
physical, and social contexts and their relationships to gestational age, birth weight and 
types of CHD in these infants.  Using a Life course model (Fine & Kotelchuck, 2010) to 
guide this research, associations or relationships between the maternal variables and 
greater risk for complex CHD in their infants were assessed separating CHD into either 
simple or complex CHD. Descriptive analyses provided correlations and identification of 
relationships of the maternal context variables to the birth outcomes of the infants.  From 
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these analyses logistic and multiple regression were used to test the hypotheses and 
answer the research questions posed. Approval was obtained from Children’s Hospital of 
Wisconsin (CHW) Internal review Board as an exempt study (Appendix E) as consent to 
participate was previously provided in the original study conducted at CHW and no 
patient contact was required. All data provided to the investigator were de-identified and 
maintained or accessed on a secure computer. 
As the WPCR was adapted from the BWIS, a modified approach from the BWIS 
to categorize the simple and complex CHD was utilized. The dependent variable of 
simple or complex CHD was derived from multiple classification techniques (Calzolari et 
al., 2003; Hoffman, & Kaplan, 2002; Warnes, et al., 2001; Ferencz et al., 1997) used to 
categorize severity of CHD in both children and adults. Many struggle to classify CHD as 
there are countless forms of severity and CHD has a heterogeneous nature. Some forms 
of CHD may not be symptomatic or identified until later in life causing no health 
changes, whereas other forms of CHD can be life threatening and cause many health 
changes throughout one’s life with detrimental effects.  
In the WPCR all CHD was diagnosed before 2 years of life by a pediatric 
cardiologist identifying various severity levels of CHD, some requiring interventions and 
other CHD spontaneously resolving. Therefore the various severity levels in the WPCR 
should be well represented over the last 10 years. In the BWIS the researchers 
categorized etiologic CHD into primary and secondary cardiogenesis defects and from 
the exposures, demographic information and medical history of the parents identified 
significant risk factors of CHD. In the BWIS they classified the CHD into six “pure” 
diagnoses and used severity ratings based upon echo results to assign case severity for 
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pulmonary stenosis, aortic stenosis, ventricular septal defect, and bicuspid aortic valve 
using echo. As an adequate control group is not available for use within the WPCR, to 
replicate the BWIS, and compare normal infants to infants with CHD, the independent 
variable of CHD was divided into either simple or complex CHD. Other studies have 
categorized CHD into simple, moderate and complex CHD (Calzolari et al., 2003; 
Hoffman and Kaplan, 2002; Warnes et al., 2001) to describe the incidence and outcomes 
of each type of CHD.  As many of the simple CHD can go undetected it is difficult to 
determine precise incidence and possible risk factors.  
It was hypothesized that the multiple maternal risk factors of  biologic (known 
genetic causes associated with CHD, age, race, chronic health conditions, family history 
of CHD), physical (history of obesity, use of alcohol, drugs, cigarettes, 
medication/vitamin use, and type of water consumed), and social variables (SES, 
occupation, education level) would  influence the risk of simple or complex CHD. A 
variety of statistical analyses including descriptive statistics, correlations, and regressions 
were used.  For hypothesis 1; a logistic regression analysis was undertaken and for 
hypothesis 2 a multiple hierarchical was proposed and performed. 
 It is recognized that the data in the WPCR were collected prior the development 
of this study and may have limitations but also has several benefits.  A significant benefit 
for using the data within the WPCR database was the large sample size that was collected 
over a decade.  Pre-existing datasets may be useful to address hypotheses and research 
questions of interest and can provide a practical component to the researcher to advance 
science (Campbell, 2007).  This dataset allowed investigation of the maternal risk factors 
not previously examined in this database. The WPCR database has been active for well 
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over a decade providing a robust sample which may not be available to most novice 
researchers. This sample provided a collection of maternal and infant variables including 
demographic, socioeconomic, personal health history and environmental exposure history 
in families affect by CHD. Using a large data can also have limitation such as 
unfamiliarity with the methods of storage, accessibility of the variables in print and 
electronic forms and knowledge of the maintenance practices (Aponte, 2010). Thus care 
should be applied in the results of the studies performed. The researcher must be cautious 
in the implications for inference of causal relationships between these variables in the 
development of CHD, as specificity and dose response cannot be elicited from the 
measures used in the WPCR.  
A limitation of the registry was lack of a robust control group which precluded the 
investigation of factors related to CHD. The families in the small control group were 
systematically different than the families in the CHD sample. First the children in the 
control group were significantly older than the CHD sample; most of the children were 
10 years older than those in the CHD sample. Second the recruitment of the control group 
was initiated in 2006 well after the original study began in 2000.  Recall for 
questionnaires would be greatly compromised by the time interval as the comparison 
children were over two years of age.  However, the large sample of mothers and their 
infants with CHD was useful in the investigation of the three outcomes, type of CHD, 
birth weight and gestational age. The WPCR was appropriate for this secondary analysis 
because of sample was large, the data were accessible and there was sufficient variability 
within the data to address the proposed hypothesis (Aponte, 2010).   
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 Although the data were not collected with a specific research question in mind, 
the WPCR was designed to allow researchers and clinicians access to temporal, 
environmental, familial, and genetic data to explore relationships of potential causative 
factors of CHD which is congruent with my specific aim.   The researcher must be 
cognizant of ethical and practical concerns when determining fit of the data to their 
research questions (Campbell, 2007).  High impact questions, such as substance use, 
comprehensive social and medical histories, and data containing infant or child 
information may be out of reach of most researchers due to time or financial constraints, 
but can be probed by secondary analysis that may allow for discovery of problems or 
concerns within the original research (Smith et al., 2010).  Understanding problem areas 
in the primary research may allow for adjustments of future research targeting a new and 
more focused research question. 
Study Summary 
There is undeniable evidence that CHD is the most prominent and costly birth 
defect in the United States.  CHD significantly contributes to the infant, child, and adult 
morbidity and mortality rates and places substantial financial burdens upon the 
individuals with CHD, medical providers and intuitions, and governmental resources 
necessary to support treatment and care for this chronic health condition.  Emphasis on 
primary and secondary prevention has been stressed and recommendations are necessary 
in the education to decrease risk factors for CHD of young child bearing aged individuals 
both male and female.  
 A review of literature was performed to gain a greater understanding and 
identification of the maternal risk factors for all CHD.  In this review it was 
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acknowledged that the literature was separated into the various maternal risk factors and 
did not provide a comprehensive review for all the maternal context variables measured 
in this study.  Small samples with methodological flaws and inability to accurately 
measure the variables relationships with greater risk for complex CHD were identified in 
this process. Only one study was found addressing the risk factors for simple verses 
complex CHD, a gap this study was designed to address.  It was also recognized that the 
genetic influence toward CHD must be elaborated separately to best appreciate the 
influence on CHD development.  
 Nursing is a leader in prevention, education, and care of humans with various 
diagnoses including complex CHD.  Research focusing on maternal context variables and 
risk for complex forms of CHD may provide knowledge for women of child bearing age 
to the known environmental risk factors associated with CHD and aid in early detection 
of complex CHD if exposed.  Timing of an intervention is of essence as the fetal heart is 
formed within the first trimester of pregnancy, most often when the woman is unaware of 
the pregnancy. Education or knowledge development of young child bearing individuals 
during the time before conception may be key for avoidance of specific environmental 
exposures which may enhance the risk of giving birth to a child with complex forms of 
CHD.    
With a greater understanding and appreciation of the mechanisms associated with 
gene-environment interactions during the processes prior to and during cardiogenesis (the 
development of the heart in the embryo) researchers and clinicians can facilitate new 
interventions in practice and research questions. These innovative ideas and practice 
changes may assist in decreasing the incidence of complex CHD.  Decreasing known 
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environmental exposures and increasing positive heath care practices may help reduce the 
number of children born with all forms of CHD.  Data was collected with a goal to 
provide the ability to test for relationships amongst the genetic, epidemiologic, temporal 
from the participants. From these results, it is hoped that identification of possible 
etiologic sources for CHD development in the infant is discovered. It is anticipated that 
this study will provide a greater understanding of the maternal contexts associated with 
complex CHD, birth weight and gestational age in these infants.  
Manuscripts 
 This dissertation is composed of an introductory chapter, three manuscripts 
(Chapters 2, 3, 4) and a chapter discussing the implication of the findings (Chapter 5). A 
review of literature is provided in chapter two and includes the first manuscript titled 
“Association of Maternal Risk Factors and Congenital Heart Defects”.  This manuscript 
synthesizes maternal risk factors for giving birth to an infant with CHD, gaps in the 
literature and implications for clinical care.  Chapter three is comprised of the second 
manuscript titled “Understanding Genetics and Pediatric Cardiac Health”.  This 
manuscript provides a review of known genetic factors on risk of CHD formation in the 
infant.  Future implications for study and practice are provided in this manuscript. 
Chapter four is the third manuscript titled, “Maternal Health and Infants Born with 
Congenital Heart Disease: A Secondary analysis of the WPCR”. In this manuscript the 
methods and results as well as study limitations are presented.  Chapter five provides an 
in-depth discussion of the results including implications for practice and policy. 
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CHAPTER 2 
 
Chapter Introduction 
 
 The purpose of this chapter is to provide a review of the literature related to the 
maternal context factors associated with CHD. This review was conducted to obtain a 
general understanding of the maternal risk factors for all CHD. The focus of this chapter 
will be the maternal environmental risk factors for CHD development in the infant. Using 
a life course perspective the maternal contexts will be arranged in a biologic, physical 
and social construct. This chapter is comprised of a systematic review in the format of an 
article to be submitted for journal submission. The referencing style of this target journal 
will be applied in this manuscript. 
Manuscript 1:  Association of Maternal Risk Factors and Congenital Heart Defects: 
State of the Science  
Abstract 
Aim and objective.  Guided by the life course model, this review summarizes the state of 
the science about the contextual maternal risk factors for giving birth to an infant with 
congenital heart defect (CHD).  
Background. CHD is the most prevalent birth defects worldwide occurring in 
approximately every 6-8 per 1,000 live births.  Only 10-15% of the CHD etiology is 
known, and are primarily genetic syndromes and disorders. The remaining 85-90% of 
CHD is thought be influenced by the environment. 
Design.  Systematic literature review using PRISMA guidelines. 
Method. Studies included in this review were identified through a Medline search which 
included studies published from 2008-2013. The articles (N=39) were analyzed to 
26 
 
 
identify the contextual maternal risk factors for CHD and were categorized into biologic, 
physical, and social environments using a life course perspective.   
Results. Multiple maternal risk factors for CHD development in the infant were 
identified in the maternal biologic, physical and social environments.  
Discussion. Women of childbearing age have the ability to optimize their health prior to 
pregnancy, thus reducing risk for CHD in their infants. Identification and discussion of 
risk factors is critical in early pre conceptual and prenatal care. 
Conclusions.  This review highlighted the contextual maternal risk factors for CHD in 
the pre-and inter-conceptual timeframes. There are many complex genetic and 
environmental interactions which influence CHD development. Further research is 
needed to better understand the risk factors for CHD. 
Relevance and clinical practice. The contextual maternal risk factors for CHD in the 
pre- and inter-conception timeframes were discussed and described allowing nurses and 
healthcare professionals the ability to provide education to their families of childbearing 
age thus reducing risk for having an infant with CHD. 
Key Words:  CHD, maternal risk factors, pre-conception, inter-conception, life course 
model. 
Introduction 
 Congenital heart defects (CHD) are the most prevalent birth defects worldwide 
occurring in approximately every 6-8 per 1,000 live births (Hoffman & Kaplan, 2002).  
CHD is one of the leading causes for infant morbidity and mortality, with only 10% to 
15% of the CHD etiologies understood.  Of all CHD, 5% to 10% can be attributed to a 
chromosomal abnormality, 3% to 5% are linked to single gene defects, and 
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approximately 2% are a result of known environmental factors (Clark, 2001).  For the 
remaining 85% to 90% of CHD cases, the etiologies remain unknown.   
 Although there has been extensive research on genetic risk factors for CHD, there 
is much less understanding of maternal environmental factors. Past and present research 
continues to support the gene-environment interaction theory (Nora, 1968), in which both 
genetic predisposition and environmental factors are responsible for the majority of CHD 
(Mone et al. 2004, Lin & Ardinger, 2005, Hobbs et al. 2010).   Some researchers have 
focused on specific disease processes such as maternal diabetes (Ferencz et al. 1997, , 
Lisowski et al. 2010),  lifestyle choices such as cigarette smoking (Grewel et al. 2008, 
Hackshaw et al. 2011), or other exposures such as chemical exposures within the home or 
workplace (Watson et al. 2006) for increased risk of CHDs.  Although there is some 
evidence there are exposures that are related to CHD development such as rubella, 
thalidomide, cigarette, drug, and ETOH during early pregnancy (Brent, 2004) the exact 
mechanism is not well understood.   
 Some researchers have focused on specific exposures and the development of 
CHD throughout pregnancy, for examples exposures to maternal illnesses, cigarette, 
drug, and ETOH (Mone et al. 2004).  A greater understanding of the critical time frames 
prior to and during CHD development have been identified; the pre-conception and inter-
conception periods (Liu et al., 2013).  Researchers are now appreciating the impact of the 
pre-conceptual exposures, particularly in the three months before pregnancy and risk for 
CHD development in the fetus (Jenkins et al. 2007).  Several reviews specifically 
addressed the nongenetic (Patel et al. 2013), non inherited (Jenkins et al. 2007), effects of 
contaminated drinking water (Bove et al. 2002, Watson et al. 2006), environmental 
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exposures (Thurlstrup et al. 2006) and environmental pollution (Gorinini et al. 2014) and 
risks for CHD.  These reviews selected specific risk factors not all with a focus on 
maternal risk factors for CHD therefore the present analysis was conducted to better 
understand the maternal context risk factors for CHD development.  All of the reviews 
acknowledged that the risk factors of CHD development require further investigation due 
to several concerns such as small sample sizes, inability to perform exact measurement of 
exposures, and confounding variables which may have influenced results. 
A Life Course Perspective 
 The life course perspective uses a model that helps explain the processes of health 
and disease patterns across populations and time (Fine & Kotelchuck, 2010).  With the 
premise that today’s choices affect tomorrow’s health (timeline), there are critical and 
sensitive periods (timing), that biological, physical, and social contexts (environment) as 
well as healthcare access (equity) affect the outcomes of health (Fine & Kotelchuck, 
2010). These multiple trajectories have complex interactions, which over a lifetime can 
be influenced in both positive and negative manners changing ones health and health 
choices.  As CHD is believed to be a complex multifactorial process a life course 
perspective was chosen to illustrate the interactions between the contextual maternal risk 
factors. The genetic syndromes and chromosomal abnormalities associated CHD were 
not included in this review. 
The maternal context variables have multidimensional relationships across time, 
which allows for categorizing the various risk factors into these contexts.  The biologic 
maternal contexts are fixed and although genetically inherited, are not defined by a 
specifically known gene or chromosomal abnormality associated with increased risk of 
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CHD. These variables are thought to be preprogrammed or difficult to change with 
lifestyle modifications and/or choices.  Physical maternal contexts are categorized by the 
physical influences or choices of the mothers which increase may the risk of CHD in 
their infant.  The physical contexts are thought to be modifiable physical choices of the 
mothers such as alcohol or drug use as examples.   Social maternal contexts are those 
contexts influenced both by maternal choice and the sociological influences of the 
immediate community surrounding these women. The social maternal contexts are 
usually not easily modified or quickly changed but can assist in identifying at risk 
populations.  
Aim 
The purpose of this review was to identify and summarize the current literature on 
contextual maternal risk factors associated with giving birth to a child with CHD.  The 
life course perspective was used as the organizational framework used to guide this 
review. 
Methods 
Using PRIMSA guidelines a review of literature was conducted. A search was 
conducted using three databases, Medline, CINAHL, and ESBCOhost and the MESH key 
terms; congenital heart defects (CHD), maternal risk factors for CHD, and congenital 
birth defects. Inclusion criteria were studies published in English after 2007 that provided 
evaluation of maternal risk factors for CHD. A total of 164 articles were identified – all 
from Medline database. A flow diagram of the review and inclusion process is provided 
(see Figure 1). To ensure the search was comprehensive the key words above were 
combined with the following key terms: smoking, alcohol, substance use, educational 
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status, occupation, socioeconomic status, and lifestyle which elicited an additional 11 
articles after duplicates and articles which were not relevant were excluded.  Included in 
the review were articles were obtained from reference lists of studies from the original 
search or reviews which included seminal research or articles published after 2007. Case 
control, retrospective and prospective studies, population studies and meta-analyses were 
included in the final analysis. Two articles published in 2004 were retained for the review 
as there were limited findings in illicit drugs and water consumption. A total of 39 
articles were retained for this review. In Tables 1, 2, and 3 the biologic, physical and 
social maternal contexts variables are summarized into the categories, author, description 
of the study and findings, specifically prevalence if provided and odds ratios/risk ratios 
prevalence showing relationships of these variables to risk for CHD development.  
Studies are presented by topic and alphabetically by first author. 
Results  
Biologic maternal contexts.   
 Maternal age.  Analyses from several large congenital defect registries within the 
United States and Canada have identified an increased risk for infant CHD if their mother 
was > 35-40 years of age (Long et al. 2010, Miller et al. 2011, Liu et al. 2013).  The 
prevalence of CHD in advanced maternal age (>35 years) was found to be about twice 
the normal prevalence of CHD (6-8/1,000 live births) in these studies.  An as association 
of advanced maternal age (>35 years) and specific types of complex CHD in the infants 
such as Tetralogy of Fallot, truncus arteriosus, coarctation of the aorta, and transposition 
of the great vessels were identified in two large population studies in Atlanta and Texas 
(Long et al. 2010, Miller et al. 2011). 
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 Maternal race.  Race is based on the premise of physical and biological 
differences, whereas ethnicity is based upon behavioral and cultural differences of groups 
with no biological underpinnings.  Race is defined as a self-identification data item in 
which respondents choose the race or races with which they most closely identify 
(Federal Office of Management and Budget, 2000). It is important to note in some of the 
studies reviewed race and ethnicity were used interchangeable. 
 Greater CHD prevalence was found in non-Hispanic White women in three 
studies (CDC 2010, Mangones et al. 2010, Miller et al., 2010). Although, these studies 
found greater prevalence in non-Hispanic white (NHW) women overall, Nembhard et al. 
(2010) reported similar rates of CHD in NHW, non-Hispanic-Black (NHB) women and 
Hispanic women in their retrospective study using the Florida Birth Defects data. In the 
CDC’s report (2010) it is important to note, the rates of CHD prevalence was less in 
NHB women.  However, the mortality rates in term infants in this group were higher than 
the NHW group (1.5 per 10,000 compared to 1.3 per 10,000).  
 The research reviewed provided evidence of racial/ethnic differences in rates of 
CHD with predominance in NHW women.  These studies reported these populations had 
higher numbers of white women and less racial diversity which may provide an 
explanation for their findings.  It is also important to recognize the differences in birth 
outcomes among the groups and higher rates of mortality in the NHB women. Although 
higher prevalence of CHD is found in NHW women, their birth outcomes are better than 
NHB, and Hispanic women. 
 Maternal chronic health conditions.  Maternal chronic health conditions can 
encompass a multitude of disease processes and several were associated with increased 
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risk for CHD development in the fetus.  Febrile and viral illnesses were associated with 
3.4 to 5 fold increased risk of CHD, particularly right sided obstructive lesions, when the 
mother has encountered this illness within three months prior pregnancy or within the 
first trimester in the infants in the Baltimore Washington Infant Study (Oster et al. 2011). 
Luteijn and Dolk (2013) found 1.5-2.5 fold risk for CHD if the mother had history of 
influenza within the first trimester of pregnancy.   The use of antibiotics and 
antihypertensives (OR 2.6-3) in the first trimester were associated with increased risk of 
CHD (Zen et al. 2011). 
Maternal diabetes was reported to increase risk of CHD in infants four times that 
of normal infants (Liu et al. 2013).  Persistent truncus arteriosus, transposition of the 
great vessels, conotruncal abnormalities and single ventricle physiology were particularly 
likely to occur. These infants were found to have a two to 18 fold increased risk if the 
mother had poorly controlled gestational diabetes in the first trimester of pregnancy. Co- 
morbid conditions such as connective tissue disorders (3.01; 95%, 2.23-4.06), 
hypertension (OR 1.81; 1.61-2.03), and obesity (OR 1.15-1.3) have also been associated 
with greater risk of CHD in the infant (Lui et al. 2013, Mills et al. 2010, Stochard et al. 
2011).   
 Family history of CHD.  The risk of having an infant with CHD was found to be 
2-4% greater if related to a first degree relative with known CHD (Fesslova et al. 2011, 
Fung et al. 2013, Hinton et al. 2007).  If more than one family member was diagnosed 
with a CHD, the concordance rate was higher still (55%) in the study of probands 
(individual affected by a disorder) with HLHS, reporting an almost 4 fold increase of 
CHD in first degree relatives (Hinton et al. 2007).   Swaby et al., (2011) showed similar 
33 
 
 
findings in their study of increased heritability of varying forms of CHD in relatives of 
adults with known 22q11.2 deletion syndrome (OR 4.43-5.88). With the greatest risk (RR 
2.68-48.6) found for heritable CHD in first relatives for variable forms was found in a 
large Danish cohort study (Øyen et al. 2009). 
Physical maternal contexts.   
 Maternal obesity.  Obesity is a chronic condition of great public health concern 
in all ages. However, in pregnancy obesity has been associated with poor birth outcomes 
and greater risk for congenital birth defects including CHD (Arias & Brown, 2010, 
Hobbs et al. 2010, Mills et al. 2010, Stothard et al. 2011, Baardman, et al. 2012). 
Maternal obesity is a factor found to have a small to moderate risk (OR 1.1-1.43) for 
CHD development in the infant (Arias & Brown, 2010, Hobbs et al. 2010, Mills et al. 
2010, Stothard et al. 2011, Baardman, et al. 2012).  Some investigators found an 
associated increased risk for CHD development with obesity and smoking status (Hobbs 
et al. 2010, Baardman et al. 2012), which may demonstrate a change in the genetic 
pathways of the mother when altered by smoking status. Although obesity is a growing 
epidemic across the United States in all ages, data demonstrate obese women have greater 
complications during pregnancy than do normal weight women (Mills et al. 2010, 
Stothard et al. 2011).   
 Maternal substance use.  Maternal history of alcohol use was identified in four 
studies as a modest risk for CHD development in the infant (OR 1.1-2.4).  These studies 
found higher rates of conotruncal (disorders of the outflow tract) CHDs (OR 1.3-1.9) 
(Grewel et al., 2008, Strandberg-Larsen et al. 2010, Zen et al. 2011). Strandberg-Larens 
et al.’s (2010) Danish study did not find an associated increased risk for CHD with low to 
34 
 
 
moderate alcohol consumption.  No significant risk for CHD was reported when binge 
drinking was present. However, Mateja et al. reported that binge drinking in the United 
States was associated with a two fold increase of CHD development. And when binge 
drinking and smoking was present in the three months prior pregnancy the risk for CHD 
development was significant (aOR 9.45 and 12.65).  
 Illicit drug use is a public health concern affecting all ages. Approximately 4% of 
pregnant women in the United States use illicit drugs (Substance Abuse and Mental 
Health Administration, 2007). Williams et al. (2004) found a twofold increased risk for 
VSD when the mother had history of marijuana use. 
 Maternal tobacco use is associated with low birth weight, prematurity, risk for 
stillbirth, and risk for congenital malformations (Malik et al. 2008).  Six studies were 
found in which a modest association with increased risk for CHD in the infant when 
maternal smoking was present (OR 1.5-2.1) (Malik et al. 2008, Hobbs et al. 2010, 
Alverson et al. 2011, Patel et al. 2012, Lee & Lupo, 2013).   
 Maternal medication/vitamin use.  Folic acid has been recommended to 
decrease risk of neural tube defects and has been shown to decrease the risk of CHD by 
18% -38%, particularly VSDs in a large European study (Van Beynum et al. 2010). 
However, vitamin E was found to increase the risk of CHD when supplemented and 
consumed at high levels in the mothers diet (Smedts et al. 2009). Prescription 
medications are complicated to prescribe and to know if it is safe to use during pregnancy 
as there are limited studies and ability to test safely in humans. Alwan et al. (2010) found 
an increased risk for left ventricular outflow tract CHD when there was maternal history 
of buproprion use in the first trimester of pregnancy. And the use of antibiotics and 
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antihypertensive medications during the first trimester was associated with a 2.6-3 fold 
increased risk for CHD formation in the fetus in Brazil (Zen et al. 2011). 
 Maternal drinking water.  Trichoroethylene (TCE) is a metal degreasing agent, 
previously used as an anesthetic, and a common persistent drinking water contaminant 
known to be a selective cardiac teratogen (Yauck et al. 2004).  In a large case control 
study in Milwaukee, Wisconsin a 6 fold increased risk in older women (≥ 38 years) was 
found when exposed to TCE (Yauck et al. 2004). Whereas in Lithuania exposure to 
trihalomethane (THM) a water disinfection agent, was found to have a 1.7 fold increased 
risk for CHD if exposed to bromodichlormethane (BDCM) a common TMH, in the first 
trimester of pregnancy (Grazuleviciene et al. 2013).   
Social maternal contexts.   
Maternal SES.  In a large population based study in the United States, low 
maternal income levels were associated with poorer birth outcomes, lower birth weight, 
prematurity or morbidity and a modest increased risk for CHD (Malik et al. 2007). 
Carmichael et al.’s (2009) case control study in California found no increased risk for 
CHD in lower income and educational level of the parents. In Lithuania, a lower 
education and lower status occupations was associated with a modest increased risk (OR 
1.48-3.43) for CHD in the infant (Kučienė and Dulskienė, 2009).  
Maternal occupation.  Occupational exposure to chemicals, air pollution, and 
hazardous situations can affect the woman and unborn child’s health as has been 
associated with increased risk for CHD (Lin et al. 2012). Three European teams in Italy 
(Cresci et al. 2013), Netherlands (Snijder et al. 2012), and Russia (Vaktskjold et al. 2011) 
all found a moderate increased risk for CHD development in occupational exposure to 
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solvents (OR 1.2-2.6). Maternal exposure within the first trimester or one month prior to 
pregnancy to any solvents and chlorinated solvents were found to increase risk of VSD, 
aortic valve disorders, D-TGA, right ventricular outflow tract (RVOTO) disorders, and 
pulmonary stenosis (Gilboa et al. 2012). In the National Birth Defects Prevention Study 
(Lin et al., 2012), nurses, janitors, scientists and engineers were found to have a 
moderately higher risk for conotruncal CHD (OR 1.35-3.48). 
 Maternal education.  Educational attainment has been associated with choice of 
life partner, smoking and drinking practices, and employment and has been shown to 
affect birth outcomes.   The educational level of the mother was not significantly related 
to increased risk of CHD in two large population studies in the United States (Carmichael 
et al. 2009, Malik et al. 2009). However, a moderate risk for CHD was found in low to 
moderate levels of maternal education in Kučienė and Dulskienė’s (2009) study in 
epidemiologic study in Kaunas Lithuania (OR 3.43, 95%, CI 1.54-7.64).    
Discussion 
 Through this review, the biologic, physical and social maternal risk factors for 
CHD were identified and presented to provide a comprehensive maternal review of risk 
for CHD development. Several maternal risk factors for CHD (advanced age, CHC, FH 
of CHD and alcohol use) were identified. However, respective of the research, often it 
revealed conflicting results and/or weak associations to CHD development (race, obesity, 
smoking, medications, water, SES, occupation, education) were present, similar to past 
reviews.  Only one study was identified in this review regarding substance use (Williams 
et al. 2004).  
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CHD is a multifactorial process with multiple sources for alteration of fetal 
development.  Timing and sensitive periods in cardiac development can vary. The critical 
time frames for CHD development were identified as pre- and inter-conception. It was 
also recognized that there are multiple exposures and other risk factors which can be 
difficult to pin point direct causative factors for CHD development.  This review 
identified binge drinking in the pre-conception timeframe increased the risk 12 fold for 
CHD development (Mateja et al. 2012).  Although current medical technology has 
allowed many infants, children, and adults to survive and live productive lives in society 
today, identification and elimination of risk factors for CHD development is critical to 
reduce the number of infants being born with this life threatening and life altering 
disease.   
Validity and Limitations of the Review 
 A review of the literature describing risk, incidence and prevalence of CHD 
throughout the world identified several maternal risk factors for CHD. However, many of 
the maternal context variables were not measured or defined sufficiently to determine if 
there is a significant risk for giving birth to an infant with CHD. Most studies in this 
review were case control, retrospective studies reviewing large amounts of registry data 
some of which reported prevalence of CHD by types. Historical recollection and 
reporting of exposure or use of a substance or situation was a concern for many of the 
reviewed studies. Better surveillance practices during these critical times for exposures 
may help identify and better isolate exposures. Another major concern of the current 
research reviewed is the ability to obtain precise measurements of dose exposures, for 
example occupational hazards, contaminated water and environmental influences.  It was 
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difficult to ensure accuracy of the data collected from the mothers, as recall bias and 
reporting errors were acknowledged.  It is acknowledged by most researchers that the 
confounding variables affect many of the study variables and cannot provide conclusive 
causal evidence linking a specific variable to CHD.  However, it is important to respect 
the relationships supported and identified in these research studies to guide future 
research in these areas. Inspection of the findings from many of the studies showed 
increased risks of CHD with various exposures or demographic variables in comparison 
to the general populations. 
Most investigators encouraged further research to better isolate and identify 
significant relationships among variables, targeting modifiable life choices, or primary 
prevention techniques to decrease risk of CHD in the infant.  These investigators 
recognized the complex interactions and inability to easily separate between variables 
and identify significant risk factors. It is likely impossible to isolate each maternal 
variable and determine cause for CHD, but studies exploring the pre- and inter-
conceptual timeframes and maternal exposures may provide evidence for increased risk 
that can be intervened upon.  As the life course perspective describes health, it is 
important to appreciate the multiple trajectories in one’s life; today’s choices affect 
tomorrow’s health. 
Relevance to Clinical Care 
 Nurses are at the frontline of patient care delivery.  Greater understanding of 
maternal risk factors for CHD development is key to reduce the most prevalent birth 
defect worldwide. By understanding the complex nature of CHD, and the risk factors 
associated, nurses can begin to identify women at risk prior to pregnancy.  A thorough 
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knowledge of the maternal risk factors, for example the modifiable lifestyle choices, such 
as drug, alcohol, tobacco, and maintenance of weight, can be indentified and discussed 
with adolescent girls and women of child bearing age decreasing their risk of CHD in 
future pregnancies. These at risk women may benefit from close monitoring, fetal 
echocardiographic screening or genetic counseling prompted by their HCPs.  Early 
morbidity and mortality can be prevented and decreased in infants with CHD if early 
identification and treatment is provided (Botto & Correa, 2003; Masmoudi & Massin, 
2008).  Women with fetuses found to have CHD can benefit from prenatal counseling of 
the options for giving birth at institutions equipped for the infant with CHD, surgical 
interventions or palliative procedures specific to the type of CHD or preparation for end 
of life considerations for the infant born with complex CHD. 
Nurses can discuss in depth the known risk factors for CHD with women who 
have chronic conditions and necessary management of the condition.  For example, early 
identification and screening of diabetes in pregnancy would allow for close monitoring 
and tight control of blood sugars of diabetic mothers, thus decreasing their risk of CHD in 
the developing infant.  In the pre-conception time frames, medication review and 
clarification of safety of medication should be discussed for risk of CHD to allow for 
changes in care management if a pregnancy is being considered.  
Central to women’s health is screening for drug, alcohol, and tobacco use from 
early adolescence through childbearing years and discussing the risks associated for birth 
defects, particularly CHD. Prevention programs are needed to address these risk factors 
throughout the community to have a positive impact on families planning a pregnancy. 
Nurses can provide education of the considerable risk of CHD associated with binge 
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drinking in the pre-conceptual timeframes. Because almost half of pregnancies in the US 
are unplanned, women’s health care providers need to aggressively address these issues 
in all well-women’s care.  Pregnancies occurring when women are in optimal health may 
help ameliorate these conditions. Early prenatal care in primary care settings is also 
crucial to identify the at risk women to provide the necessary interventions if CHD is 
identified. These initiatives can be used by multiple health care providers addressing 
health of the family in pediatric and community settings.  
Conclusion 
 Through this review of maternal biologic, physical and social contexts associated 
with risk of CHD, identification of the associated risk factors for CHD was clarified. 
There were studies in which types of CHD and associated risk factors in comparison the 
general public were discussed. But, no studies other than the BWIS identified risk 
between types of CHD. Although there was conflicting results among some of the 
contextual variables (race, obesity, smoking, medications, water, SES, occupation, 
education) the risk for CHD was identified.  Development of future research in these 
areas is necessary to not only identify potential etiological sources, but to identify 
families at greater risk for having a child with CHD.  Nurses and healthcare providers 
require an understanding of the processes and mechanisms associated with CHD to 
decrease risk of CHD development.  Although the etiology of CHD remains a mystery, 
scientists, nurses, and researchers continue to study potential causes appreciating and 
respecting the multifactorial nature of this disease.   
An in depth history of biologic, physical, and social exposures of  women of child 
bearing age should be performed to assist in identification for risk of CHD.  Prompt 
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identification of the mother and fetus with CHD allows time for decisions, treatment, and 
planning to avoid adverse outcomes.  Research in the environment exposures experienced 
among child bearing adults may provide evidence for the identification of risk factors for 
CHD, allowing for genetic counseling and targeting of resources for the affected 
individuals to maximize growth and development of the infant born. There are multiple 
known maternal risk factors for CHD development in the inter- and pre-conception 
periods in a woman’s life which requires greater study. Researchers agreed further 
investigation is necessary to gain understanding of the etiological sources of CHD.   
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Table 1 
Biologic Maternal Contexts 
Maternal 
context 
Article Description Findings: Prevalence, adjusted prevalence ratio 
Odds ratio, risk ratio  (values are significant,  p 
<0.05*, p < 0.001**) 
Age Liu et al. 2013 Population based cohort study (n=2,278,838 maternal infant pairs, 26,488 
infants with CHD) in Canada from 2002-2010. Several chronic maternal 
medical conditions, including: diabetes, hypertension, connective tissue 
disorders, and congenital heart disease, showed an increased risk of CHD in the 
offspring. 
Risk factors: Maternal age ≥ 40 yrs, aOR 1.48; 
95% CI, 1.39-1.58, multi-fetal pregnancy aOR  
4.53; CI, 4.28-4.80, diabetes mellitus type 1: aOR, 
4.65; CI,4.13-5.24; type 2: aOR 4.12; CI, 3.69-
4.60, hypertension aOR 1.81; CI, 1.61-2.03, 
thyroid disorders aOR, 1.45; CI, 1.26-1.67, CHD 
aOR 9.92; CI, 8.36-11.8, systemic connective 
tissue disorders aOR 3.01; CI, 2.23-4.06, and 
epilepsy and mood disorders aOR 1.41; CI, 1.16-
1.7) 
 Long et al. 2010 Large population birth defect registry- Texas 1999-2004 2,208,758 births, 
prevalence rates TA-0.76, dTGA-2.98, TOF-3.40/ 10,000 births. Advanced 
maternal age >35 years showed a linear increase to risk of giving birth to a child 
with non-syndromic TOF, TA, d-TGA*. 
Unadjusted prevalence ratios maternal age > 35 
yrs: TA 2.03, 95%, CI 0.80-5.14, dTGA- 2.37, CI 
0.82-1.56, TOF-1.45, CI 1.10-1.91.    
 
 Miller et al. 2011 Large population birth defects registry-Metropolitan Atlanta Congenital Defects 
Program (MACDP) case control 5,289/1,301,143. Possible association with 
advanced maternal age > 35 yrs, with specific CHD phenotypes.  
Mother 35 ≥ years of age: laterality CHD 
aPR=2.03, 95%, CI, 1.01-4.10, conotruncal CHD 
aPR=1.30, CI, 1.03-2.03, VSDs aPR=1.20, CI, 
1.06-1.336, ASDs aPR=1.36, CI, 1.05-1.77, 
DTGA aPR=1.65, CI, 1.10-2.48, COA aPR=1.54, 
CI1.10-2.16.  
Race CDC, MMWR, 2010 Report: Infant birth/death data in US 2003-2006, neonatal mortality attributable 
to CHD was 30% lower in black mothers than white mothers. In term infants, 
black mothers had a 20% higher neonatal mortality rate attributed from CHD to 
those of white mothers. 
Preterm infants (< 37 weeks) with CHD of black 
mothers 4.2/10,000 compare to white mothers 
6.8/10,000, Rate ratio (RR= 0.7**). Term infants 
with CHD of black mothers 1.5/10,000 compared 
to white mothers 1.3/10,000 (RR= 1.2*). 
 Mangones et al. 2010 Population study from NYS Dept of Health Vital statistics, congenital 
malformations registry1992-2001, (n=2,303/235,230- 13/1000 live births. 
Highest prevalence among NHW followed by NHB, then Others. 
 NHW 14.4/1000 live births, NHB 12.8/1000 
(Rate ratio=RR 0.89 (95%, CI, 0.80-0.99), then 
others 12.5/1000 (RR 0.58, CI, 050-0.69), NHB 
8.8/100 (RR 0.61, CI, 0.54-0.68). 
 Miller et al. 2011 Large population birth defects registry-Metropolitan Atlanta Congenital Defects 
Program (MACDP) case control 5,289/1,301,143. Greater prevalence in white 
mothers vs. non-white mothers for CHD. 
White mothers (n=3,259)  aPR=42.4(CI,  41-43.9) 
Non-white mother (n=2,016) aPR=38.1(RR 38.1, 
CI, 36.5-39.8) 
 
Note: TA, truncus arteriosus, dTGA, d-transposition of the great arteries, TOF, Tetralogy of Fallot, NHW, non-Hispanic White, NHB, non-Hispanic Black 
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Table 1 (Continued) 
Maternal 
context 
Article Description Findings: Prevalence, adjusted prevalence ratio 
Odds ratio, risk ratio(values are significant, p 
<0.05*, p < 0.001**) 
Race Nembhard et al. 2010 Retrospective cohort using data from the Florida Birth Defects Registry-1998-
2003. n=9,352/1,216,142. Prevalence for specific and all CHD among non-
Hispanic (NH)-white, NH-black and Hispanic infants was similar.  
CHD prevalence per 10,000 live births- Hispanic- 
80.09/10,000; NH-white 79.11/10,000; NH-black 
77.67/10,000. 
Chronic 
health 
conditions 
Lisowski, et al. 2010 Multicenter retrospective clinical study, literature review and meta analysis 
comparing the study population and in the literature of the offspring of type 1 
DM mothers. Study showed an increased likelihood of specific heart anomalies, 
transposition of the great arteries (TGA), persistent truncus arteriosus (PTA), 
visceral heterotaxia and single ventricle (SV), among offspring of diabetic 
mothers particularly in the first trimester. This study was in accordance with the 
distribution in the literature.  
TGA OR 2.85, 95%, CI, 1.92-4.23. PTA OR 4.72, 
CI 2.21-10.08, SV OR 18.24, CI, 7.13-46.63. 
Visceral heterotaxia OR 6.22, CI, 2.17-17.86. 
 Liu et al. 2013 Population based cohort study (n=2,278,838 maternal infant pairs, 26,488 
infants with CHD) in Canada from 2002-2010. Several chronic maternal 
medical conditions, including: diabetes, hypertension, connective tissue 
disorders, and congenital heart disease, showed an increased risk of CHD in the 
offspring. 
Risk factors: Maternal age ≥ 40 yrs, aOR, 1.48; 
95% CI, 1.39-1.58), multi-fetal pregnancy aOR, 
4.53; CI, 4.28-4.80, diabetes mellitus type 1: aOR, 
4.65; CI, 4.13-5.24; type 2: aOR, 4.12; CI, 3.69-
4.60, hypertension aOR, 1.81; CI, 1.61-
2.03,thyroid disorders aOR, 1.45;CI, 1.26-1.67, 
congenital heart disease aOR, 9.92; CI, 8.36-11.8, 
systemic connective tissue disorders aOR, 3.01; 
CI, 2.23-4.06, and epilepsy and mood disorders 
aOR, 1.41; CI, 1.16-1.72. 
 Luteijn et al. 2010 Meta-analysis of influenza and congenital anomalies. Including neural tube 
defects, hydrocephaly, CHD, cleft lip, digestive system and limb reduction 
defects. First trimester maternal influenza exposure was associated with 
increased risk of CHD.  
aOR 1.56; 95%, CI, 1.13-2.14, aortic valve 
disorder aOR 2.59, CI, 1.21-5.54, VSD aOR 1.59 
CI, 1.24-2.14. 
 Oster et al. 2011 
 
Case- control study using data from BWIS, cases n= 2,361 controls 3,435. 
Greater risk for CHD infants when mother had history of fever pre-and during 
1st 3 months of pregnancy.  
Infants born with CHD -Fever: OR, 2.04: 95% CI, 
1.27-3.27; influenza: OR 1.75;  CI, 1.16-2.62. 
 Zen et al. 2011 Prospective case- control study in Brazil- 302/303 controls. Risk factors for 
CHD included, maternal antibiotic use, ETOH use, anti-hypertensive med use in 
the 1st trimester 
Use in 1st trimester of anti-hypertensive OR 2.62; 
95% CI, 1.00–6.87, Antibiotic OR 3.17, CI 1.55-
6.49. 
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Table 1 (Continued) 
Maternal 
context 
Article Description Findings: Prevalence, adjusted prevalence ratio 
Odds ratio, risk ratio(values are significant, p 
<0.05*, p < 0.001**) 
Family history 
of CHD 
Fesslova et al. 2011 
 
 
 
 
Fung et al. 2013. 
Prospective study with 1634 pregnant women with FH of CHD 1,477 cases with 
single FH, 157 with multiple FH. 157 women were rescanned for multiple 
pregnancies. Increased recurrence risk for CHD 3.98% when positive FH of 
CHD. 
 
Prospective case control study in Canada 2008-20111 (n=2339 cases/199 
controls). Family history, frequency of extra-cardiac anomalies (ECAs), and 
antenatal risk factors were assessed using questionnaires and genetic testing. 
Risk for CHD in offspring with 1 or more FH of 
CHD, 1 CHD- 4.06%, 2 CHD- 2.9%, multiple 
CHD 5% recurrence rates. 
 
 
Family history of CHD and frequency of major 
extra cardiac anomalies was higher in cases versus 
controls.  Left heart lesions OR 2.8, 95%, CI 1.5-
5.1, PDA OR 2.3, CI, 1.1-4.5, right heart lesions 
OR 2.1, CI, 1.1-3.9, septal defects OR 2.1, CI, 1.1-
3.9. Only 9.5% of cases with CHD had a 
confirmed genetic diagnosis. Later year of birth, 
family history of CHD, presence of major ECAs, 
maternal smoking during pregnancy, and maternal 
medication exposure were associated with 
increased odds of CHD. 
 Øyen et al. 2009 National cohort study, Danish residents, 1,763,591/18,708 1977-2005. Specific 
CHD showed variable but strong familiar clustering in 1st degree relative 
ranging from 3-80 fold increased prevalence of CHD compared to the general 
population. 
Among first-degree relatives, recurrence risk ratrio 
79.1 (95% CI; 32.9- 190), heterotaxia, 11.7 ( CI, 
8.0 - 17.0), conotruncal defects, 24.3 (CI,12.2 -
48.7), atrioventricular septal defect, 12.9 (CI, 
7.48- 22.2) for left ventricular outflow tract 
obstruction, 48.6 (CI, 27.5- 85.6) for right 
ventricular outflow tract obstruction, 7.1 (CI, 4.5 - 
11.1) for isolated atrial septal defect, and 3.4 ( CI, 
2.2- 5.3) for isolated ventricular septal defect. The 
overall recurrence risk ratio for the same defect 
was 8.15 (CI, 6.95- 9.55), 2.68 (CI, 2.43 -2.97) for 
different heart defects 
 Swaby et al. 2011 Convenience sample of 104 probands with 22q11.2 deletion syndrome were 
compared to the general population prevalence of CHD in their 1st-3rd degree 
relatives. 4-5 fold increased risk for varying forms of CHD in these family 
members. 
15 (0.9%) of 1,663 relatives had CHD, increase 
prevalence compare to general population, (OR 
4.43, 95%, 1.03-40). Relatives with severe CHD 
had significantly higher prevalence compared to 
the general population (OR 5.88, CI 2.16-12.85). 
  
 56
 
Table 2  
Physical Maternal Contexts 
Maternal 
context 
Article Description Findings: Prevalence, adjusted prevalence ratio 
Odds ratio, risk ratio (values are significant,  p 
<0.05*, p < 0.001**) 
Obesity Arias & Brown, 2010.  Case-control study in Rhode Island 2007-2009, N=995 cases, N=2344 controls. 
Pre-pregnancy obesity was associated with increased risk of giving birth to an 
infant with CHD, specifically conotruncal abnormalities. 
All CHD: In obese (BMI >30) women aOR 
1.43(95%, CI, 1.05-1.95), conotruncal CHD, aOR 
1.88(CI, 1.09-3.24). 
 Baardman et al. 2012 Case-control study in the Northern Netherlands, n= 658 cases/322 controls.  
Smoking or high BMI alone, the risk for CHA in the offspring of women with high 
BMI (≥25 kg/m(2) who also smoked was significantly increased. 
Adjusted OR 2.65 (95% CI, 1.20 to 5.87) for all 
CHD. 
 Mills et al. 2010 Population based nested case-control study. N= 7392 cases, 56,304 control. Obese 
but not overweight women had increased risk of bearing children with CHD.  
Obese= BMI ≥ 30, OR 1.15 (95%, CI 1.07-1.23). 
Morbidly obese ≥ 40 OR 1.33 (CI 1.15-1.54). 
 Hobbs et al.  2010 Population case-control study 575/363 cases of mothers in Arkansas 1998-2007. 
Maternal obesity, smoking and ETOH use can increase risk of CHD if mother has 
functional SNPs in genes that encode folate-dependent pathways. 
Obesity (carriers of 2 copies MTHFR 677 TT) 
4.62 time (95% CI, 1.54, 13.83) > risk for CHD, 
Smoked (G allele in TCII polymorphism) 1.81(CI, 
1.06, 3.11) > risk for CHD, ETOH (GC or GG 
genotype in TCII polymorphism) OR 1.71 (CI, 
1.00- 2.92). 
 Stothard et al. 2011 Meta-analysis (18 articles). Obesity was found to be a small risk factor for 
structural anomalies including CHDs.  
BMI > 30 = obese, OR 1.30 (95%, CI, 1.12-1.51) 
BMI 25-29 overweight OR 1.17 (CI 1.03-1.34).   
 Waller et al. 2007 Ongoing multisite case control study in the US, 1997-2002. Overweight= BMI 25-
30 171cases/858 controls. Obese ≥ 30 137 cases/572. Modest risk for all CHDs in 
overweight and obese women. 
Overweight aOR 1.8 (CI 1.43-2.26). Obese aOR 
1.5 (CI, 1.22-1.85) 
Alcohol Grewal et al. 2008 Population based case control study of California births 1999-2003. Maternal 
intake of ETOH less 1 day per week was associated with dTGA. 
DTGA: 76 cases, 425 controls OR 1.9(95%, CI 
1.1-3.2). 
 Mateja et al. 2012 Case control study extracted from the Pregnancy Risk Assessment Monitory 
Survey (PRAMS) linked to birth certificate data from 9 states over 10 years (1996-
2005). Significant increase in CHDs among mothers who reported binge drinking 
> 1x in the 3 months prior to pregnancy.  
Significant interaction between any binge drinking or binge drinking > 1x and 
cigarette use. 
Binge drinking > 1x in the 3 months before 
pregnancy aOR 2.99, (95% CI, 1.19-7.51).  
Any binge drinking or more once 3 month prior 
pregnancy and smoking aOR 12.65 (CI, 3.54-
45.25) and aOR 9.45, (CI, 2.53-35.31). 
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Table 2 (Continued) 
Maternal 
context 
Article Description Findings: Prevalence, adjusted prevalence ratio 
Odds ratio, risk ratio (values are significant, p 
<0.05*, p < 0.001**) 
Alcohol Strandberg-Larsen 
et al. 2010 
Cohort study using the data in the Danish National Birth Cohort 1996-2002. 477 
infants with CHD, N=80,346 infant/mother pairs. No statistically significant risk 
was found for CHD (ASD/VSD) in the infants in women who consumed low-
moderate (0-3 drinks/week) ETOH and infrequent binge drinking did not have a 
significant risk for isolated CHD (ASD or VSD). 
VSD, 1/2-1 drink/wk, aPR=1.22(95%, CI, 0.90-
1.66), 2 drink/wk, aPR=1.38 (CI, 0.83-2.28), 3+ 
drinks/wk, aPR=1.10 (CI, 0.54-2.23). Test trend 
was 0.29. 
 Zen et al. 2011 Case- control study in Brazil- 302/303 controls. Risk factors for CHD included, 
maternal illness-fever, UTI, ETOH use, antihypertensive med use, 
UTI-  p<0.001, Infection- p<0.001, 
Antihypertensive med use- p=0.011, antibiotic use 
p<0.001, ETOH use in 1st trimester p=0.066 
Illicit drugs Williams et al. 2004 Atlanta Birth Defects Case control study found a 2 fold increase risk of VSD 
with maternal self-reported marijuana use. 
RR for CHD; Marijuana- VSD 1.9; Ebsteins 2.4. 
Smoking Alverson et al. 2011 BWIS case controlled large study. Statistically significant associations for CHD 
and maternal smoking in the 1st trimester. n=2525 case, 3435 control infants.  
ASDs OR 1.36 (95%, CI, 1.04-1.78), RVOT OR 
1.32 (CI, 1.06-1.65), PVS OR 1.5 ( CI, 1.05-1.74), 
TA OR 1.90 (CI, 1.04-3.45), LTGA OR 1.79 (CI, 
1.04-3.10) 
 Hobbs et al.  2010 Population case-control study 575/363 cases of mothers in Arkansas 1998-2007. 
Maternal obesity, smoking and ETOH use can increase risk of CHD if mother 
has functional SNPs in genes that encode folate-dependent pathways. 
Obesity (carriers of 2 copies MTHFR 677 TT) 
4.62 time (95% CI, 1.54, 13.83) > risk for CHD, 
Smoked (G allele in TCII polymorphism) 1.81(CI, 
1.06, 3.11) > risk for CHD, ETOH GC or GG 
genotype in TCII polymorphism 1.71 (CI, 1.00, 
2.92). 
 Lee & Lupo, 2013 Systematic review and meta analysis. The authors observed a positive 
association between maternal smoking during pregnancy and the risk of CHDs 
as a group. Women who smoked during pregnancy were more likely to have a 
child with 12 (71 %) of 17 CHD subtypes analyzed compared with women who 
did not smoke. Highest risk was for septal defects, 
Smokers (RR, 1.11; 95 %, CI, 1.02-1.21. n = 
18,282). Smokers and risk for septal defects RR, 
1.44 (CI, 1.16-1.79). n = 2977. 
 Malik et al.2008 Population based case control n= 3,067 non syndromic CHD. Found an 
association with right sided obstructive CHD and maternal smoking.  
OR 2.1 (95%, CI, 1.2-3.5) 
 Patel et al. 2012 Multi site large population study 1997-2005, US. Case control study, n=187 
cases/6703 controls. he association was strongest in mothers who smoked >25 
cigarettes/day. Mothers with periconceptional passive smoke exposure were 
more likely to have infants with AVSDs than unexposed mothers, 
independent of maternal age, active periconceptional smoking, infant gestational 
age, and family history of CHDs 
Smoker (aOR 1.5, 95% CI, 1.1-2.4), Passive 
smoke exposure (aOR 1.4, CI, 1.0-2.0). 
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Table 2 (Continued) 
Maternal 
context 
Article Description Findings: Prevalence, adjusted prevalence ratio 
Odds ratio, risk ratio(values are significant, p 
<0.05*, p < 0.001**) 
Medication, 
vitamin use 
Kučienė & Dulskienė, 
2009 
Epidemiologic case control study in Kaunas 1999-2005, 187cases/643 controls. 
Low and moderate maternal education significantly increased the risk of CHDs. 
Housewives and workers had a higher risk of delivering a newborn with CHDs 
than the office workers. Maternal smoking during pregnancy tended to increase 
the risk of CHDs by 48%. 
Low-moderate maternal education level OR=3.43; 
95% CI, 1.54-7.64 OR=1.56; CI, 1.00-2.45. 
Housewives, workers higher risk OR=2.34; CI, 
1.34-4.10 and office workers OR=1.28; CI, 0.79-
2.07. Maternal smoking OR=1.48; CI, 0.82-2.67. 
Alwan et al. 2010 
 
 
 
Van Beynum et al. 
2010 
Retrospective case control study of birth defects and risk factors. n= 6853 
infants with CHD, n= 5869 controls born in 1997-2004 in the US. Positive 
association between early pregnancy bupropion use and left outflow tract heart 
defects. 
Large regional registry (EUROCAT-Northern Netherlands), 1996-2005, case-
control study. n=611cases/2401 controls. Mothers who used periconceptual folic 
acid had an 18% reduced risk of delivering an infant with any CHD; a 38% 
reduced risk for VSD.  
aOR, 2.6; 95%  CI 1.2-5.7. 
 
 
 
Any CHD and folic acid supplementation 
OR=0.82 (95%, CI, 0.68-0.997, septal defects, OR 
0.62 (CI, 0.47-0.82) 
 Smedts et al. 2009 Case control study. Food frequency questionnaires were administered. 276 
cases/324 controls in the Netherlands. Dietary vitamin E intake was higher in 
case mothers than in controls. CHD risk increased with rising dietary vitamin E 
intake. Periconception use of vitamin E supplements plus a high dietary vitamin 
E intake above 14.9 mg/day had a up to nine-fold increased CHD risk. Retinol 
intakes were not significantly different between the groups and not associated 
with CHD risk. 
Dietary vitamin E intake, OR 13.3 (CI 95%, 8.1-
20.4) and OR 12.6 (8.5-19.8) mg/day. 
Supplemental vitamin E intakes, Odds ratios at the 
highest quartiles of vitamin E intake were OR 9.1, 
(CI 2.0-41.4) and OR 4.8, (CI 1.1-20.2). 
 Zen et al. 2011 Case- control study in Brazil- 302/303 controls. Risk factors for CHD included, 
maternal illness-fever, UTI, ETOH use, antihypertensive med use, 
UTI-  p<0.001, Infection- p<0.001, 
Antihypertensive med use- p=0.011, antibiotic use 
p<0.001, ETOH use in 1st trimester p=0.066 
Water 
 
Grazuleviciene et al. 
2013 
Prospective cohort study 2007-2009 in Kaunas Lithuania. Cases n=57 CHD, 
musculoskeletal n=37, urogenital n= 23. 3,074 women participated in 
questionnaire. A dose response relationship for BDCM, DCBM both THMs in 
the 1st month of pregnancy was noted for CHD 
OR increased by 70% (OR 1.70, 95% 1.06-2.66) 
for every 0.1 μg/d increase in the internal dose of 
BDCM and by 26% (OR 1.26, CI 1.01-1.54) for 
every 0.01 μg/d increase in the internal dose of 
DBCM. 
 
 
Note: THM, trihalomethane, BDCM, bromodichloromethane, DBCM, dibromochloromethane. 
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Table 3  
 
Social Maternal Contexts 
Maternal 
context 
Article Description Findings: Prevalence, adjusted prevalence ratio 
Odds ratio, risk ratio(values are significant 
<0.05*, p < 0.001**) 
Water Yauck et al. 2004 Case control study, Milwaukee, WI. n= 4025 infants. Older mothers ≥ 38 yrs 
and had TCE exposure had greater risk of CHD in their infants than that of the 
control group. 
Older mothers & TCE exposure had 6 fold greater 
CHD in case infants and control infants 3.3%, 
95%, CI 8-245 vs. 0.5% 19-3780. Non exposed 
older mothers OR 3.2, CI 1.2-8.7. 
SES Carmichael et al. 2009 Case-control study-California population n= 277 conotruncal defects, 608 
orofacial cleft cases/ 617 controls. No increased risk for conotruncal defects in 
lower/poor SES or educational levels. 
Maternal education high school to college OR 1.0-
1.9 (95%, CI 0.6-3.4), paternal education 1.0-1.6 
(CI 0.6-2.8). 
 Kučienė & Dulskienė, 
2009 
Epidemiologic case control study in Kaunas 1999-2005, 187cases/643 controls. 
Low and moderate maternal education significantly increased the risk of CHDs. 
Housewives and workers had a higher risk of delivering a newborn with CHDs 
than the office workers. Maternal smoking during pregnancy tended to increase 
the risk of CHDs by 48%. 
Low-moderate maternal education level OR=3.43; 
95% CI, 1.54-7.64 OR=1.56; (CI, 1.00-2.45). 
Housewives, workers higher risk OR=2.34; (CI, 
1.34-4.10) and office workers OR=1.28; (CI, 0.79-
2.07). Maternal smoking OR=1.48; (CI, 0.82-
2.67). 
 Malik et al. 2007 Large population based birth defect registry (8 US states), case control study, 
n=3,395 cases, n=3,924 controls. No statistically significant association between 
maternal educational level or SES and SGA in the case or control groups. SGA 
and CHD were significant. 
SGA 516(15.2%), adjusted OR for state of 
residence 2.07(95% CI, 1.78-2.40), adjusted for 
infant race parity, maternal age at conception, 
education, pre-pregnancy BMI, weight gain during 
pregnancy, cocaine use 3 mo before pregnancy to 
end, smoking and ETOH status 1 mo before 
pregnancy to end, maternal HTN, and state of 
residence. OR 2.09 (CI 1.78-2.46). 
Occupation Cresci et al. 2013 Case control study in Italy, n=190 cases/190controls, maternal questionnaires 
collected on preconception exposures and lifestyle practices. Higher frequency 
of mothers of children with CHD (38 %) reported a positive history of exposure 
to toxicants (occupational and environmental) than mothers of healthy children 
(23 %) (p = 0.0013). 
OR 2.6; (95 % CI, 1.6-4.2). 
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Table 3 (Continued) 
Maternal 
context 
Article Description Findings: Prevalence, adjusted prevalence ratio 
Odds ratio, risk ratio(values are significant, p 
<0.05*, p < 0.001**) 
Occupation Gilboa et al. 2012 Multi site population study in the US. Case control study. 2951 controls, 2047 
cases. Associations were observed for exposure to any solvent and any 
chlorinated solvent with perimembranous ventricular septal defects, aortic 
stenosis, D-TGA, RVOTO defects and pulmonary valve stenosis. 
Solvents, chlorinated solvents, VSD (OR 1.6, 
95%, CI 1.0 to 2.6 and OR 1.7, CI, 1.0 to 2.8; any 
solvent exposure with aortic stenosis (OR 2.1, CI, 
1.1 to 4.1); and Stoddard solvent exposure with D-
TGA (OR 2.0, CI ,1.0 to 4.2), RVOTO defects 
(OR 1.9, CI, 1.1 to 3.3) and PV stenosis (OR 2.1, 
CI, 1.1 to 3.8). 
 Lin et al. 2012 Multi center case-control study of National Birth Defects Prevention Study data- 
United States (10 states), 1997-2004. n=4132 case/controls. Higher risk for 
LVOTO defects in Nurses, septal defects in janitors and higher risk for 
scientists-chemical, and engineers had higher risk for conotruncal defects. 
Nurses- LVOTO defects OR 1.35, 95%, CI, 1.03-
1.77, Janitor -septal defects OR 2.19, CI, 1.10-
4.36. Chemical scientist - conotruncal defect, OR 
2.44, CI, 1.01-5.91, engineer- conotruncal defects 
OR 3.48, CI, 1.45-8.37. 
Occupation Snijder et al. 2012 Age matched European case-control study 2003-2010 of cases 424 mothers, 421 
fathers, controls 480 mothers, 477 fathers. No maternal exposure to specific 
chemicals and increased risk of CHD was found. Increased risk for CHD and 
exposure to specific chemicals in the father was found. 
Mother OR 0.92, 95%, CI, 0.26-3.25.  Fathers: OR 
1.23, CI, 0.39-3.91. 
 Vaktskjold et al. 2011 Prospective cohort study, Russia, 1973-2005, included were mothers employed 
as painters, painter-plasterers, and spoolers (all have exposures to solvents), 
higher risk for circulatory system malformations in these groups. 
Circulatory system (primarily aortic and mitral 
valve disorders) OR 2.03 (95%, 0.85-4.84) 
Educational 
level 
Carmichael et al. 2009 Case-control study-California population n= 277 conotruncal defects, 608 
orofacial cleft cases/ 617 controls. No increased risk for conotruncal defects in 
lower/poor SES or educational levels. 
 Maternal education high school to college OR 
1.0-1.9, 95%, CI, 0.6-3.4, paternal education 1.0-
1.6, CI, 0.6-2.8. 
 Kuciene & Dulskiene, 
2009 
Epidemiologic case control study in Kaunas 1999-2005, 187cases/643 controls. 
Low and moderate maternal education significantly increased the risk of CHDs. 
Housewives and workers had a higher risk of delivering a newborn with CHDs 
than the office workers. Maternal smoking during pregnancy tended to increase 
the risk of CHDs by 48%. 
Low-moderate maternal education level OR=3.43, 
95%, CI, 1.54-7.64, OR=1.56; CI, 1.00-2.45. 
Housewives, workers higher risk OR=2.34; CI, 
1.34-4.10 and office workers OR=1.28; CI, 0.79-
2.07. Maternal smoking OR=1.48; CI, 0.82-2.67. 
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Table 3 (Continued) 
Maternal 
context 
Article Description Findings: Prevalence, adjusted prevalence ratio 
Odds ratio, risk ratio(values are significant, p 
<0.05*, p < 0.001**) 
Educational 
level 
Malik et al. 2007 Large population based birth defect registry (8 US states), case control study, 
n=3,395 cases, n=3,924 controls. Found no statistically significant association 
between maternal educational level or SES and SGA in the case or control 
groups. SGA and CHD were significant. 
Total case subjects 3,395, SGA 516(15.2%), 
adjusted OR for state of residence 2.07(95%, CI, 
1.78-2.40), adjusted for infant race parity, 
maternal age at conception, education, pre-
pregnancy BMI, weight gain during pregnancy, 
cocaine use 3 mo before pregnancy to end, 
smoking and ETOH status 1 mo before pregnancy 
to end, maternal HTN, and state of residence. OR 
2.09(CI, 1.78-2.46). 
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CHAPTER 3 
Chapter 3 Introduction 
The purpose of this chapter is to provide a review of the literature related to the 
known genetic risk factors associated with CHD. The focus of this chapter will be the 
known maternal genetic risk factors for CHD development in the infant. This chapter is a 
review of the literature in the format of an article to be submitted for journal submission. 
The referencing style of this target journal will be applied in this manuscript. 
Manuscript 2: Understanding Genetics and Pediatric Cardiac Health 
Abstract 
Purpose:  Congenital heart defects (CHD) continue to be the most prevalent birth defect 
that occurs worldwide in approximately 6-8 of every 1,000 live births. High rates of 
morbidity and mortality in infants, children, and adults living with CHD place a growing 
need for health care professionals (HCPs) to better understand potentially modifiable 
genetic and environmental influences.  This paper will present examples of research and 
governmental initiatives that support genetics education and research and a review of 
known genetic factors associated with CHD development. 
Organizing Construct:  A review the known genetic factors on risk for CHD formation 
in infants will be provided to help health care professionals gain a greater understanding 
of the genetic influences on pediatric cardiac health.   
Conclusions:  There are known genetic pathways and risk factors that contribute to 
development of CHD. This paper is a primer for nurses and HCPs providing information 
of the genetics and inheritance patterns of CHD to useful in daily clinical practice.   
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Clinical Relevance: Nurses work in multiple communities where they are uniquely 
positioned to educate and provide information about research and current models of care 
with families affected by CHD.  Nurses and HCPs who better understand genetic risk 
factors associated with CHD development can more promptly refer and offer treatment 
for these children and families thus providing individuals of childbearing age with the 
necessary resources and information about risk factors. 
Key Words:  Congenital heart defects, genetics, epidemiology, etiology, cardiac 
development. 
Introduction 
Congenital heart defects (CHD) are the most prevalent birth defect in the world 
and occur in approximately 6-8 of every 1,000 live births (Hoffman & Kaplan, 2002). It 
is important to identify etiological factors of CHD as CHD is one of the leading causes of 
infant morbidity and mortality. Only 10-15% of the etiologies for CHD are understood or 
known. In 2001 The National Heart, Lung, and Blood Institute (NHLBI) convened a task 
force in Pediatric Cardiovascular Disease to identify research priorities, and scientific 
opportunities to address the growing public health problem of CHD in children and adults 
(NHLBI, 2002).  This task force identified eight research priorities that varied from 
supporting basic science studies of the heart and blood vessel formation to transitional 
research to enhance clinical care. 
In 2012 the American Heart Association (AHA) publically recognized the impact 
of genetics in diagnosing and directing treatment of cardiovascular disease (Ashley et al, 
2012).  The AHA published a policy statement and recommendations that prompt 
clinicians to better understand and incorporate genetic technology and modalities into the 
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care of children and adults with cardiovascular disease or increased risk of CHD. This 
report addresses the following and provides recommendations for use of genetic 
information in healthcare:   
 Legal ability and ramifications of patenting personal genetic material 
 Patient protection against genetic discrimination, regulation and monitoring of 
genetic testing materials to deliver reliable and valid testing  
 Expert consensus on clinical involvement in recommending and selecting 
appropriate current and next generation genetic testing   
 Multidisciplinary and multi-institutional involvement in adaptation for the use of 
pharmacogenetics in disease treatment and management  
 Use of common variant and risk prediction genetic testing of the general 
population-feasibility and risk for discrimination,  
 Reimbursement and insurance coverage for genetic testing,   
 Private and public access to genetic testing and storage of genetic material-ability 
to monitor and protect 
 Education of “Core Competencies in Genetics and Genomics” for all healthcare 
professionals (HCP’s)  
Technology to identify genetic markers specific to heart disease continues to evolve 
and is an innovative part of research and clinical care.  Thus, greater knowledge of 
genetics is required of HCP’s who care for individuals with or with increased risk of 
CHD.  This article is a primer for nurses and HCP’s providing a review of known genetic 
factors associated with increased risk of CHD for use in daily clinic practice. The 
implications for nursing research and clinical care will be presented in the conclusion.  
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The Basic Building Blocks of Life 
During the last two decades, scientists’ ability to map the human genome has 
evolved and the complex molecular processes sustaining daily life continues to be 
critically studied.  As a central concept of molecular biology, the Central Dogma of 
Molecular Biology describes the one-way directional flow of genetic information; 
deoxyribonucleic acid (DNA) produces ribonucleic acid (RNA) which then produces 
proteins (Strachan & Read, 2011). Although there are many complex processes and 
components to the creation of genetic material, scientists noted that these essential 
processes are needed by all cellular organisms to sustain life.  Over the last several years, 
scientists have appreciated that these processes and DNA are not the only factors 
responsible for expressing our genetic makeup, but include more complex interactions 
between various environmental, prenatal, and chemical exposures throughout an 
individuals’ life. During this rapid evolution of molecular genetics, a new area of study 
called epigenetics has developed to promote knowledge generation about the influences 
the environment has on our genetic makeup. 
Epigenetics is a rapidly evolving field of study that focuses on the interactions 
and factors that influence chemical changes that switch parts of the genome off and on. 
Epigenetic is defined as “Heritable (from mother cell to daughter cell, or sometimes from 
parent to child), but is not produced by a change in DNA sequence” (Strachan & Read, 
2011, pg. 724).  The epigenetic mechanisms that influence changes in gene expression in 
cardiac development include histone modifications, RNA interferences, and DNA 
methylation (Chang & Bruneau, 2012; Vallaster, Vallaster & Wu, 2012; Weerd, Koshiba-
Takeuchi, Kwon & Takeuchi, 2011).  These mechanisms occur within the cells that either 
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silence or activate specific genes thus causing a cascade of events, which eventually 
change the expression of the genetic material (Kim, Ryan, Marshboom, & Archer, 2011). 
Epigenetic changes appear to be influenced by environmental conditions that 
include famine, chemicals, and diet to name a few in which these exposure induced 
changes may be passed to children and grandchildren (Perera & Herbstman, 2011).  
Exposures to environmental disasters, chemical spills, or other naturally occurring events 
disrupting the current conditions or environment over time may provide an explanation 
for the increase in specific phenotypes that contribute to obesity, cancer or increased birth 
defects as examples (Hou, Zhang, Wang & Baccurelli, 2011).   As the human race has 
learned to manufacture and sustain resources of water, food, and healthcare, the human 
genome has also learned to adapt to the ever changing environment turning genes off and 
on, sometimes with adverse effects. 
As HCPs acquire a greater understanding of the complexity of molecular genetics, 
this information will be important when exploring genetic factors influencing embryonic 
and fetal development of the heart in relation to formation of congenital heart defects 
(CHD).   Of all cases of CHD in live births, 5%-10% can be attributed to a chromosomal 
abnormality, and 3%-5% are linked to single gene defects (Botto & Correa, 2003; Brent, 
2004). Therefore the majority of CHDs are thought to be of a multifactorial etiology, 
resulting from a combination of environmental and gene interactions.  Normal cardiac 
development is a complex process and is influenced by many transcription factors and 
cardiac-specific genes. CHD can develop at various times in embryonic/fetal 
development during which teratogenic or chemical exposures may create varying types of 
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CHD that include but are not limited to valve disorders, muscular dysfunction, septal 
defects or circulatory disorders resulting in cyanosis.  
The classification and description of cardiac defects has been difficult due to the 
complexity and multiple forms they come in.  Categorizing CHDs genetically is also 
difficult as some CHDs are heterogeneous with varying degrees of pathology.  A 
description of the multifactorial nature of CHDs and phenotype variability within humans 
is discussed in the descriptions of each disorder and its associated CHD.   
Genetics of CHD 
The heart is formed during embryonic development -frequently before the mother 
is aware she is pregnant.  The primitive heart tube begins to form as early as embryonic 
day 15 (Srivastava, & Olson, 2000).  Various transcription factors signal cardiac genes to 
begin cellular development and specification, creating the beginning of the cardio-
specific regions and chambers of the heart seen around embryonic day 21.  Through 
embryonic day 28, the heart tube segments, ventricular chambers differentiate, and early 
valvar regions begin to form.  By embryonic day 50 the fully formed heart is visible with 
each chamber, valve and vessel designated to support further fetal development of the 
other body systems. Cardiogenesis is a complex process. Figure 1 illustrates the structural 
changes that occur within the specific regions of the developing heart in the first 7-8 
weeks of gestation.  Each color illustrates the specification and differentiation during the 
stages that form the fully developed heart. For example the purple and orange colors 
represent the ventricular formation and specification of the right and left ventricles. 
Through the process of looping (Days 21-28) the primitive heart tube begins 
differentiating the atria, ventricles, conduction systems, arterial and venous circulation 
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systems, each with specific regions and genetic material signaling the next process. If 
there are genetic mutations or miscommunications along these routes various CHD 
formations may occur.  (INSERT FIGURE 1). 
Single Gene Mendelian Mutations 
Single gene Mendelian mutations account for approximately 3-5% of CHD in live 
human births (Botto & Correa, 2003; Brent, 2004).  Single gene Mendelian mutations are 
those mutations occurring at a single locus or the unique chromosomal location which 
defines the position of the individual gene or DNA sequence (Strachan & Read, 2011).  
There are a small number of children and adults affected by familial inherited CHD, thus 
it remains important to identify these individuals to assure proper allocation of resources.  
The patterns of inheritance are classified into five categories: autosomal dominant (AD), 
autosomal recessive (AR), X-linked dominant, X-linked recessive and Y-linked.  The 
basic Mendelian patterns of inheritance (Figure 2) can be complicated by other factors, 
including penetrance of a trait, later presentation of a disease, and variable expression. 
Although the probability of inheritance of a specific disease linked mutation can be 
calculated, many other factors affect gene expression and the risk for disease.  Referral to 
an expert in genetics is appropriate for pre- and interconception counseling for families 
with increased risk. 
Autosomal dominant inheritance patterns are those in which either parent can pass 
the affected gene to the offspring.  There is a 50% risk in every pregnancy if one parent 
carriers the affected allele that the offspring will express the trait. Male and female 
offspring have an equal risk of being affected.  In autosomal recessive inheritance 
patterns, if both parents are unaffected carriers, there is a 75% risk in each pregnancy that 
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they will receive the abnormal gene but only a 25% risk that they will be homozygous for 
the diseased allele. Where one parent is an unaffected carrier of the autosomal recessive 
faulty gene, and the other parent is affected by the condition, there is a 50% risk in each 
pregnancy that the child will inherit both copies of the faulty gene.  
In X-linked disorders, males will be affected if they inherit a faulty gene since 
they only have one X chromosome. The male with an X-linked disorder pass their Y 
chromosome to their male offspring thus none of their sons will be affected. However, all 
of their female offspring will inherit the faulty gene, and present the disease if the trait is 
dominant. In X-linked recessive disorders, the female is often a carrier of the trait, and 
each female carrier has a 50% risk in each pregnancy that the male offspring will be 
affected with the trait, and a 50% risk of passing the faulty gene to a female offspring. In 
X-linked dominant traits, all female offspring are affected, and will pass the defect to 
each of their offspring. Y-linked disorders affect only males, the affected father will 
produce male offspring affected by the disorder (Strachan & Read, 2011).  (INSERT 
FIGURE 2) 
 
Although there are only a small number of children and adults affected with 
inherited CHDs; the developmental, physical, and financial impact can be substantial to 
the child and family.   HCPs need to be aware of the patterns and risk of inheritance for 
the CHD disorders when women and men of childbearing age receive pre- and 
interconception counseling.  HCPs may have the ability to provide pre- and 
interconception counseling so that individuals are able to make decisions about planning 
a pregnancy with information about potential risk of having a pregnancy with a mutation 
or birth/cardiac defect.  Once a woman becomes pregnant, she should have access to 
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genetic testing for single gene disorders through amniocentesis or chorionic villus 
sampling. If a CHD is diagnosed, an early diagnosis allows time to screen with fetal 
echocardiography and considerations for delivery plan of an infant affected with a CHD.  
Since individuals with a genetic defect have up to a 50% chance of passing the genetic 
defect in each pregnancy, pre- and interconception genetic counseling and screening 
should be available in order to plan care for each pregnancy and infants with CHDs (Lin 
& Garver, 1988).   
Some examples of  single gene disorders associated with CHD include Alagille 
syndrome (AD), Duchene muscular dystrophy (X-linked), Noonan’s syndrome (AD), 
Holt-Oram syndrome (AD), Marfan’s syndrome (AD), Char syndrome (AD), Williams 
syndrome (AD) and Ellis-van Crevald syndrome (AR) (Carey, 2002; Hinton, Yutzey, & 
Benson, 2005; Lin & Ardinger, 2005). Individuals with these disorders exhibit other 
physical features which may include CHDs.  It is important that HCP pay attention to 
dysmorphic appearances in parents, siblings or the newborn, so that families receive 
prompt genetic referrals, analysis and/or consultation with a genetic specialist. Although, 
these disorders are linked to a single genetic pattern of inheritance, the type of CHD can 
vary in degree of severity, again reiterating the multifactorial nature of CHD and role 
exposures that can lead to epigenetic changes during one’s lifetime.  
Chromosomal Abnormalities 
Chromosomal abnormalities occur in approximately 1 in 150 live births (ACOG, 
2007; ACOG, 2001; Cary, 2003). In this group of children with chromosomal disorders, 
5-10% will have a CHD.  Thus children with chromosomal disorders require prompt 
cardiovascular evaluation to decrease or manage risk of morbidity and mortality 
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associated with CHD.  Many infants with chromosomal disorders will exhibit other 
physical features prompting early genetic analysis to diagnose or determine if a disorder 
is present. 
Chromosomes are thread-like molecular materials of DNA and proteins that 
contain genes which determine individual traits such as hair color or height.  Humans 
normally have 46 chromosomes, 23 chromosomes from each parent. Chromosomal 
abnormalities are a result of large-scale mutations within the sperm or ova that occur 
before fertilization.  These mutations can occur from deletions (absence of a segment of a 
chromosome), replications (extra copy or segment of a chromosome), mosiacisms (two or 
more populations of cells with different genetic or chromosomal constitutions), or 
translocations (a whole chromosome or segment of a chromosome becomes attached to or 
interchanged with another whole chromosome or segment) resulting in varying forms of 
diseases and disorders dependent upon the chromosomal region affected (Genetics Home 
Reference, 2013). Certain chromosomal abnormalities will result in early fetal demise or 
miscarriage.   
There are several chromosomal abnormalities associated with varying forms of 
CHD.  For example, Turner’s syndrome, William’s syndrome, Trisomy 21, and DiGeorge 
syndrome (Carey, 2002; Huang, Liu & Lv, 2010) may have varying forms of CHD or 
may not exhibit any CHD.   Trisomy 21 is the most frequent chromosomal abnormality 
that occurs in 1 in 660 live births (Carey, 2002).  Of the infants born with Trisomy 21, 
approximately 40% will be affected with a form of CHD, and are most commonly an 
atrioventricular canal defect, ventricular septal defect, and/or atrial septal defect. 
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DiGeorge syndrome, 22q11.2 deletion, is found commonly in patients with 
conotruncal defects such as Tetralogy of Fallot, aortic arch anomalies, truncus 
arteriousus, and malaligned ventricular septal defects (Clark, Yutzey, & Benson, 2006).  
The region of chromosome affected is the DiGeorge critical region (DGCR), where 30 
genes are deleted in this region.  There can be varying degrees of CHD, cognitive 
function and other syndromes such as velocardio-facial and conotrucal anomaly face 
syndrome seen in the DGCR abnormality.    
Multifactoral Inheritance 
The human genome is complex and the genetic processes which make up human 
development are dependent on multiple complex reactions. Cardiac development is just 
as intricate and complex which has made it difficult to isolate the exact mechanism of 
CHD development with the many varying forms of CHD.  Therefore with the 
multifactorial nature of CHD, a genetic mechanism cannot be the sole focus as an 
etiology.  However, understanding possible genetic pathways and vulnerable stages to 
specific exposures may allow individuals to experience decreases in risk of CHD.   
The genetic mechanisms of the majority of CHDs, as well as many other disease 
processes is thought to be a polygenic process; where multiple loci or areas on the 
chromosome cause various effects on the phenotype (Strachan & Read, 2011).   The 
genetic environmental theory postulates that specific genotypes will produce or react, 
dependent upon either optimal or suboptimal conditions in the environment, thus 
affecting the phenotype (Falconer, 1952).  As researchers uncover the intricate 
relationships between the molecules of DNA, RNA, and epigenetic processes (e.g. DNA 
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methylation, histone modification and RNA interference) and their roles in abnormal 
heart development, the genetic environmental theory can be supported.    
As there are multiple interactions between genetic materials and environmental 
factors in males and females of childbearing age, women during pregnancy, and during 
the first few weeks of fetal development, they should be aware of the known risk factors 
for CHD. Understanding the potential risk factors for development of CHD is a goal for 
both bench and clinical researchers working together to gain insight into the formation 
and early identification of CHDs (Kaltman, Schramm, & Pearson, 2010).  A summary of 
the most common CHDs with known genetic causes, the genes and chromosomes that are 
affected, and the modes of inheritance are provided in Table 1.  It is important that 
scientists and HCPs develop greater understanding of the epigenetic pathways in order to 
provide information about risk for the heritable patterns across generations for non-
Mendelian disease.   
Research Implications 
The NHLBI has designed the Bench to Bassinet research program to encourage 
and accelerate the discovery and translation of basic research of CHD etiology into 
clinical studies through large scale collaborations of four large research centers in the 
United States (Kaltman, Schramm, & Pearson, 2010).  The NHLBI’s first goal in their 
strategic plan is, “To improve understanding of the molecular and physiological basis of 
health and disease, and to use that understanding to develop improved approaches to 
disease diagnosis, treatment and prevention” (as cited in Kaltman, Schramm, & Pearson, 
2010, pg 1264).  The Bench to Bassinet Program is comprised of two research consortia: 
the Pediatric Cardiac Genomics Consortium (PCGC) and the Cardiovascular 
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Development Consortium (CvDC), administered through a common Coordinating Center 
(CC), and aligns with the Pediatric Heart Network, which has been funded by NHLBI 
since 2001. These groups are working on studies to accelerate the translation of basic 
research findings into clinical studies and trials, and to provide clinical input on pressing 
needs for basic research. 
Multidisciplinary research in pre- and interconception care, prenatal health and 
prevention of potentially harmful exposures to women and men of childbearing age is 
important for nurses in the context of health promotion through the lifespan.  Nurses are 
uniquely positioned in the community and health care settings with readily available 
access to young women and men of childbearing age.  Engaging in further research to 
address barriers or deficits in access to preventative and pre- and interconception 
healthcare practices may provide another avenue to decrease CHD in infants.  Nurses can 
also identify “hot spots” or locations of multiple cases of CHD or other genetic 
syndromes when employed in public health agencies, as well as various in- and outpatient 
settings. Nurses have a unique opportunity to collect data and vital statistics to promote 
further research of the multifactorial factors that contribute to CHD in infants. 
Clinical Implications 
With over three million nurses in various clinical, educational and research 
settings across the United States, and over 19.3 million nurses worldwide (World Health 
Statistics, 2011) nurses have strong potential to influence patient centered care and 
research. Understanding genetic influences, resources and genetic testing to better 
understand a disease process are necessary to provide comprehensive and preventative 
care to children and families affected by and at risk for CHD and other genetic disorders. 
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This initiative on genetic education in nursing is being promoted as a priority by the 
American Association of Colleges of Nursing and the Council on Cardiovascular Nursing 
of the American Heart Association (Ashley et al, 2012).  Providing genetic education for 
the nursing profession is essential to support and offer appropriate counseling and care 
for this a growing number of individuals with and at increased risk for CHD. As the 
infant with CHD grows into adolescence and adulthood, transition of care and education 
of healthy lifestyles and informed reproductive choices are crucial to improve the lives of 
our patients and families affected by and at increased risk for CHD. Several clinical 
exemplars are presented in Figure 3 providing practical application of the modes of 
inheritance (INSERT FIGURE 3). 
These exemplars in Figure 3 illustrate different modes of inheritance from figure 
1 of specific genetic cardiac conditions that nurses and HCPs may encounter in practice. 
All members of the healthcare team must remain aware and knowledgeable about 
physical characteristics, clinical results, and family history which may help determine an 
increased risk for a genetic disease. Although, all nurses and HCPs may not all have a  
comprehensive knowledge of all genetic disorders, it is important for nurses and HCPs to 
provide a thorough health history and exam which may save a life and potentially 
decrease the risk of CHD through informed reproductive choices of future generations. 
There are many other genetic syndromes with various modes of inheritance outside of 
CHD, and HCP’s need to be aware of the patterns of inheritance as they provide pre- and 
interconception counseling to family members of childbearing age. The nurses and 
HCP’s caring for children and families with genetic disorders or increased risk of genetic 
disorders are not be solely responsible for the genetic expertise in various disorders, but 
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must have, an adequate understanding of genetic transmission and risk in order to 
appropriately refer individuals with questions or an increased risk of genetic diseases to a 
genetic specialist and their team.  
Conclusion 
Nurses and other HCPs have a responsibility to obtain current knowledge about 
genetics through education, research and review of current clinical practices in order to 
provide multiple resources for individuals and families with CHD and increased risk for 
other genetic disorders to optimize health outcomes. As the science of genetics is quickly 
evolving, members of all health disciplines including nursing must maintain currency in 
the research, clinical care, and education in the field of genetics.  While genetic testing 
may provide specific information to tailor individual care, pre- and interconception 
counseling are critical to include with individuals at increased risk of a genetic disorder. 
An understanding of basic genetics, genomics and resources available to nurses and all 
HCP’s are critical to care for and promote health of individuals and families affected by 
or at increased risk of CHD. 
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Figure 1. Cardiac development 
 
 
From the following article: A genetic blueprint for cardiac development. Srivastava, D. & Olson, E. (2000).  Bilaterally symmetrical 
aortic arch arteries (III, IV and VI); aortic sac (AS); conotruncal (CT) and atrioventricular valve (AVV); A, atrium; Ao, aorta; DA, 
ductus arteriosus; LA, left atrium; LCC, left common carotid; LSCA, left subclavian artery; LV, left ventricle; PA, pulmonary artery; 
RA, right atrium; RCC, right common carotid; RSCA, right subclavian artery; RV, right ventricle; V, ventricle. Used with permission 
from Macmillan Publishers Ltd: Nature, Srivastava, D. & Olson, E.N. A genetic blueprint for cardiac development. Nature, 407, 221-
226A   doi:10.1038/35025190, 2000. 
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Figure 2.  Patterns of inheritance for disease linked to a single gene polymorphism or mutation. 
 
 
Autosomal Dominant 
Affected parent Aa 
Unaffected parent aa 
 
 A a 
a  Aa aa 
a  Aa aa 
 
50% risk of having an affected child in 
each pregnancy 
 
 
Autosomal Recessive 
Carrier parent  Aa 
Carrier parent  Aa 
 
 A a 
A AA Aa 
a Aa aa 
 
25% risk of having an affected child in 
each pregnancy 
50% risk of having a carrier child in each 
pregnancy 
 
X linked-Dominant 
Affected father XY 
Unaffected mother XX 
 
 X Y 
X XX XY 
X XX XY 
 
50% risk of having an affected daughter 
in each pregnancy 
 
X linked Dominant 
Unaffected father XY 
Affected mother XX 
 
 X Y 
X XX XY 
X XX XY 
 
25% risk of having an affected daughter 
or affected son in each pregnancy 
 
X linked Recessive 
Carrier father XY 
Unaffected mother XX 
 
 X Y 
X XX XY 
X XX XY 
 
50% risk of having a carrier daughter in 
each pregnancy 
 
X linked Recessive 
Carrier mother XX 
Unaffected father XY 
 
 X Y 
X XX XY 
X XX XY 
 
50% risk of having a carrier daughter, 
50% chance of an affected son in each 
pregnancy 
Note:  Patterns of genetic inheritance discussed in the text. Characters in red indicate a chromosome with a 
disease-associated allele. 
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Figure 3.  Clinical Exemplars. 
A 32 year old women is expecting a child, her husband has a diagnosis of Marfan’s syndrome, an autosomal dominant 
syndrome. She is concerned for her risk of having a child with Marfan’s. She also wonders if her sister-in-law who 
does not have Marfans’s is at risk. How would you address these concerns?   
 She and her husband have a 50% chance of having an affected child in each pregnancy due to her husband’s 
genetic history.  
 A child with Marfan’s may not exhibit cardiac problems initially at birth and thus requires lifelong follow-up 
with a cardiologist to monitor for mitral valve prolapse and ascending aortic dilation. 
 You would also advise your patient that her sister-in-law needs to address her risk with her physician because 
you know that a comprehensive evaluation is needed to rule out the syndrome. However, you also know that 
because this is an autosomal dominant syndrome one biological parent has to have the condition to pass it on 
to their child.  If her sister-in-law does not have the genetic condition she cannot pass Marfan’s on to her 
offspring. 
An Amish couple is at the cardiologist to discuss care of their child with common atrium and Ellis-van Creveld 
syndrome, an autosomal recessive condition. She is concerned her next pregnancy may be at risk for this syndrome.  
What is her chance of another. child with Ellis-van Creveld syndrome?  
 She and her husband have a 25% of having a child with this condition, and a 50% chance of having child who 
is a carrier in this pregnancy and in each subsequent pregnancy. 
 If they have a child with Ellis-van Creveld syndrome, this child will have physical attributes of dwarfism 
(short stature, short limbs) and can be at risk for an atrial septal defect or common atrium. 
An 18 year old girl with Turner’s syndrome, an X-linked syndrome, comes in for follow-up of her surgically repaired 
coarctation of the aorta. Her mother is concerned as she is entering adulthood and thinking about having children, what 
is her risk for passing Turner’s syndrome on to her children.  What are her chances of having a daughter or son with 
Turner’s syndrome?   
 
 She has a 50% chance of having a female child with Turner’s in each pregnancy.   
 If her child is genetic positive for Turner’s syndrome a full cardiac evaluation is necessary as some children 
with Turner’s do not have a cardiac condition. Coarctation of the aorta and bicuspid aortic valve are most 
common CHDs.  
 Hypertension is a common condition in Turner’s syndrome which can manifest later in life. 
In each of these cases, if a child does not inherit the genetic condition from his or her parents, the child will have the 
same risk for CHD due to the multifactoral causes.  The risk for CHD in a child is 6-8/1,000 live births. 
Because the risk of inheritance with each of these conditions is the same in each pregnancy, a family with a family 
history of each of these conditions and two children could have 1, 2 or no children with the condition. 
 
Note:  Clinical exemplars of genetic inheritance patterns for CHD.   
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Table 1 
Genetic Causes of CHD in the Human (congenital and adult CHD) 
Types of CHD or 
Syndromes Associated with CHD 
Pattern of  
Inheritance 
Associated Genes or 
Chromosomes 
 
Familial CHD (ASD, AV-block, TOF, HCM, TV 
abnormality) 
MF NKX2.5  
D-TGA, DORV MF CFC1  
D-TGA MF PROSIT240  
Tetrology of Fallot (TOF) 
 
MF ZFPM2 
NKX2.5 
 
  JAG1 
FOG2 
 
ASVD MF CRELD1  
ASD/VSD, ASVD, PV dysplasia MF GATA4  
Heterotaxy MF ZIC3, CFC1  
  ACVR2B, LEFTY A  
  ELN  
Supravalvar AS 
T/PAPVR, TA, PS 
ASD, AVSD, AVB, TOF 
Syndromes Associated with CHD 
MF 
MF 
MF 
 
GATA 
 
Holt-Orem syndrome AD TBX5  
Alagile syndrome, PS/PPS AD JAG1  
Char syndrome, PDA AD TFAP2B  
Noonan syndrome, PS, PV dysplasia, ASD, AVSD  AD PTPN2  
  KRAS  
  SOS1  
CHARGE syndrome AD CHD7  
Ellis-van Creveld, (ASD, common atrium) AR EVC, EVC2  
Marfan syndrome 
Connective tissue disorders 
AD FBN1,TFGBR2  
 
 
Cardiofaciocutaneous syndromes MF KRAS BRAF MEK1 
MEK2 
 
 
Costello syndromes 
Turner’s syndrome 
William’s syndrome 
 
 
Trisomy 21, 18, 13 
DiGeorge 
 
AD 
X-linked 
AD 
 
 
MF 
MF 
 
HRAS  
SHOX 
CLIP2, ELN,  
GTF2IRD1, 
GTF2I, IMK1 
Additional 
chromosome 
DGCR, TBX1, 22q-
11.2 
 
    
Note. AD, Autosomal dominant; AR, Autosomal recessive, ASD, atrial septal defect; AVB, atrioventricular 
block; AVSD, atrioventricular septal defect; Chrom-Chromosome; D-TGA, dextro-transposition of the 
great arteries; DORV, double outlet right ventricle; HCM, hypertrophic cardiomyopathy; MF, 
multifactorial; PDA, patent ductus arteriosus; PS, pulmonary stenosis; PPS, peripheral pulmonary stenosis; 
T/PAPVR, total/partial anomalous venous return; TV, tricuspid valve. Adapted from “Molecular 
mechanisms of congenital heart disease,” by Huang, Liu, Sun, Lv, Ming, and Fan, 2010, Cardiovascular 
Pathology, 19, e185.  Copyright 2010 by Elsevier Inc.  
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CHAPTER 4 
 
Chapter Introduction 
The purpose of this chapter is to provide a presentation and discussion of the 
results from this dissertation study. The focus of this chapter will be findings from the 
study including the risk factors for complex CHD and factors related to gestational age 
and birth weight in this population. This chapter presents the outcomes of the study in the 
format of an article to be submitted for journal submission. The referencing style of this 
target journal will be applied in this manuscript.  Supplemental data will include 
correlation tables for both the dissertation as well as the journal submission. 
Manuscript 3:  Maternal Health and Infants Born with Congenital Heart Disease: A 
Secondary Analysis of the WPCR 
 
Abstract 
Objective:  Examine the relationships of select maternal variables to the type of CHD, 
birth weight and gestational age in infants born with CHD participating in the Wisconsin 
Pediatric Cardiac Registry (WPCR). 
Design: Descriptive secondary analysis.  
Setting: Wisconsin Pediatric Cardiac Registry 
Participants: 1,687 parent/child participants  
Methods:  Descriptive analysis, correlations, logistic and multiple regression. 
Results: Maternal history of CHD, OR 2.382 (95 % CI 1.424-3.984) and history of 
serious health conditions OR 1.537 (CI 1.085-2.178) were found to increase the risk for 
complex CHD in their infants.  Predictors of birth weight included; maternal history of 
hypertension, serious health condition six months prior or during pregnancy, CHD, 
obesity and income (R² = 0.049, p < 0.05). Predictors of gestational age included; 
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maternal history of hypertension, flu, and serious health conditions six months prior or 
during pregnancy, and type of housing (R² = 0.045, p < 0.05). 
Conclusion: Maternal history of CHD and chronic health conditions were associated 
with increased risk for complex CHD in this sample.  Nurses can identify risk factors of 
CHD prior to pregnancy and provide education to women and their partners when 
planning a future pregnancy. The findings from this study reinforces that there are risk 
factors for complex CHD. It also illustrates the multifaceted nature of CHD and need for 
further investigation of maternal and paternal exposures to help identify other risk factors 
for complex CHD.  
Key words:  Congenital heart defects, pregnancy, cardiac, maternal exposures. 
Congenital heart defects (CHD) are the most common type of birth defect 
occurring in approximately 6-8/1,000 live births in the United States and continue to be a 
leading cause of illness and death in infants (Hoffman & Kaplan, 2002). Although, 
healthcare has made great strides in recognition and diagnosis of CHD, CHD prevalence 
appears to be increasing (Botto, Correa, & Erickson, 2001). In 2004, an estimated $1.4 
billion was spent for hospitalizations of individuals with CHD in the United States, of 
that $511 million was used to treat complex CHD (Russo & Elixhauser, 2007).  
During pregnancy a woman has many exposures within her environment of which 
she may or may not be aware that can influence cardiac formation in her fetus. She, in 
fact, may not be aware she is pregnant as cardiac formation occurs within the first 50 
days of pregnancy (Sartiani et al, 2010). There is an increasing awareness of the sensitive 
timeframe prior to and early in pregnancy and the influences of maternal health.  
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 The Wisconsin Pediatric Cardiac Registry (WPCR) was created in 1999 to collect 
subjective and genetic information on the parents and infants of children born in 
Wisconsin with various forms of CHD (Hanson-Morris, Pelech, 2006). It is estimated 
that 400-600 new cases of CHD are diagnosed each year in Wisconsin (Hanson-Morris & 
Pelech, 2006) or 6-7/1,000 live births (Harris et al., 2011). By studying the demographic 
and subjective information provided from these families it was hoped to identify risk 
factors for having an infant with complex CHD. 
Maternal health and exposures have also been associated other birth outcomes 
including birth weight and gestational age. Low birth weight and early gestational age 
have been associated with maternal risk factors such as chronic health conditions 
(Palmer, Bonzini, Harris, Linaker, & Bonde, 2013), history of smoking (Ashford et. al,  
2010; Rogers, 2009) , and socioeconomic status (Blumenshine, Egerter, Barclay, Cubbin, 
& Braveman, 2010; Jansen et al., 2009; Messer et al., 2008). In this group of infants with 
various forms of CHD, it is hypothesized that these maternal risk factors are also 
associated with the infants’ birth weight and gestational age as well as type of CHD.  It is 
important for women to optimize their health prior to and during pregnancy to decrease 
the risk for low birth weight and premature birth.  These infants with complex CHD were 
also believed to be at greater risk for low birth weight and prematurity due to the 
complexity of CHD diagnosis (Williams et al., 2010; Malik, Cleves, Zhao, Hobbs, & 
NBDS, 2007).  
 This study was developed to address the relationships between the maternal 
contextual factors and exposures prior to and during pregnancy to their birth outcomes 
using the data in the WPCR database.  Understanding the relationships of maternal health 
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and contextual factors may identify risk factors for having an infant with CHD in this 
sample. 
Conceptual Framework 
 A life course perspective on health was chosen as a theoretical model to guide this 
study as this theory conceptualizes health as a reflection of an underlying developmental 
trajectory.  The goal of the life course perspective is to understand, explain, and improve 
health and disease patterns across various populations (Halfon & Hochstein, 2002). The 
life course model uses a multidimensional approach incorporating the biological, 
psychological, behavioral, and social contexts to better explain health and disease 
processes of the person or community, allowing for the development of interventions and 
education practices to identify risk and protective factors (Fine & Kotelchuck, 2010). 
 This model acknowledges throughout the developmental trajectory, some contexts 
are fixed, or hard wired, and others contexts are highly flexible or amenable to change.  
The life course model fits well in the study of CHD as many of the contexts are both 
fixed and plastic occurring along a developmental trajectory.  The life course model 
reflects the epigenetic nature of diseases, or the heritable process of disease development 
(from mother cell to daughter cell, or sometimes from parent to child), which is not 
produced by a change in DNA sequence (Strachan & Read, 2011, pg. 724) and how 
today’s experiences and exposures determines tomorrow’s health.  Those health 
trajectories are particularly affected during critical or sensitive periods (timing) and the 
broader environment - biologic, physical, and social contexts – significantly affects the 
ability to be healthy (Kotelchuck, 2011).  Included in the study model were the maternal 
contextual and risk factors identified through a review of the current literature (Butler, 
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Johnson, & Cavan, 2014) (see Figure 1).   The purpose of this study was to explore the 
relationships of select maternal variables to the type of CHD, birth weight and gestational 
age in infants born with CHD participating in the WPCR from 2000-2010.  The 
hypotheses evaluated were: 
 Hypothesis 1:  Multiple maternal risk factors of  biologic (genetic causes 
associated with CHD, age, race, chronic health conditions, family history of CHD), 
physical (history of obesity, use of alcohol, drugs, cigarettes, medication/vitamin use, and 
type of water consumed), and social variables (SES, occupation, education level) 
influence the risk of complex CHD. 
 Hypothesis 2: Multiple maternal risk factors (biologic, physical, social) influence 
the risk of low birth weight or prematurity in the infants born with CHDs. 
Methods 
Design 
 Although, the original data were not collected with a specific research question in 
mind, the WPCR was designed to allow researchers and clinicians access to temporal, 
environmental, familial, and genetic data to explore relationships of potential causative 
factors of CHD, which is congruent with the specific aim and hypotheses of this study.  A 
secondary analysis of preexisting data was used in this study. Approval was obtained 
from Children’s Hospital of Wisconsin (CHW) Internal review Board for an exempt 
study.  Consent to participate was provided in the original study conducted at CHW and 
no patient contact was required. All data was de-identified, maintained and accessed on a 
secure computer.  This sample represented approximately 1/3 of the infants with CHD 
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and their caregivers who were consented and participated in the WPCR (1,687/4,919) 
during this timeframe (Harris et al., 2011).  
Setting and participants 
 Data for this secondary analysis were obtained from the WPCR database. The 
original study included children that were conceived and born in Wisconsin after January 
1, 2000, and diagnosed with a structural heart defect.  Participants were identified and 
recruited from pediatric cardiac referrals in Wisconsin. The cardiac defect was confirmed 
from echocardiography, catherization procedures or autopsy. Exclusions included; 
isolated patent foreman ovale, patent ductus arteriosus, electrophysiological disturbances, 
and acquired heart diseases. The sample was limited to children under the age of two 
years in order to reduce caregiver’s difficulty with recall bias when answering the 
questionnaire (Harris et al., 2011).  The present study contained 1,687 completed 
questionnaires from the WPCR of infant and maternal information that were used.   
Measures 
 Maternal context variables. The maternal contexts were divided into three 
categories (see Figure 1); biologic (genetic causes associated with CHD, age, race, 
chronic health conditions (CHC), family history of CHD) physical (obesity, ETOH/drug 
use, cigarette use, medication/vitamin use, type of water consumed), and social contexts 
(socioeconomic status (SES), occupation, education level). In the WPCR questionnaire, 
only questions specific to the maternal context variables were used to measure these 
concepts delineated in the conceptual framework.  Several concepts were represented by 
multiple questions to better capture the maternal contexts in this sample (see table 1).   
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 Infant outcomes. Three infant outcomes were used in the model; simple or 
complex CHD, gestational age and birth weight. The type of CHD variable was created 
using a modified classifications schema modified from the Baltimore Washington infant 
study (Ferencz, Loffredo, Correa-Villaseñor, & Wilson, 1997).  All CHD diagnoses were 
provided by ICD-9 codes which were recorded by the research coordinator. Simple CHD 
was defined as a single CHD diagnosis of:  atrial septal defect (ASD), ventricular septal 
defect (VSD), pulmonary valve disorders (PV), coarctation of the aorta (COA), and 
bicuspid aortic valve (BAV), mitral valve disorders (MV). Complex CHD was defined 
as: multiple CHD diagnoses and/or the diagnoses of Tetralogy of Fallot (TOF), 
atrioventricular septal defect (AVSD), transposition of the great arteries (TGA), 
pulmonary atresia (PA), hypoplastic left heart syndrome (HLHS), univentricular heart 
disease or variants including multiple lesions.  
Statistical Analysis 
 An initial evaluation of the dataset was undertaken to determine which items 
would be used to measure study concepts. After thorough evaluation of numeric, text data 
and cleaning of the dataset, 29 variables were chosen to measure the 14 maternal context 
variables proposed in this study. Variables were omitted if they included free text data, 
had more than 30% missing data, or were slightly different in the print or online 
questionnaires. A power analysis based on the work of Peduzzi et al. (1996) was 
performed to determine adequacy of size of the sample.  Using the formula of N=10k/p 
(k=number of covariates) (p=the smalls of the proportion of negative or positive cases).  
N=10(15)/.3, N= 500; 500 cases were required for this study.  A total of 1,687 cases were 
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available for study which was well over the 500 cases needed to identify significant 
relationships between the independent and dependant variables. 
 Characteristics of the sample were identified through descriptive analysis. 
Frequencies were used to describe the sample and to assess for skewness (distribution), 
kurtosis (clustering), central tendencies, and variability of the variable. Means, medians 
and standard deviations were calculated for continuous variables. Percentages were used 
for dichotomous and categorical variables. Demographic (race-Caucasian, water type-
city, marital status-married, income->$25,000 and education-some college) categorical 
variables were collapsed into dummy variable (yes or no) for the regression analysis.  
Pearson’s correlations, Spearman rho correlations, Phi coefficient and Cramer’s V tests 
were used to examine relationships between predictor and outcome variables. Only the 
significantly correlated variables were included in the final regression models 
(Tabachanick & Fidell, 2013).   
 An assessment of the reduced dataset (text in variables eliminated) using Little’s 
test determined patterns of the missing data.  Little’s test was significant at .885, p <.001, 
indicating the interval variables showed a pattern of data missing completely at random 
(MCAR) (Tsikriktsis, 2005).  One categorical variable had 12.2% of missing data which 
remained below 15% missing and was retained.  The remaining categorical variables had 
< 5% missing data. Because the majority of missing data was less than 10%, multiple 
imputations were used to impute the missing data (Tsikriktsis, 2005).    
 A direct logistic regression was performed to access the impact of a select number 
of maternal context factors (predictors) on the likelihood of having a child with complex 
CHD (outcome) in hypothesis 1. The logistic regression model was conducted with three 
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significantly correlated biologic maternal contexts (age, serious health condition six 
months prior or during pregnancy, and history of CHD) and two social maternal contexts 
(income and educational level). Correlations were noted to be small but significant (see 
tables 7-10). 
 Two hierarchical multiple regressions analyses were used to test hypothesis 2 and 
determine predictors for gestational age and birth weight.  Preliminary analyses were 
conducted to ensure no violation of the assumptions of normality, linearity, 
multicollinearity and homoscedasticity (Tabachanick & Fidell, 2013). An exploratory 
correlational analysis was also undertaken to address the following question. Does type 
of CHD (simple or complex) influence birth weight and/or gestational age?  Pearson’s 
correlations were used to address this exploratory research question. 
Results 
Sample Characteristics 
 This sample of 1,687 infants and mother dyads had overall normal birth weight 
(mean 3.178 kg/7#, 11.2 oz) and gestational age (mean 37.92 weeks) in the infants in this 
sample. The women in this sample were generally healthy with few chronic health 
conditions and healthy age for child bearing (mean 29 years). In this sample sex was 
equally distributed of 51% male and 49% female infants with CHD. Of these infants 73% 
had simple CHD, and 27% had complex CHD (see table 2).  
  The majority of the mothers in this sample were Caucasian, married, and 
educated with some college. These women were mildly overweight (mean BMI=26, 
overweight= 25-29.9) and 17% reported history of obesity. Most were middle to upper 
class living in single family homes. Many of these mothers were healthy with asthma 
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noted most frequently as a chronic health condition (29%). The majority of these women 
used multivitamins prior and/or during pregnancy (91%) and less than a 25% reported 
taking a prescription medication. Many women reported history of smoking (41%) and 
the majority consumed alcohol (70%). Few reported using illicit drugs (< 2.3%).  Over 
75% of the women worked prior their pregnancy and continued to work during their 
pregnancy (See table 3, 4). 
Predictors of complex CHD  
 To test the first hypothesis a direct logistic regression was performed entering the 
variables by domain per the conceptual framework. The final model contained five 
significantly correlated maternal context variables (see tables 7-10).   The model as a 
whole containing all predictors was statistically significant, χ² (5, N = 1687) =34.1, 
p<.001, indicating that the model was able to distinguish between subjects with simple or 
complex CHD. The model explained 2% (Cox & Snell R²) and 2.9% (Nagelkerke R²) of 
the variance in type of CHD (simple/complex) and correctly classified 73.1% of complex 
CHD cases (Field, 2013). As shown in Table 5, two context variables made a uniquely 
statistically significant contribution to the final model, maternal history of serious health 
condition and history of CHD. The strongest predictor of having an infant with complex 
CHD was maternal history of CHD, (B=.420, SE = .179; Exp(B) =2.389), indicating that 
mothers who had a history of CHD were 2.4 times more likely to have an infant with 
complex CHD. These mothers with history of a serious health condition prior or during 
the pregnancy was a significant predictor of complex CHD (B=.871, SE = .262; Exp(B) 
= 1.523), were 1.5 times more likely to have an infant with complex CHD (see Table 5). 
Predictors of Birth Weight and Gestational Age. 
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 To test the first part of hypothesis 2, which studied the predicators of birth weight, 
nine significantly correlated maternal variables to birth weight were into the regression 
using the domains in the conceptual framework (see tables 7-9). The significant 
correlations were small (r = < 0.1). 
 A hierarchical multiple regression were performed to assess the ability of the nine 
maternal context variables to predict birth weight of the infant born with CHD (see Table 
6). Biological variables, age, maternal race, history of respiratory infection, hypertension, 
serious health conditions and history six months prior or during pregnancy of CHD were 
entered at Step 1, and explained 3.1 % of the variance of birth weight. The physical 
variables history of obesity, BMI, and income level entered in Step 2, explained another 
1.3 % of the variance and all of but history of respiratory infection, remained significant, 
R² change = .013, F change (2, 1592) = 10.486, p <.001. In Step 3 the addition of social 
variable of income level explained .6 % of the variance, R² change = .006, F change (1, 
15911) = 10.125, p < 0.05. In the final model five maternal context variables were 
statistically significant explaining a total of 4.9% of the variance in the final model.  
History of hypertension, serious health conditions, obesity, annual income and history of 
history of CHD remained to be significant predictors of birth weight in the final model 
explaining 4.9% of the variance of birth weight. 
 To determine predictors of gestational age, six maternal variables with significant 
correlations to gestational age were entered into the hierarchical regression using the 
domains in the conceptual framework (see table 7-9).  The significantly correlated 
variables had small correlations (r = < 0.1). 
96 
 
 
 Biologic variables, history of emotional disorder, hypertension, flu and serious 
health conditions six months prior or during pregnancy were entered at Step 1, and 
explained 3.8% of the variance of gestational age. The physical variable of alcohol use 
was entered in Step 2, which explained another .2 % of the variance. In Step 3 with the 
addition of a social variable, type housing, .4% of the variance was explained, R² change 
= .004, F change (1, 1680) = 7.875, p < 0.05. In the final model four maternal context 
variables (history of HTN, flu, and serious HC, and type of housing) were statistically 
significant explaining 4.5% of the variance of gestational age (see table 6). 
Exploratory Analysis. 
 The type of CHD was not significantly correlated with birth weight and 
gestational age (BW= -.014, GA .011, r). In this study type of CHD did not influence 
gestational age and birth weight.  
Discussion 
 Two significant relationships were obtained between the maternal context 
variables (serious health condition and history of CHD) and risk for complex CHD.  
Although the model had 14 maternal context variables, only five significantly correlated 
variables were retained for the logistic regression. In this sample the majority of women 
were generally healthy, educated and had minimal reported substance use that would be 
put them at risk. However, history of a serious health condition showed a 1.5 fold 
increased risk for complex CHD in their infants.   
  Having a serious health condition or chronic health condition prior to or during 
pregnancy has been associated greater risk for all CHD (Miller et al., 1981; Oster, Riehle-
Colarusso, Alverson, & Correa, 2011; Srinivasan, Dheen, & Tay, 2007).  Although the 
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type of illness or serious health condition is not well delineated to type of illness or exact 
timing in this sample, it does support that there is a relationship with history of any 
chronic illness and increased risk of CHD if present prior or during pregnancy.  
 In this study we found an associated greater risk for complex CHD when there 
was maternal history of CHD, 2.4 fold increased risk. The BWIS (1997) reported an 
increased risk for CHD when there was first degree family history of CHD (OR 4.1, CI 
1.6-10.7), however they did not find an association with greater risk complex CHD. 
Romano-Zelehka et al.’s (2001) study which found increased risk for CHD (aOR 1.73, CI 
0.89-2.44), most commonly ASDs, when there was parental history of CHD.  Although, 
the exact mechanism of inheritance remains unknown it is consistent with the multi-genic 
complex developmental process and greater propensity for producing offspring with 
CHD when there is family history of CHD (Ferencz et al., 1989).    
 The second hypotheses revealed several maternal context predictors influencing 
gestational age and birth weight of this sample. Although these maternal context 
variables were statistically significant, they only explained about 4-5% of the variance in 
the outcome variables (gestational age, birth weight). Gestational age and birth weight 
did not statistically impact risk for complex CHD in this sample and maybe be related to 
the socioeconomic status of this population.  The findings of no relationship were not 
consistent with other studies. Some have found the greater the severity of the CHD the 
greater risk for prematurity and low birth weight are present (Malik, Cleves, Zhao, Hobbs 
& NBDS, 2007, BWIS, 1997).   
   In the model 4.4% of the variance was explained. Although, 95% if the variance 
was not explained by this model, this study identified specific risk factors for lower birth 
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weights in these infants’ born with CHD from a relatively healthy group of women. 
Maternal history of hypertension, serious health condition, CHD, obesity six months prior 
or during pregnancy were consistent with the literature finding poor birth outcomes when 
CHD was present (Stochard, Tennant, Bell & Rankin, 2011).  Obesity in this study was 
significant and also has been associated with a number of congenital malformations 
including neural tube defects and CHD (Mills, Troendle, Conley, Carter & Druschel, 
2010; Stothard, Tennant, Bell & Rankin, 2009; Watkins & Botto, 2001).   
 The common risk factors associated with CHD and other birth defects, such as 
alcohol (Jenkins et al, 2007; Matok, Pupco, Koren, 2011), illicit drug use, smoking 
(Alverson, Strickland, Gilboa & Correa, 2011; Gianicolo, Cresci, Ait-Ali, Foffa & 
Andresassi, 2010; Sartiani et al, 2010) and teratogenic exposures did not significantly 
correlate with type of CHD or poor birth outcomes. Although, these risk factors are 
associated not only with CHD but other birth defects, if the mother does not report such 
exposures, further review of health history for chronic health conditions and social 
history should be reviewed as our sample had other identifiable risk factors. 
 There was a relationship of each of maternal contexts and one of the infant 
outcomes. However, in the exploratory analysis in the conceptual that were not supported 
by the findings of this study was the relationship between type of CHD and birth weight 
or gestational age.  Although gestational age and birth weight were highly correlated to 
each other neither was correlated to type of CHD.  If future research using a more diverse 
and larger sample supports our findings, the conceptual framework may be revised.  
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Statistical considerations and limitations  
 The large sample available in the dataset allowed for relationships to be explored 
comparing birth outcomes of the infants born with CHD, however these risks cannot be 
inferred to the infant without CHD.  Alcohol, smoking and drug use questions were used 
in this study but from review in the literature, the accuracy of information about sensitive 
questions such as smoking, alcohol and drug consumption can be a problem in survey 
data (Van de Mortel, 2008; Del Boca & Darkes, 2002).  Poor recall or bias in reporting 
these variables may account for the lack of relationships identified in this study. 
Generalizability may be limited as the sample is included only infants born in the state of 
Wisconsin from 2000-2010 which is a predominantly Caucasian, middle class, 
Midwestern state. The finding may not be representative of other demographic locations 
in the United States.  
 Most research exploring CHD risk factors and prevalence has used a control 
group for comparison; however, an adequate control group was unavailable for this study 
but not essential to test the hypotheses. The BWIS (1997) was the largest population 
study to identify multiple risk factors for CHD. In the BWIS, although a case control 
study, CHD type was classified according to severity and risk factors for the types of 
CHD ranging from simple, moderate and complex. More risk for complex CHD was 
identified when there was maternal history of chronic health conditions. 
 Specificity of critical time frames of exposure is limited in this study. This study 
uses cross sectional data collected over a decade, thus predictors must be interpreted 
cautiously as it does not indicate causal evidence. The maternal variables reporting 
history of illness, chronic health conditions, serious health conditions and obesity all were 
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measured using a six month prior to or during pregnancy timeframe.  Some of the 
variables were non-specific such as the serious health condition variable.  These variables 
which were available may have been a factor in the prediction of the model rather than a 
flaw in the model itself. 
 In this sample serious health conditions were found to be a greater risk for 
complex CHD.  This finding may be influenced by the general health status of the 
sample. Due to the lack of a sufficiently robust control sample and the type of serious 
health condition cannot be determined, the most influence health condition affecting risk 
for complex CHD cannot be elicited. Additional research will be needed to clarify these 
relationships. 
Implications for Practice and Research 
 In this study we found several significant maternal risk factors for having an 
infant with complex CHD.  These maternal context factors were also significant 
predictors for birth weight and gestational age in this population. Although the sample 
was limited, the findings can be used to guide the assessment of women’s health history 
and health practices.  This study supports the practice of a thorough review of health 
history and health practices with all women to identify potential risk factors for having an 
infant with CHD. In the recently published Scientific Statement for the management of 
fetal cardiac disease (Donofrio et al. 2014), it is recommended that women with personal 
history of CHD, specific CHC’s or infections (pre-gestational diabetes, lupus, 
hypertension- on ACE inhibitors, rubella), or history of known genetic condition have a 
fetal echo performed.  These maternal conditions are just a few examples indicating the 
necessity of a prenatal cardiac evaluation due to increased risk for CHD. There are 
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several modalities for prenatal cardiac evaluation dependant on the maternal history and 
type of congenital heart disease present during pregnancy.  If CHD is diagnosed promptly 
in the prenatal timeframes planning and/or management can be provided to ensure 
optimal outcomes of the infant and pregnant woman can be initiated.   
 The use of electronic medical record systems has been a nationwide undertaking. 
Many nurses are using an electronic medical record (EMR) system; accurate recording of 
family history, past medical history and social history may facilitate screening of women 
and families. A three generation genogram may be critical in the identification of cardiac 
risk factors for future pregnancy (Wright & Leahey, 2013). Development or training for 
use of an electronic version in the EMR may be helpful and resourceful for a busy 
practice.  Review of these families educational level, occupation, and medical history can 
help identify at risk women and families when previewed by the health care professional. 
Accessing programs and obtaining suitable teaching materials may assist at risk 
individuals and provide opportunities to review current recommendations for healthy 
pregnancies. Many of the maternal risk which we have identified in this study can be 
identified through thorough history and physical assessment at routine health visits.  The 
known modifiable risk factors should be discussed with all women and their partners who 
are contemplating pregnancy.   
 Inclusion of the man’s health and exposures is extremely important and often 
overlooked.  As we learn more about epigenetic influences and the influences of 
generational health practices, a thorough health history for both woman and man will be 
necessary to identify risk factors for birth defects, particularly CHD for example when 
there are multiple family members reporting history of CHD.  It is being better 
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understood the exposure history of the father may have as great of an impact on the risk 
for CHD development during the pre-pregnancy stage as well as at conception as the 
woman. Nurses and HCP’s can help identify these risks factors and provide counseling to 
these families and future generations for good healthcare practices prior to pregnancy to 
help decrease the risk of complex CHD and promote healthy infant outcomes. As our 
healthcare systems shift to a preventative model for healthcare delivery, nurses can excel 
in leading prevention and education. 
 The conceptual framework was generally supported the by relationships between 
the maternal contexts and infant outcomes. However, not all relationships between 
maternal contexts and outcomes in the model were supported by the data; physical and 
social contexts were not related to type of CHD. The biological realm showed the most 
influence on type of CHD which could be due to the generally healthy sample. Or it may 
be related to a biologic predisposition occurring early in cardiogenesis that does not 
influence the type of CHD but rather the development of CHD in general. Interestingly 
the relationship between type of CHD and birth weight and gestational age were not 
supported as previously suggested in the literature (Williams et al., 2010; Malik, Cleves, 
Zhao, Hobbs, & NBDS, 2007).  Future research may better clarify these relationships 
which then the conceptual framework could be modified accordingly.  
Summary 
 CHD continues to be the leading birth defect occurring worldwide.  There are 
known risk factors which can be identified to help decrease the risk of complex CHD, 
premature birth and low birth weight in infants.  It is important to discuss the risk factors 
with our families of childbearing age to raise awareness for positive health practices 
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which may contribute to reducing the risk of complex CHD. Prenatal diagnosis of 
complex CHD through fetal echo and other modalities can assist in providing optimal 
outcomes of the infant and pregnant woman.  Continued research in this area is needed 
but also inclusion of the paternal health practices. It is necessary to capture the entire 
family as one of the most significant risks for complex CHD is personal maternal history.  
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Figure 2. 
 
Call outs:  (3 required- no more than 25 words each) 
 
Call out 1: After introduction 
Congenital heart defects are the leading birth defect in the world. Positive prenatal 
maternal health practices can help decrease risk for complex CHD. 
Call out 2: Before the results section 
Maternal history of CHD increases risk for having a child with complex CHD. 
Call out 3:  Prior the discussion 
Identification of at risk women prior to pregnancy is critical in reducing their risk of 
complex CHD for future pregnancies. 
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Table 1 
Maternal questions used in analysis 
Domain Context Question 
Infant  Gestation What was mother’s expected delivery date? 
 Gestation When was mother‘s last menstrual period prior to this pregnancy? 
 Birth weight How much did your baby weight at birth? Lbs/oz. 
Biologic Race Please circle mother’s race or ethnic group. 
 Age What is mother’s date of birth? 
 Genetic causes Did/does mother have any birth defect, malformation, or condition other than CHD 
which was present from birth? 
 FH CHD Did/does mother have a CHD, heart condition that she was born with? 
 CHC Has mother ever been told she has diabetes? 
 CHC Has mother ever been told that she has any of the following illnesses? 
(asthma/allergies, epilepsy, thyroid, peptic ulcer, eating disorder, cancer, other) 
 CHC In the 6 months prior to or during this pregnancy did mother have any of the following 
illnesses or conditions? (high blood pressure, obesity, bladder or kidney infections, 
emotional, vaginal infections, arthritis, headaches, colds, sinus infection, bronchitis) 
 CHC In the 6 months prior to or during pregnancy did mother have or was mother exposed 
to anyone with the following infections? (influenza, mumps, measles, rubella, chicken 
pox, hepatitis, AIDs/HIV) 
 CHC In the 6 months prior to or during pregnancy did mother have any other serious health 
problems or was she hospitalized for any reason, excluding delivery? 
Physical Med/vit Did mother take vitamins or multi-vitamins during this pregnancy? 
 Med/vit During this pregnancy did mother regularly take medications not mentioned above? 
 Obesity Mothers height 
 Obesity What was mother’s pre-pregnancy weight? 
 Tobacco Did mother ever smoke cigarettes? 
 Alcohol In the 6 months prior to or during pregnancy did mother drink any alcoholic 
beverages? 
 Alcohol On average, how often did mother drink alcoholic beverages during the 6 months prior 
to or during pregnancy? 
 Drug  During this pregnancy, did mother use any of the following drugs? (cocaine, 
marijuana, hash/hashish, amphetamines, pain killers, glue sniffing, crack, heroin, 
barbiturates, valium, other) 
 Water What was the source of mother’s drinking water during this pregnancy? 
Social SES Select the category that best represents the total annual family income. 
 SES What is mother’s marital status 
 SES In what type of house did mother live? 
 Education What was the highest grade of schooling mother has completed? 
 Occupation Was mother working during the 6 months before she became pregnant? 
 Occupation Was mother working during this pregnancy? 
Note: CHC, chronic health condition, FH CHD, family history of congenital heart defect, SES, socioeconomic status. 
 
 
Table 2 
Infant Demographic Characteristics    
Infant outcomes Mean Range N % 
Gestational age 37.92weeks 24-45weeks 1,687  
Birth weight 3.17 kg .54-5.37 kg 1,687  
simple   1,232 73 
complex   453 26.9 
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Table 3 
Maternal Characteristics (n=1,687) 
Maternal Context Maternal Context 
Variables 
Demographics 
Biologic Age Mean 29.19 
SD 5.739 
Range 14-48 
 Race 4.2 % African American 
1.4  % Asian 
86.2 % Caucasian 
4.4 % Hispanic 
1.6 % Native American 
2.2 % Other 
Physical BMI Mean 26 
SD 6.26 
Range 15.19-56.57 
 Water type 62.8 % city 
20.3 % well 
13.6 % bottle 
3.3 % other 
Social Marital 17.7 % single, widowed 
78.9 % married 
 3.3% divorced, separated 
 Housing 69 % single family 
12.8 % row/duplex/townhouse 
13.1 % apartment 
3.4 % trailer 
1.6 % other 
 Income 7.5 % < $10 
7.1 % $10-19999 
7.2 % $20-24999 
21.9 % $25-49999 
40.4 % $50-99999 
14.1 % >$100K 
 Education 6.9 % grammar 
27.7 % HS/equiv 
11.6 % voc/tech 
18.2 % some college 
23.6 % bachelors 
10.4 % masters 
1.6 % doctorate 
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Table 4 
Maternal Health and Substance History (n=1,687) 
Maternal Context Maternal Context 
Variables 
Yes 
Biologic Chicken pox/exp 4.9% 
 Birth defect 5.9% 
 CHD 7.7% 
 Diabetes 7.8% 
 Bladder 11% 
 HTN 11.4% 
 Serious HC 13.8% 
 Emotional disorder 14.5% 
 Flu or exp 23.1% 
 HA 32.9% 
 Respiratory infection 46.9% 
Physical Painkillers 2.7% 
 Marijuana 2.9% 
 Hx obesity 16.6% 
 Pres drug 25.4% 
 Ever smoke 40.7% 
 Alcohol use 67.9% 
 Vitamin 91.3% 
Social Work during 76.5% 
 Work before 79.4% 
Note: HA=headache, HTN=hypertension, SHC=Serious health condition, CHD=congenital heart defect  
 
Table 5  
 
Logistic regression for predictors of type of CHD (simple complex or complex)  
 
Maternal 
Context 
Variables 
B S.E. Wald df   p Odds Ratio 95% C.I. 
for OR  
Lower 
 
 
Upper 
Step 1 Biologic         
Age -.025 .010  7.211 1 .009   .975   .957   .994 
SHC  .436 .178   6.446 1 .014 1.546 1.091 2.192 
CHD  .842 .262   9.742 1 .001 2.322 1.389 3.880 
Step 2 Social         
Age -.012 .011     1.100 1 .297   .989   .967 1.010 
SHC  .420 .179   5.916 1 .019 1.523 1.073 2.161 
CHD  .871 .262 10.500 1 .001 2.389 1.429 3.996 
Income -.053 .049   1.008 1 .285   .949   .862 1.045 
Education -.069 .044   3.526 1 .118   .934   .857 1.018 
Note:  SHC=Serious health condition, CHD=Congenital heart defect 
*p  <  .05, **p  <  .001 
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Note:  Resp inf= respiratory infection, HTN=hypertension, SHC=Serious health condition, CHD=congenital heart 
defect, BMI=body mass index 
*p  <  .05, **p  <  .001 
Table 6 
 
Hierarchical Regression coefficients for predictor variables 
 B S.E.  R
2 
R2 
Birth weight 
Step1 Biologic  .66437  .031** .031** 
Race .035  .037   
Age .003  .025   
Resp inf -.075  -.048*   
HTN  .228  .105**   
Serious HC .200  .100**   
CHD -.158  -.063*   
Step2 Physical  .66045  .043** .013** 
Race .037  .040   
Age .002  .021   
Resp inf -.064  -.039   
HTN  .257  .118**   
Serious HC .213  .107**   
CHD -.164  -.065*   
BMI .002  .021   
Obesity -.179  -.099*   
Step 3 Social  .65857  .049* .006* 
Race .034  0.36   
Age -.003  -.024   
Resp inf -.064  -.039   
HTN .249  .114**   
Serious HC .217  .109**   
CHD -.170  -.068*   
BMI .004  .040   
Obesity -.162  -.091*   
Income .044  .091*   
Gestational age 
Step 1 Biologic  2.244  .038** .038** 
Emotion .277  .050   
HTN .628  .089**   
Flu -.308  -.061*   
SHC .955  .142**   
Step 2 Physical   2.242  .040 .002 
Emotion .257  .047   
HTN .620  .088*   
Flu -.287  -.056*   
SHC .958  .142**   
Alcohol -.195  -.043   
Step 3 Social  2.238  .045* .004* 
Emotion .296  .053   
HTN .634  .091**   
Flu -.304  -.059*   
SHC .958  .142**   
ETOH 6 -.218  -.048   
Housing .159  .068*   
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Table 7 (supplemental material) 
Correlations Matrix: Simple/complex CHD and BW and GA    
Biologic maternal context variables 
 BW GA S/C Race Age Diabetes  Bladder Resp HA Emotion HTN Flu SHC Chic CHD BDF 
BW¹ 1                
GA¹ .690** 1               
S/C³ -.014 .011 1              
race² .051* .018 -.029 1             
age¹ .062* -.037 -.062* -.013 1            
diabetes ³ .043 .046 .048 .007 -.009 1           
bladder³ .016 -.026 .003 -.069* .107** .019 1          
Resp³ -.055* -.047 .039 -.010 -.039 - .008 .019 1         
HA³ .016 .023 .034 .004 .069** -.025 .105** .264** 1        
Emotion³ .034 .060* .026 -.026 .018 .010 .168** .027 .121** 1       
HTN³ .118* .109** .024 .001 .032 -.005 .115* .013 .116** .070* 1      
Flu³ -.049 -.050* .005 -.013 -.049 .038 .061* .191** .096** .042 -.002 1     
Chixpox³ -.043 -.040 .006 -.021 -.009 -.009 .039 .058* .045 .023 .035 .197** 1    
SerHC³ .111** .157** .067* -.025 -.014 -.015 .064 .019 .045 .093** .128** .034 -.023 1   
CHD³ -.053* -.043 .080** -.004 .018 -.031 .047 -.002 .038 .065* .028 .037 -.019 .060* 1  
BDF³ .030 .008 .032 -.026 -.001 -.010 .043 .024 .019 .100** .012 .019 .027 .049* .161 1 
Note. Comparisons were two-tailed and (1) Pearson’s r statistics, Spearman’s rho (2) or Phi Coefficient (3) 
* Correlation is significant at the 0.05 level (2-tailed) **Correlation is significant at the 0.01 level (2-tailed) 
*p=<.05, **p<.0006. 
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Table 8 
Correlations Matrix: Simple/complex CHD and BW and GA    
Physical Maternal context variables 
 
 BW GA S/C BMI Obesity Presdrug MVI H2O Marij Painkill Smoke ETOH 6 mo 
BW¹ 1            
GA¹ .690** 1           
S/C³ -.014 .011 1          
BMI¹ .062* .001 .045 1         
Obesity³ -.093** -.007 .018 -.645** 1        
Predrug³ .004 .026 .024 -.047 .063* 1       
MVI³ .000 .016 .005 .051* -.024 .010 1      
H20² -.003 -.017 -.018 -.036 .033 .028 .012 1     
marij³ -.016 -.011 .001 .019 -.032 .007 .027 -.011 1    
painkill³ -.043 -.028 .019 .094** -.128** -.107* -.009 -.025 .165 1   
smoke_³ .029 -.011 .023 -.029 .056* .053* -.070** -.011 -.111** -.092** 1  
ETOH6mo³ -.047 -.050* .015 .056* .031 .038 .094** .024 -.036 .014 .164** 1 
Note. Comparisons were two-tailed and (1) Pearson’s r statistics, Spearman’s rho (2) or Phi Coefficient (3) 
* Correlation is significant at the 0.05 level (2-tailed) 
**Correlation is significant at the 0.01 level (2-tailed) 
*p=<.05, **p<.0006 
  
 11
8
 
 
Table 9 
      Correlations Matrix: Simple/complex CHD and BW and GA    
      Social Maternal context variables 
 BW GA S/C Marital Annual  
income 
Education housing Work 
before 
Work 
during 
BW¹ 1         
GA¹ .690** 1        
S/C³ -.014 .011 1       
Marital² .040 -.039 -.038 1      
Annual income¹ .077** .002 -.074** .416** 1     
Education¹ .033 -.018 -.075** .299** .547** 1    
Housing² .001 .049* -.015 -.165** -.389** -.267** 1   
Work before³ .045 .033 .006 -.095** -.173** -.169** .055 1  
Work during³ .045 .020 .006 -.103* -.191** -.190** .083** .752** 1 
Note. Comparisons were two-tailed and (1) Pearson’s r statistics, Spearman’s rho (2) or Phi Coefficient (3) 
* Correlation is significant at the 0.05 level (2-tailed) 
**Correlation is significant at the 0.01 level (2-tailed) 
*p=<.05, **p<.0006. 
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    Table 10 
    Correlations Matrix: Simple/complex CHD and BW and GA    
Birth outcomes 
 Birth weight Gestational age Simple/complex CHD 
Birth weight¹ 1   
Gestational age¹ .690** 1  
Simple/complex CHD³ -.014 .011 1 
   Note. Comparisons were two-tailed and (1) Pearson’s r statistics, Spearman’s rho (2) or Phi Coefficient (3) 
  * Correlation is significant at the 0.05 level (2-tailed) **Correlation is significant at the 0.01 level (2-tailed) 
  *p=<.05, **p<.001. 
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Chapter 5 
 The purpose of this study was to provide of synthesis of the manuscripts including 
a review of literature on the maternal risk factors for congenital heart defects CHD and 
the known genetic risk factors for CHD. A discussion of the findings from the 
dissertation study that identified significant relationships between the maternal context 
factors and the birth outcomes of their infants (type of CHD-simple/complex, birth 
weight, and gestational age) is provided. This chapter begins with a synthesis of the 
manuscripts and continues with a discussion, limitations, and future implications in 
theory, practice, education, research and policy.  
Synthesis of Manuscripts 
 A review of literature of all CHD was performed to gain an enhanced 
understanding of the risk factors for CHD in the mother was the focus of the dissertation 
and the hypothesis.  The exploratory research questions regarding birth weight and 
gestational age were undertaken to better understand and explain the type of CHD in this 
dataset.  The first manuscript titled, “Association of Maternal Risk Factors and CHD” 
provided an examination of the current state of the science of the maternal context factors 
associated for having an infant with CHD.  In this review of literature, identification of 
the maternal risk factors associated with CHD during pregnancy was analyzed and sorted 
into maternal context variables of biologic, physical and social contexts using a life 
course perspective.   An abundance of literature was discovered initially and was 
narrowed to provide the most recent research. The majority of the literature was written 
by medical or epidemiological disciplines with limited literature in the nursing domain. 
In this review the studies consisted of population based, registry based, case control or 
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retrospective studies conducted worldwide.  Several reviews were also discovered, which 
discussed specific maternal risk factors for CHD but, none of which contained all of the 
maternal contexts of interest in one study (Gorini, Chiappa, Gargani, & Picano, 2013; 
Luteijn, Brown, & Dolk, 2013; Patel & Burns, 2013; Stothard, Tennant, Bell & Rankin, 
2009; Jenkins at al., 2007; Thulstrup & Bonde, 2006; Watson, Jacobson, Williams, 
Howard & DeSesso, 2006; Lin & Ardinger, 2005).   
In the first manuscript, a review of literature of maternal CHD risk factors in 
pregnancy was conducted using the theoretical life course perspective as the context 
within which to place findings.  The intention of the life course perspective is to 
understand, explain and improve health and disease patterns across various populations 
(Halfon & Hochstein, 2002). The life course perspective employs key components 
including timelines, timing, environment, and equity of health (Kotelcheck, 2011; Fine & 
Kotelcheck, 2010).  These key components reflect the multilayer complexity of human 
life and health which is helpful when discussing a complex disease process such as CHD.  
Using this perspective allowed for arrangement of the risk factors identified in the 
literature under the realms of biologic, physical and social contexts.  A conceptual 
framework was developed from the review of literature and framed using the life course 
perspective which then guided the dissertation study (see Figure 1). 
In this review the maternal contexts associated with CHD identified in the 
literature included the biologic contexts of known genetic causes, maternal age, race, 
chronic health conditions, and family history of CHD; the physical maternal contexts of 
obesity, substance use, medication and vitamin use, and water consumption; and the 
social maternal contexts of socioeconomic status, occupation history, and educational 
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level (Gorini, Chiappa, Gargani, & Picano, 2013;Luteijn, Brown, & Dolk, 2013; Patel & 
Burns, 2013; Stothard, Tennant, Bell & Rankin, 2009; Jenkins at al., 2007; Thulstrup & 
Bonde, 2006; Watson, Jacobson, Williams, Howard & DeSesso, 2006; Lin & Ardinger, 
2005).  These maternal risk factors were found to be risk factors for developing CHD in 
their fetuses.  Although, these risk factors were identified, many of the researchers 
recognized the limitations for accurately measuring the types of exposures, isolating the 
types of exposures, or identifying immediate causal relationships of the risk factors for 
CHD due to the multifactorial nature.  Many researchers commented on the need for 
continued research of the etiology of CHD. Some suggested larger sample size and 
prospective studies to provide other perspectives to better understand the risks for CHD 
development in the fetus.  
As a result of this review of literature, it was recognized that the current studies 
separated many of the maternal risk factors and did not provide a comprehensive review 
for all the maternal context variables.  Small samples, others with methodological flaws 
and inability to accurately measure the variables associated with greater risk for CHD 
were identified in this process.  It was also recognized that the genetic influence toward 
CHD must be elaborated separately to best appreciate the influence on CHD 
development.  Therefore the second manuscript reviews the known genetic influences on 
CHD development.  
The second manuscript titled, “Understanding Genetics and Pediatric Cardiac 
Health” was produced as the genetic association for CHD development was substantial 
and required further discussion. The objective of this manuscript was to provide a review 
of the known genetic pathways and risk factors associated with CHD development for 
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nurses and health care providers (HCPs).  This manuscript provided an overview of 
inheritance patterns, identified genes associate with CHD, and discussion of the 
additional educational, clinical and research needed to better understand genetic CHD 
development.  During the construction of this manuscript, limited nursing literature was 
found on this topic illustrating a need for greater understanding and integration of 
genetics into nursing practice and research. The majority of literature was found in the 
medical and epidemiological disciplines and well describes the known genetic influences 
on CHD formation.   
The reviews of the maternal risk factors for having an infant with CHD helped 
identify the need to understand these risk factors.  It was then proposed that these 
maternal contexts could influence the type of CHD in the infant. In this review the studies 
were case control with the majority studying the risk for general CHD rather than type of 
CHD. Some studies reviewed prevalence of the types of CHD, but no study was 
identified which compared risk for simple verses complex CHD, and if greater risk for 
complex CHD was present when more maternal contexts were present. This is the first 
study reviewing the maternal data from 2000-2010 in the WPCR database.  Due to the 
lack of a robust control group a hypothesis was derived using the dependant variable- 
type of CHD (simple or complex) as there was an adequate sample size to provide 
comparison.  The dissertation study was conducted using a life course perspective as this 
model acknowledges the multilevel interactions and trajectories of the mother.   Using 
data within the WPCR from 2000-2010 exploration of the maternal data was performed 
to identify relationships to types of CHD (simple or complex).  Two hypotheses and one 
exploratory research questions were asked.   
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Hypotheses 1:  Multiple maternal risk factors of  biologic (known genetic causes 
associated with CHD, age, race, chronic health conditions, family history of CHD), 
physical (history of obesity, use of alcohol, drugs, cigarettes, medication/vitamin use, and 
type of water consumed), and social variables (SES, occupation, education level) 
influence the risk of complex CHD. 
Hypothesis 2: Multiple maternal risk factors (biologic, physical, social) influence the 
risk of low birth weight and/or early gestational age in the infants born with CHDs.  
The third manuscript was constructed from this study, and is titled, “Maternal 
Health and Infants Born with Congenital Heart Disease: A Secondary Analysis of the 
WPCR”.  This manuscript provided the study design, methodology and results of the 
dissertation study. In this study 1,687 completed questionnaires from 2000-2010 were 
used with focus on maternal and infant pre-conception and inter-conception history.  The 
maternal history was self reported information and the infant history was a combination 
of reported information from the caregiver and clinical data provided by the research 
team.  After thorough cleaning of the data, 29 questions were used to represent the 14 
maternal context variables organized according to the conceptual model (see Figure 1).  
Descriptive analysis was conducted using these variables which provided rich 
demographic, health and social history information for this population. These variables 
were then analyzed for relationships between the maternal context variables and types of 
CHD and infant birth outcomes in which the significantly correlated variables were 
retained in the final analysis.  The infant birth outcome of simple or complex CHD was 
developed from a model used in the larger Baltimore Washington Infant Study (Ferencz, 
Loffredo, Correa-Villaseñor, & Wilson, 1997) which the WPCR was modeled after.  The 
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type of CHD was used to compare differences in this population as there was not an 
adequate control group available. With this large data set the comparison of risk for 
simple or complex CHD in this group was performed using logistic regression.  
 The WPCR went through several transitions over the years, moving from a print 
questionnaire and paper data source to completely electronic database. Due to these 
changes, during the cleaning of this dataset some variables were eliminated due to 
inconsistencies and concern for error and poor reliability.  Data entry and interrator 
reliability was not able to be accurately assessed therefore text in variables were used 
cautiously. Education was the only text in variable retained in the final analysis and was 
re-coded into a categorical variable.  All other variables for the final analysis were either 
continuous or categorical variables.  
 Another concern with using a large pre-existing data set was missing data.  With 
guidance and constant review of the data from a statistician, missing values analysis was 
performed. In this dataset the variables selected did not contain significant amounts of 
missing data therefore a listwise deletion method was not used to preserve the entire 
dataset. The majority of missing data was < 10% missing, and the data missing more than 
10% was well below 50%; therefore multiple imputations were used to impute the 
missing data (Tsikriktsis, 2005).   
From the analysis of this dataset the third manuscript provided a discussion and 
presentation of the results of this study. The main findings of this study included two 
significant predictors for having a child with complex CHD.  These two variables, 
maternal history of CHD (OR 2.382, 95 % CI, 1.424-3.984) and history of serious health 
condition (OR 1.537, CI 1.085-2.178) showed a greater risk for having an infant with 
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complex CHD.  The women with reported personal history of CHD were 2.4 times more 
likely to have an infant with complex CHD.  Although, this study was not a case control 
and cannot infer generalization to infants without CHD.  The findings in this study was 
consistent with the literature, in which first degree family members with history of CHD 
had a 2-4 fold increased risk of any CHD in their offspring (Hinton et al., 2007; Lin & 
Ardinger, 2005; Ferencz et al., 1989). In Caputo et al. (2005) large case control study, 
they did not find a significant risk relationship in simple CHD (atrial septal defects). 
However, In Nora et al. (1969) study of atrial septal defect (ASD) and ventricular septal 
defect (VSD) inheritance risk, a 2.6-3.7% higher risk was noted.  The majority of infants 
in this study (73%) had simple CHD, with about 1/3 of the infants having complex CHD 
(27%).  This study supports the findings of having a first degree relative as a risk factor 
for complex CHD. 
 In the current study, history of a serious health condition was a significant 
predictor for complex CHD in the infant and is supported as a risk factor for CHD in the 
literature. This group of women was 1.5 times more likely to have an infant with complex 
CHD if the mother reported a serious health condition prior to or during the pregnancy.  
This variable was measured as a yes or no answer with the ability to text in the type of 
serious health.  When the text comments were reviewed this variable was described by 
the mother with many different serious health conditions provided.  The mother reported 
what they felt as a serious health condition. With this in mind this variable must be 
interpreted cautiously as the serious health conditions were defined loosely by some of 
the mothers in this study and may be difficult to accurately define a serious health 
condition.  For example some mothers reported history of gestational diabetes, pre-
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eclampsia, and falls as a serious health condition.  Others did not specify the type of 
serious health condition.   
Serious health conditions and several other chronic health conditions were 
included in the maternal context variable of chronic health conditions; which included 
history of hypertension, diabetes, flu, bladder infections, history of emotional disorders, 
chicken pox, and headaches as the literature found these conditions to be risk factors for 
CHD. Only the significantly correlated variables in this study were retained for the final 
logistic regression. History of a serious health condition six months prior or during 
pregnancy was the only significantly correlated chronic health condition found in the 
analysis.  The finding from the current study supports the previous conclusions in the 
literature of having a serious health condition as a risk factor for having a child with a 
complex CHD. In the literature many serious and chronic health conditions were 
combined or grouped together, such as history of fever, diabetes, hypertension, and viral 
illnesses. Two studies identified that the timing of the serious health condition 
particularly early in pregnancy was important, as greater risk for CHD was observed 
(Oster, Riehle-Colarusso, Alverson, & Correa, 2011; Zen et al, 2011).  Serious and 
chronic health conditions were noted to be risk factors for CHD including fever, diabetes, 
hypertension, and viral illnesses (Oster, Riehle-Colarusso, Alverson, & Correa, 2011, 
Stothard, Tennant Bell, & Rankin, 2011, Zen et al, 2011).  This study did not support the 
history of diabetes, fever, hypertension or viral illness specifically; however, some 
mothers in the text descriptions of serious health conditions reported these conditions.  
Timing of the serious health condition is important to note. When illnesses occur either in 
the pre- or inter-conception timeframes, or first trimester can be important to determine 
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risk for CHD.  Febrile illnesses in the first trimester have been associated with increased 
risk of all CHD (Oster, Riehle-Colarusso, Alverson, & Correa, 2011; Zen et al, 2011).   
Maternal self report of serious health conditions was identified in this study to be 
a greater risk for having an infant with complex CHD. However, some caution should be 
made in this finding as the specificity of the serious health condition is not present. Also, 
when looking at the timing of the illness or serious health condition the timeframe of the 
questions is quite broad (6 months prior to or during the pregnancy) in which some of the 
serious health conditions may be a chronic problem and not accurately represented. 
A second hypothesis was tested to determine if predictors for gestational age and 
birth weight were present in this study.  To test this hypothesis hierarchical multiple 
regressions were used.  Predictors of birth weight included; maternal history of 
hypertension, serious health condition six months prior/during pregnancy, CHD, obesity 
and income level.  In the final regression model 4.4% of the variance of birth weight of 
these infants with CHD was explained, R² change = .044, F change (1, 15911) = 10.125, 
p < 0.05. 
In this sample of infants with CHD, the maternal context variables that had the 
most influence on birth weight in the regression model included; maternal chronic health 
conditions of hypertension or serious health conditions, history of maternal CHD, history 
of obesity and income level. This study supports the literature and risk for having a low 
birth weight infant if specific maternal context variables are present such as obesity and 
lower incomes levels (Messer et al., 2008). In pregnancy, maternal chronic health 
conditions are important to address as they can be predictors for the birth outcomes of 
gestational age and birth weight (CDC, 2011; UNICEF & WHO, 2002).  This study was 
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consistent with the literature describing maternal risk factors of having an infant with low 
birth weight but the relationship was small as only 4.4-4.5% of the variance was 
described in the model.  There are many influences of gestational age and birth weight in 
this sample that were not elicited from this model. 
A hierarchical multiple regression was performed to assess predictors of 
gestational age in the group of infants with CHD. Predictors of gestational age included; 
maternal history of hypertension, flu, and serious health conditions 6 months prior/during 
pregnancy, and type of housing.  In the final model 4.5% of the total variance of 
gestational age was explained, R² change = .004 F change (1, 1680) = 7.875, p < 0.05. 
Findings from the current study support the literature that associated maternal 
history of chronic health conditions (diabetes, hypertension, obesity) as a greater risk for 
having a premature infant as described above (Di Renzo, et al., 2011; Magnussen, Jatten, 
Myklestad, Salvesen, & Romundstad, 2011). Maternal history in the preconception 
period of diabetes (OR -0.6, CI; -2.1 to 0.8), hypertension (OR -1.8, CI; -3.2 to -0.5) and 
high cholesterol (OR -1.8 CI; -3.2 to -0.3) were associated with preterm birth < 37 weeks 
(Magnussen et al., 2011). The type of housing was also found to be a variable influencing 
the risk for prematurity and is consistent with the findings in Messer et al.’s (2008) 
census data study finding a small association between poor housing and preterm birth 
(OR 1.1-1.7). The majority women in this study with both simple and complex CHD 
infants predominantly lived in single family homes, educated and had middle to upper 
class income levels. However, the remainder of the participants may have been 
representative of a lower SES, with risk for nutritional deficiencies and environmental 
exposures which may explain the poorer birth outcomes.  There were no reports of 
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homelessness, although this was not an option in the questionnaire.  The BWIS (Ferencz 
et al. 1997) found in the women with lower SES a greater risk for CHD, particularly 
laterality and looping defects.  The findings of this study supports the literature in which 
maternal health history and SES is crucial in the infants’ birth outcomes of birth weight, 
gestational age, and risk for CHD (Patel, 2012; Kučienė & Dulskienė, 2009).  However 
the majority of the variance in this sample was not described in the model with ~95% of 
the predictors for gestational age and birth weight unable to be determined from this 
study. 
The exploratory research question was posed, “Does the type of CHD (simple or 
complex) influence birth weight, and gestational age in infants born with CHD?”  It was 
believed that the more complex the CHD the greater the risk for prematurity and low 
birth weight would be observed.  However, in this study group of infants with CHD, type 
of CHD (simple or complex) was not significantly correlated to birth weight and 
gestational age, BW= -.014, GA .011, r). In this study, gestational age and birth weight 
were not found to influence type of CHD. The complex CHD infants did not overall have 
lower birth weights (simple, mean BW 3.18 kg vs. complex 3.16 kg) or history of 
prematurity (simple mean GA 37.91 weeks vs. complex 37.96 weeks) in this sample. In 
fact this group of infants with CHD was found to have generally normal mean birth 
weights and normal gestational ages.  
In the literature, CHD has been associated with small for gestational age and 
lower birth weights (Malik, Cleves, Zhao, Hobbs & NBDS, 2007).  Malik et al.’s (2007) 
study was a case control study which compared the severity of the heart defect and risk 
for low birth weight and gestational age.  In Malik et al’s (2007) study, a system which 
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categorized simple CHD as a single lesion verses associated CHD which combined 
several CHD diagnoses was used. They found a significant difference in the small for 
gestational age in the simple (OR 1.96, CI; 1.67-2.30) versus the associated CHD groups 
(OR 2.54; CI; 1.99-3.23).  The simple CHD cases represented 82.4% of the cases, 
whereas the associated cases represented less than 20% of the cases in this study. 
Limitations 
Using a large data set has many positive features; access to large samples, and 
cost-effective to the novice researcher as the data has already been collected, access 
multiple variables to analyze, and access to data which may not otherwise have been 
easily collected by nursing (Aponte, 2010; Pollack, 1999).  As with the benefits of 
secondary analysis come limitations.  The data was collected prior to the development of 
the hypothesis or research question, and congruency of the questions asked or tested can 
be compromised or may need to be altered dependent on the data (McCall & Appelbaum, 
1991).  
 A major limitation of the WPCR was the lack of specific data on the timing of 
exposures. There were many variables included in this study; however, the dose response 
to exposure could not be elicited. The questions in the WPCR were not specific enough to 
isolate a critical time period prior or during pregnancy for exposures. Many of the 
maternal co-morbid conditions were collected as a yes/no question to having or being 
exposed six months prior to or during the pregnancy and text in variables avoided due to 
inability to accurately or reliably code.   
Recall is a significant concern in the collection of maternal data. The questions 
were all asked, “Did an event occur prior or during pregnancy?”  The WPCR tried to 
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decrease recall bias by enrolling infants less than two years of age and their caregivers to 
the study.  Variables were chosen to avoid large amounts of missing data. But because of 
this there is limited information.  Text in variables was not used therefore this study loses 
some ability to understand the complexity of CHD and use of sensitivity of this 
information.  
From review of the literature, sensitive questions such as smoking, alcohol and 
drug consumption are known to be variables of bias and may not be accurately answered 
by the participants (Polit & Beck, 2008).  Smoking, drug and alcohol history were 
included in this study and used with caution in the interpretation of results.  Even though 
this study chose these variables with little missing data, sensitive questions are still 
problematic. In the analysis of missing data; these questions had more missing data than 
the other variables particularly if there were several questions associated with that 
variable.  Therefore only yes/no questions were included in the analysis.   
Generalizability of the results may be limited as the sample included only mothers 
of infants born in the state of Wisconsin from 2000-2010.  Wisconsin was a 
predominantly Caucasian, middle class, Midwestern state during the data collection 
period, which may not be representative of other demographic locations in the United 
States. The sample in this study represented approximately 1/3 of the known infants and 
children with CHD who were approached to participate in the WPCR (1,687/4,919) and 
thus even the generalizability of findings to families in the state of Wisconsin may be 
limited (Harris et al., 2011).   
In this study comparison between types of CHD (simple and complex) were used 
due to lack of a robust control group.  The sample was large and provided the power to 
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answer the hypotheses.  Although the WPCR began collecting a control group in 2007, 
the majority of the controls enrolled were adolescents seen for chest pain, syncope or 
murmur.  Financial ability was a concern initially to enroll a control group. The control 
group when started was used to compare the genetic component, which the control group 
did not provide the type of data which would be useful for comparison to this data.  
However, after a decade of collection the WPCR changed the questionnaire 
dramatically to adjust for concerns of reliability, consistency, and inability to draw 
conclusions from some of the questions asked. This poses concerns of the reliability of 
some questions used for the analysis in this study.  Although, these concerns and 
limitations are present, this study was able to identify several maternal risk factors for 
type of CHD and the birth outcomes of these infants. Although the relationships in this 
study were small, these maternal context variables were associated with greater risk for 
complex CHD, lower birth weight and prematurity. The multiple and logistic regression 
results must be interpreted with caution as they do not imply causality (Pallent, 2007).  
More importantly this study provided a descriptive analysis of the maternal and infant 
data collected from 2000-2010.  
Implications  
Implications for Theory 
The conceptual model was generated using literature that identified variables 
associated with risk for CHD development prior to and during pregnancy in women.  
From this review of literature sufficient gaps regarding the factors associated with the 
risk for developing a complex CHD were found and therefore this study undertaken to 
test these relationships 
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The results of this study generally supported the relationships of the maternal 
context variables to risk for infant outcomes delineated in the conceptual framework. 
However the study did not support every domain (biologic, physical, or social) or every 
variable in these domains.  The biologic domain was the only category predicting risk for 
complex CHD. The physical and social domains did not reveal significant relationships. 
Similarly, the physical domain did not predict gestational age. These findings may be 
related to the positive health practices of the sample, the measurement of the variables, or 
to the lack of diversity in the sample.  For CHD, this lack of relationship could also be 
related to the timing of the CHD development in which the other domains are not as 
influential for affecting type of CHD, as CHD development occurs early in gestation.  It 
is possible that once the CHD occurs it is only biological factors that determine the type 
of CHD. Measurement of context variables available for the study may also have been 
problematic. Variables with greater specificity as well as objective measures of the 
concepts should be considered for future studies. The lack of diversity could have also 
limited the findings of social variables on outcomes.  
An interesting finding was the lack of support for greater risk of low birth weight 
or prematurity in the infant with complex CHD. This finding differs from others in the 
literature where having CHD and particularly, complex CHD has been found to be a risk 
factor for premature birth and low birth weight in other studies (Williams et al., 2010; 
Malik, Cleves, Zhao, Hobbs, & NBDS, 2007). It is possible that once the CHD occurs it 
is only biological factors that determine the type of CHD  
This was the first test of the proposed conceptual model. Although five 
relationships were not supported (physical and social to CHD; physical to gestational age 
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and CHD to birth weight and gestational age it is premature to revise the model based 
only this study. This is particularly true for the lack CHD to birth weight and gestational 
age where evidence of a relationship exists in the literature.  Further research with 
demographically, geographically and ethnically diverse samples would be important to 
conduct for a robust test of the model.   
Practice  
The findings of this study have several implications for practice. The study 
showed an increased risk for complex CHD when the mother reported personal history of 
CHD or history of a serious health condition prior to or during the pregnancy. HCP’s 
should pay particular attention to women with a serious health condition and discuss with 
women of childbearing age the importance of alerting their HCP of any significant health 
care concern when it occurs. HCP’s can have a discussion with these women if a 
pregnancy is being planned and these risk factors are present to allow planning.  In the 
recent publication from the AHA regarding management of fetal cardiac disease, 
parameters for intervention and scanning increased prenatal risk of CHD are provided 
(Donofrio et al, 2014).  For example, if a mother has personal history of CHD, history of 
rubella, diabetes, or specific medication taken during the beginning of the pregnancy a 
fetal echo is recommended between 18-22 weeks gestation to screen for CHD.  The 
findings of this study which is now concluding are in concert with the recommendations 
published within the Scientific Statement for the care of fetal cardiac disease.  This study 
supports the recommendations for thorough screening of family history, maternal health 
history particularly history of CHD, CHC’s and/or infections to identify fetuses at risk for 
complex CHD and CHD in general. Early fetal diagnosis is critical in the prevention of 
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the increased morbidity and mortality associated with undiagnosed fetal CHD. A fetal 
echocardiogram may be performed in such cases when maternal history of CHD or 
serious health conditions are present, thus allowing for referral to perinatology, delivery 
coordination, or options for continuation of the pregnancy to be discussed. 
Although, this study focuses on risk for type of CHD (simple or complex), 
maternal risk factors were identified in the literature review (Butler et al., 2014) 
identifying risks for all CHD. Identification of maternal CHD risk factors should become 
regular part of women’s care. Nurses and HCPs, whether at the beginning of their career 
or those who are experienced require continuing education in maternal health and 
promotion of healthy pregnancies.  There is an expectation to maintain competency in 
these areas of healthcare, we must provide these resources for success.  Continuing 
education may include case studies, case review, and morbidity and mortality discussions 
among the healthcare team as a regularly scheduled commitment to maintain up to date 
competency. 
This study found that serious health conditions and maternal history of CHD to be 
risk factors for complex CHD.  So recognition of serious health conditions and chronic 
health conditions (Liu et al., 2013; Oster, Colarusso, Alverson & Correa, 2011) and first 
degree family history (Romano-Zelekha et al., 2001) are important as the literature 
identified these maternal contexts as risk factors for all CHD development.  It is 
important for HCPs to be aware of their patients’ health and family history as this 
information may alert the HCP of risk factors for CHD which could be flagged on the 
electronic health records when planning of future pregnancies. 
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Investigators continue to study the influences of epigenetic factors and 
generational health practices in the risk for CHD development. A thorough health history 
of the mother and father may provide the ability to identify risk factors for birth defects, 
particularly CHD and should be expected as a standard of care (Seibert, 2010). HCPs can 
identify these risks and counsel families and future generations of good healthcare 
practices prior to pregnancy to help decrease the risk of CHD and other infant diseases. 
As healthcare systems shift to a prevention model for healthcare delivery, nurses are 
uniquely positioned to identify and educate these men and women of childbearing age 
and can convey this information to decrease risk of CHD.   
Education 
 In this study maternal history of serious health conditions and history of CHD 
showed an increased risk for complex CHD in the infant.  Nurses requires educational 
resources which encompass the pre-conceptual health promotion practices for both 
women and men of childbearing age to identify risk for complex CHD and CHD in 
general. Education strategies to promote a greater understanding of the complexity of the 
environmental and genetic risk factors for CHD must be incorporated at all levels of 
education.  Interactive dialogues and examples between instructors and students of 
normal pregnancy recommendations followed by the abnormal findings associated with 
CHD to illustrate the importance to be aware and ask questions to elicit information 
which can impact the care. 
In 2001 the American Heart Association (AHA) and the National Heart, Lung, 
and Blood Institute (NHLBI) recognized that a greater understanding by all HCPs of the 
environmental and genetic influences was essential.  An expert panel produced a policy 
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statement to share recommendations for education, research, and need for creation of 
interdisciplinary teams in the study of genetics and CHD (Ashley et al., 2012).  This 
panel provided recommendations to address each discipline of HCP’s separately but 
recognizing a need all HCP’s to receive education in genetics. Therefore the “Core 
Competencies in Genetics for Health Professionals” was published in 2007.  As only 10-
15% of CHD etiologies are attributed to chromosomal or single gene mutations (Brent, 
2004; Botto & Correa, 2003) with new research discoveries occurring rapidly the 
educational resources for HCPs require updates to reflect the new knowledge acquired.  
Future Research  
 CHD is an elusive birth defect affecting multiple families worldwide. This study 
revealed two maternal context factors influencing the risk for complex CHD.  However, 
as only 5% of the variance of the model was described by these contexts additional 
research is needed to understand the 95% of unexplained relationships. The majority of 
the influences of CHD were unexplained in this study; similar to much of the literature 
reviewed when studying non-genetic risk factors for CHD all which suggested the need 
for continued research (Fung et al., 2013; Patel & Burns, 2013; Jenkins et al., 2007).  The 
NHLBI supports new research when studying CHD. A task force was created with focus 
on several areas of basic research, clinical outcomes research, and translational research 
with the hope of reducing CHD (NHLBI, 2001).   Using a model which compared type of 
CHD may provide a different lens to view the risk factors for CHD. All of these women 
in this study appeared generally healthy but had infants with various forms of CHD, and 
approximately 1/3 with complex CHD.  Future studies may also increase delineation 
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between severity of CHD and these risk factors between these groups in the analysis as 
well. 
This study identified significant relationships between the maternal context 
variables and infant outcomes in this sample. There were several maternal context 
variables identified which influenced birth outcomes, however the majority of the 
variance in the models was not explained.  Future research needs to include the paternal 
contexts which may provide a greater understanding of risk for CHD.  The risk of 
complex CHD in this sample provided another perspective on CHD development other 
than case control methods.  This may allow understanding of the subtle differences in the 
mother’s health when all had an infant with CHD. Most research stressed the need for 
more research isolating variables and exposures. This study may provide another method 
to view affects of health practices on the severity of CHD. 
Policy 
 Secondary analysis may provide and avenue to advance science and the science of 
understanding CHD.  However, attention to the quality and maintenance of the data must 
be acknowledged. The WPCR was helpful providing a glimpse of the maternal and infant 
data. In a time limiting funding opportunities secondary analysis can be advantageous 
method of research.  As new researchers, locating large repositories of data may provide 
resources, previously unavailable to aid in the answers to research questions or 
development of new hypotheses.  This study helped to recognize the needed skills, 
resources and expertise to use a large dataset is important in the success of the study.  A 
multi-disciplinary team approach would be recommended to better understand the dataset 
to recognize the strengths and limitations of particular variables.   
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The AHA created an expert policy statement which highlights the relationship 
between genetics and cardiovascular disease (AHA, 2012). Congenital heart disease is a 
multifactorial process that requires a comprehensive approach recognizing the genetic 
and environmental interactions. The AHA recently published recommendations for fetal 
diagnosis and treatment of cardiac disease (Donofrio et al. 2014) that identified several 
maternal and paternal health conditions or history that can increase risk for CHD in their 
infants.  These recommendations provide structured guidelines for nurses and HCP’s to 
help identify and treat families who may be at greater risk for complex CHD and CHD’s 
in general. This study and these guidelines may assist nurses and HCP’s in the treatment, 
screening and counseling of families affected by CHD. 
Conclusion 
CHD continues to be the leading birth defect in the world leading with extremely 
high rates of morbidity and mortality.  Although, there have been immense advances in 
the understanding of cardiac formation in the fetus, the majority of CHD etiology remain 
unknown.  This study identified maternal risk factors for having an infant with complex 
verses simple CHD. These findings of maternal history of CHD and history of a serious 
health conditions during pregnancy enhanced the understanding of the increased risk for 
complex CHD in their infants. Because of numerous exposures during pregnancy the 
importance of obtaining a complete health history is critical for identifying greater risk. It 
is critical for nurses and healthcare professions to become aware of these risk factors 
when caring for women of childbearing age so identification and interventions can 
proceed. It is essential to continue the search for risk factors associated with CHD, 
pinpointing the critical time frame for CHD development. Nurses and HCPs must remain 
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active in CHD research, education and evidence based practice techniques to improve the 
care provided to those affected by CHD. The findings of this study reinforce the necessity 
to intensively and accurately review family history, medical history and social history of 
all women of childbearing age. This particular cohort of women was overall healthy with 
few co-morbid conditions or risky behaviors reported and still gave birth to infants with 
CHD. Women are at risk for CHD, as nurses and healthcare professionals it is our 
responsibility to promote positive health practices and be aware of risk factors providing 
this valuable information to these patients.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
142 
 
 11
9
 
References 
Age (n.d.).  In Merriam-Webster’s online dictionary. Retrieved from 
http://www.merriam-webster.com/medical/age 
Alverson, C. J., Strickland, M. J., Gilboa, S. M., & Correa, A. (2011).  Maternal smoking 
and congenital heart defects in the Baltimore-Washington Infant Study.  
Pediatrics, 127(3), e647-653.  doi: 10.1542/peds.2010-1399  
American Heart Association (2009).  Facts: Small hearts, big challenges, congenital 
heart defects in children, youth and adults.  American Heart 
Association/American Stroke Association.  Retrieved from 
http://www.heart.org/idc/groups/heart-
public/@wcm/@adv/documents/downloadable/ucm_304875.pdf 
Aponte, J. (2010).  Key elements of large survey data sets.  Nursing Economics, 28(1), 
27-36. Ashley, E.A., Hershberger, R.E., Caleshu, C., Ellinor, P.T., Garcia, J.G.N., 
Herrington, D.M….Worrall, B.B. (2012).  Genetics and cardiovascular disease:   
A policy statement from the American Heart Association.  Circulation, 126. doi: 
10.1161/CIR.0b013e31825b07f8 
Ashford, K., Hahn, E., Hall, L., Rayens, M., Noland, M., & Ferguson, J. (2010).  The 
effects of prenatal secondhand smoke exposure on preterm birth and neonatal 
outcomes. Journal of Obstetric, Gynecologic, & Neonatal Nursing, 39, 525-535. 
doi: 10.1111/j.1552-6909.2010.01169.x 
Ashley, E.A., Hershberger, R.E., Caleshu, C., Ellinor, P.T., Garcia, J.G.N., Herrington, 
D.M….& Worrall, B.B. (2012).  Genetics and cardiovascular disease:   A policy 
143 
 
 11
9
 
statement from the American Heart Association.  Circulation, 126. doi: 
10.1161/CIR.0b013e31825b07f8 
Bentham, J., & Bhattacharya, S. (2008).  Genetic mechanisms controlling cardiovascular 
development.   Annals of the New York Academy of Sciences, 1123, 10-19.  doi:  
10.1196/annals.1420.003 
Blumenshine, P., Egerter, S., Barclay, C., Cubbin, C., & Braveman, P. (2010). American 
Journal of Preventive Medicine, 39(3), 263-272.  doi: 
10.1016/j.amepre.2010.05.012 
Botto, L. D., & Correa, A. (2003).  Decreasing the burden of congenital heart anomalies:  
An epidemiologic evaluation of risk factors and survival.  Progress in Pediatric 
Cardiology, 18, 111-121.  doi:  10.1016/S1058-9813(03)00084-5 
Brent, R. L. (2004). Environmental causes of human congenital malformations: The 
Pediatrician’s role in dealing with these complex clinical problems caused by a 
multiplicity of environmental and genetic factors. Pediatrics, 113(Supplement 3), 
957-968. 
Butler, M., Cavan, M., & Johnson, T. (2014).  Understanding Genetics and Pediatric 
Cardiac Health. Manuscript in preparation. 
Calzolari, E., Garani, G., Cocchi, G., Magnani, C., Rivieri, F., Neville, A., Astolfi, G…& 
IMER Working Group, 2003.  Congenital heart defects: 15 years of experience of 
the Emilia-Romagna registry (Italy).  European Journal of Epidemiology, 18, 
773-780.   
Campbell, D. A. (2007).  Secondary analysis.  Orthopaedic Nursing, 26(4), 241-242. 
144 
 
 11
9
 
Caputo, S., Capozzi, G., Russo, M., Esposito, T., Martina., L., Cardaropoli., D., Ricci., 
C.,…& Calabrò, R. (2005).  Familial recurrence of congenital heart disease in 
patients with ostium secundum atrial septal defect.  European Heart Journal, 26, 
2179-2184.  doi:  10.1093/eurheartj/ehi378 
Center for Disease Control and Prevention (April 2012).  Overweight and Obesity. Center 
for Disease Control and Prevention.  Retrieved from 
http://www.cdc.gov/obesity/adult/defining.html 
Centers for Disease Control (October, 2011).  PNSS Health Indicators. Retrieved 
fromhttp://www.cdc.gov/pednss/what_is/pnss_health_indicators.htm. 
Center for Disease Control and Prevention (June, 2011). National center on birth defects 
and developmental disabilities, Center for Disease Control and Prevention.  
Retrieved from http://www.cdc.gov/ncbddd/index.html 
Centers for Disease Control and Prevention (2010).  Promoting the health of babies, 
children, and adults and enhancing the potential for full, productive living. 
Retrieved from 
http://www.cdc.gov/ncbddd/AboutUs/documents/AR_508C__22311.pdf 
Chronic health condition-definition (2005). The Council for Children and Adolescents 
with Chronic Health Conditions.  Retreived from: 
http://www.clanchildhealth.org/index.php/CAH/what-is-a-chronic-health-
condition.html 
Clark, E. B. (2001).  Etiology of congenital cardiovascular malformation: epidemiology 
and genetics.  In:  Allen, H., Cark, E., Gutgesell, H., Driscoll, D. Eds.  Moss and 
145 
 
 11
9
 
Adams’ Heart Disease in Infants, Children and Adolescents.  6th ed. Philadelphia, 
PA:  Lippincott Williams & Wilkins; 2001.  
Clark, E. (1996). Pathogenic mechanisms of congenital cardiovascular malformations 
revisited.  Seminars in Perinatology, 20(6), 465-472.   
Clark, K.L., Yutzey, K.E., & Benson, D.W. (2006).  Transcription factors and congenital 
heart defects.  Annual Reviews of Physiology, 68, 97-121. doi: 
10.1146/annurev.physiol.68.040104.113828 
Cronk, C., Gangnon, R., Cossette, S., McElroy, J., & Pelech (2011).  Modeling 
geographical risk of complex congenital heart defects in Eastern Wisconsin. Birth 
Defects Research (Part A): Clinical and Molecular Teratology. 00:000-000.  doi: 
10.1002/bdra.20828  
Cronk, C., Pelech, A., Malloy, M., & McCarver (2004).  Excess birth prevalence of 
hypoplastic left heart syndrome in Eastern Wisconsin for birth cohorts 1997-1999.  
Birth Defects Research (Part A): Clinical and Molecular Teratology, 70, 114-
120.  doi: 10.1002/bdra.20007 
Cronk, C., Malloy, M., Pelech, A., Miller, R., Meyer, S., Cowell, M., & McGarver, G. 
(2003).  Completeness of state administrative databases for surveillance of 
congenital heart disease.  Birth Defects Research (Part A): Clinical and 
Molecular Teratology, 6, 597-603.  doi: 10.1002/bdra.10107 
Di Renzo, G., Giardina, I., Rosati, A., Clerici, A., Torricelli, M., Petraglia, F., & the 
Italian Preterm Network Study Group (2011).  Maternal risk factors for preterm 
birth:  a country-based population analysis.  European Journal of Obstetrics & 
146 
 
 11
9
 
Gynecology and Reproductive Biology, 159, 342-346.  doi: 
10.1016/j.ejogrb.2011.09.024   
Donofrio, M., Moon-Grady, A., Hornberger, L., Copel, J., Abuhamad, A., Cuneo, B., 
Huhta, J., …& Rychik, J. (2014).  Diagnosis and treatment of fetal cardiac 
disease, a scientific statement from the American Heart Association, Circulation. 
129, 00-00  doi:  10.1161/01.cir.0000437597.44550.5d  
Emmanouilides, G.C. (2001). The Developments of Pediatric Cardiology: Historical 
Milestones.  In Allen, H.D., Clark, E.B., Gutgesell, H. P., & Driscoll, D. J. (Eds.), 
Moss and Adams’ Heart Disease in Infants, Children, and Adolescents. 6th ed. 
(xxi-xxiv).  Philadelphia, PA: Lippincott Williams & Wilkins.  
Engle, W.A. (2004). Age terminology during the perinatal period," Pediatrics, 2004, 
114(5):1362-4. 
Federal office of Management and Budget, Tabulation Working Group (2000).  
Provisional guidance on the implementation of the 1997 standards for federal 
data on race and ethnicity. Retreived from:  
http://www.whitehouse.gov/omb/inforeg_statpolicy#dr 
Ferencz, C., Boughman, J. A., Neill, C. A., Brenner, J. I., Perry, L. W., & the Baltimore-
Washington Infant Study Group (1989).  Congenital cardiovascular 
malformations:  Questions on inheritance.  Journal of American College of 
Cardiology, 14(3), 756-63. 
Ferencz, C., Loffredo, C. A., Correa-Villaseñor, A. & Wilson, P. D. (1997). Perspectives 
in pediatric cardiology, Volume 5, Genetic and environmental risk factors of 
147 
 
 11
9
 
major cardiovascular malformations, the Baltimore Washington Infant Study 
1981-1989.  New York: Futura Publishing Company, Inc. 
Fine, A. & Kotelchuck, M. (2010).  Rethinking MCH:  the life course model as an 
organizing framework: Concept paper, 1-20. U. S. Department of Health and 
Human Services, Health Resources and Services Administration, Maternal and 
Child Health Bureau Retrieved from 
http://mchb.hrsa.gov/lifecourse/rethinkingmchlifecourse.pdf 
Flaskerud, J.H. & Halloran, E.J. (1980). Areas of agreement in nursing theory 
development. Advances in Nursing Science, 3(1), 1-7.  
Fung, A., Manlhiot, C., Naik, S., Rosenberg, H., Smythe, J., Lougheed, J., Modal, T….& 
Mital, S. (2013).  Impact of prenatal risk factors on congenital heart disease in the 
current era.  Journal of the American Heart Association, 2e000064. doi: 
10.1161/JAHA.113.000064 
Gibson, P. H., Burns, J. E., Walker, H., Cross, S., & Leslie, S. J. (2010). Keeping track of 
congenital heart disease--is it time for a national registry? International Journal of 
Cardiology, 145(2), 331-332. doi:10.1016/j.ijcard.2009.11.055  
Gorini, F., Chiappi, Gargani, L., & Picano, E. (2013).  Potential effects of environmental 
chemical contamination in congenital heart disease.  Pediatric Cardiology, 
published online. doi:  10.1007/s00246-014-0870-1  
Grech, V. (1999).  Trends in presentation of congenital heart disease in a population-
based study in Malta.  European Journal of Epidemiology, 15, 881-887.   
148 
 
 11
9
 
Halfon, N. & Hochstein, M. (2002). Life course health development:  An integrated 
framework for developing health, policy, and research.  The Milbank Quarterly, 
80(3), 433-479. 
Hanson-Morris, K. A., & Pelech, A. N. (2006).  The Wisconsin pediatric cardiac registry:  
a mechanism for exploring etiologies of congenital heart defects.  Wisconsin 
Medical Journal, 105(3), 45-48. 
Harris, S. E., Cronk, C., Cassidy, L.D., Simpson, P., Tomita-Mitchell, A., & Pelech, A. 
(2011).  Exploring the environmental and genetic etiologies of congenital heart 
defects:  the Wisconsin pediatric cardiac registry.  Journal of Registry 
Management, 38(1), 24-29. 
Hinton, R. B., Martin, L. J., Tabagin, M. E., Mazwi, M. L., Cripe, L. H., & Benson, D. 
W. (2007).  Hypoplastic left heart syndrome is heritable. Journal of the American 
College of Cardiology, 50(16), 1590-1595. doi: 10.1016/j.jacc.2007.07.021 
Hinton, R.B., Yutzey, K.E., & Benson, D.W. (2005).  Congenital heart disease: genetic 
causes and developmental insights.  Progress in Pediatric Cardiology, 20, 101-
111.  doi:  10.1016j.ppedcard.2005.04.002 
Hoffman, J.I., & Kaplan, S. (2002).  The incidence of congenital heart disease. Journal of 
American Cardiology. 39(12), 1890-1900. 
Huang, J., Liu, Y., Sun, P., Lv, X. Du, M., & Fan, X. (2010). Pathogenic mechanisms of 
congenital heart disease.  Cardiovascular Pathology, 19, e183-193.  doi:  
10.1016/j.carpath.2009.06.008   
149 
 
 11
9
 
Huang, J.B., Liu, Y.L., & Lv, X.D. (2010). Pathogenic mechanisms of congenital heart 
disease.  Fetal and Pediatric Pathology, 29, 359-372.  doi: 
10.3109/15513811003789628 
Jacobs, J.P., Mavroudis, C., Jacobs, M.L., Maruszewski, B., Tchervenkov, C.I. Lacour-
Gayet, F.G., …& Elliot, M.J. (2007).  Nomenclature and databases — The past, 
the present, and the future.  Pediatric Cardiology, 28, 105-115.  doi: 
10.1007/s00246-006-1447-4 
Jacobs, J.P., Wernovsky, G., & Elliot, M.J. (2007).  Analysis for outcomes of congenital 
cardiac disease: can we do better?  Cardiology in the Young, 2(1), 145-158. 
Jansen, P.W., Tiemeier, H., Jaddoe, V., Hofman, A., Steegers, E., Verhulst, F., 
Mackenbach, J., & Raat, H. (2009). Archives of Disease in Childhood. Fetal and 
Neonatal Edition, 94, F28-34. doi:  10.1136/ach.2007.136945 
Jenkins, K. J., Correa, A., Feinstein, J. A., Botto, L., Britt, A. E., Daniels, S. R….& 
Webb, C. L. (2007).  Noninherited risk factors and congenital cardiovascular 
defects:  current knowledge.  Circulation, 115, 2995-3014.  doi:  
10.1161/CIRCULATIONAHA.106.183216 
Karatza, A. A., Giannakopoulos, I., Dassios, T. G., Belavgenis, G., Mantagos, S. P., & 
Varvarigou.  Periconceptional tobacco smoking and xisolated congenital heart 
defects in the neonatal period.  International Journal of Cardiology, 148, 295-
299.  doi:  10.1016/j.ijcard.2009.11.008 
Kotelchuck, M. (2011).  Rethinking MCH: The Life Course Theory and Its Implications 
for Practice: Moving to Action – Knowledge Base, Social Strategy and Political 
Will.  Eunice Kennedy Shriver Center – LEND Program.  Retrieved from 
150 
 
 11
9
 
http://www.amchp.org/programsandtopics/LifeCourse/Documents/Kotelchuck_L
ENDtalk.pdf 
Kornosky, J.L. & Salihu, H.M. (2008). Getting to the heart of the matter: Epidemiology 
of cyanotic heart defects.  Pediatric Cardiology, 29, 484–497. doi: 
10.1007/s00246-007-9185-9 
Kučienė, R. & Dulskienė, V. (2009).  Maternal socioeconomic and lifestyle factors 
during pregnancy and the risk of congenital heart defects.  Medicina (Kaunas), 
45(11), 904-909.   
Lin, A. E., & Ardinger, H. H. (2005).   Genetic epidemiology of cardiovascular 
malformations.  Progress in Pediatric Cardiology, 20, 113-126.  doi:  
10.1016/j.ppedcard.2205.04.003 
Lin, A. E. & Garver, K. L. (1988).  Genetic counseling for congenital heart defects. The 
Journal of Pediatrics, 113(6), 1105-1109. 
Liu, S., Joseph, K.S., Lisonkova, S., Rouleau, J., Van den Hof, M., Sauve, R., & Kramer, 
M. (2013). Association between maternal chronic conditions and congenital heart 
defects. A population –based cohort study.  Circulation, 128, 583-589.  doi:  
10.1161/CIRCULATIONAHA.112.001054 
Luo, Z. C., Wilkins, R., Kramer, M. S., & the Fetal and Infant Health Study Group of the 
Canadian Perinatal Surveillance System (2006). Effect of neighbourhood income 
and maternal education on birth outcomes: a population-based study.  CMAJ, 
174(10), 1415-1421.  doi:  10.1503/cmaj.051096 
151 
 
 11
9
 
Luteijn, J. M., Brown, M. J., & Dolk, H. (2013).  Influenza and congenital anomalies: a 
systematic review and meta-analysis. Human Reproduction, 0(0), 1-15.  doi: 
10.1093/humrep/det455 
Magnussen, E., Vatten, L., Myklestad, K., Salvesen, K., & Romundstad, P. (2011).  
Cardiovascular risk factors prior to conception and the length of pregnancy:  
population-based cohort study.  American Journal of Obstetrics and Gynecology, 
204(526), e1-8.  doi:  10.1016/j.ajog.2011.02.016 
Malik, S., Cleves, M. A., Zhao, W., Correa, A., Hobbs, C. A., & National Birth Defects 
Prevention Study. (2007). Association between congenital heart defects and small 
for gestational age. Pediatrics, 119(4), e976-82. doi:10.1542/peds.2006-2742 
Marelli, A.J., Mackie, A.S., Inoescu-Ittu, R., Rahme, E., & Pilote, L. (2007).  Age 
Distribution Congenital Heart Disease in the General Population: Changing 
Prevalence and Circulation, 115,163-172.  doi: 
10.1161/CIRCULATIONAHA.106.627224 
McCall, R. B., & Appelbaum, M. I. (1991).  Some issues of conducting secondary 
analysis.  Developmental Psychology, 27(6), 911-917. 
McFadden, D. G., & Olsen, E. N. (2002).  Heart development:  Learning from mistakes.  
Current Opinion in Genetics & Development, 12, 328-335. 
Messer, L., Vinikoor, L., Laraia, B., Kaufman, J., Eyster, J., Holzman, C., Culhane, J., 
…& O’Campo (2008).  Socioeconomic domains and associations with preterm 
birth. Social Science & Medicine, 67, 1247-1257. doi:  
10.1016/j.socscimed.2008.06.009   
152 
 
 11
9
 
Mitchell, S. C., Korones, S.B., & Berendes, H.W. (1971).  Congenital heart disease in 
56,109 births; incidence and natural history.  Circulation, XLIII, 323-332. 
National Heart, Lung, and Blood Institute (NHLBI) (2002).  Report on the task force on 
research in pediatric cardiovascular disease. U.S. Department of Health and 
Human Services. Retrieved from 
http://www.nhlbi.nih.gov/resources/docs/pediatric_cvd.pdf 
National Heart, Lung, and Blood Institute (NHLBI) (2014) Body mass index calculator.  
Retrieved from https://www.nhlbi.nih.gov/guidelines/obesity/BMI/bmicalc.htm 
Nembhard, W. N., Salemi, J. L., Loscalzo, M. L., Wang, T., & Hauser, K. W. (2009).  
Are Black and Hispanic infants with specific congenital heart defects at increased 
risk of preterm birth?  Pediatric Cardiology, 30, 800-809.  doi:  10.1007/s00247-
009-9420-7 
Nora, J. J., Dodd, P. F., McNamara, D. G., Hattwick, M. A. W., Leachman, R. D., & 
Cooley, D. A. (1969). Risk to offspring of parents with congenital heart defects. 
Journal of the American Medical Association, 209(13), 2052-2053.  
Nora, J. J. (1968). Multifactorial inheritance hypothesis for the etiology of congenital 
heart diseases:  the genetic-environmental interaction.  Circulation, 38, 604-617. 
Oster, M., Riehle-Colarusso, T., Alverson, C. J., & Correa, A. (2011). Abstract 1944: 
Associations of maternal fever and influenza with congenital heart defects. The 
Journal of Pediatrics, 158, 990-995. doi: 10.1016/j.peds.2010.11.058 
Palmer, K., Bonzini, M., Harris, E., Linaker, C., & Bonde, J. (2012).  Work activities and 
risk of prematurity, low birth weight and pre-eclampsia: an updated review with 
153 
 
 11
9
 
meta-analysis.  Occupational and Environmental Medicine, 70, 213-222.  doi: 
10.1136/oemed-2012-101032   
Patel, S. S., & Burns, T. L. (2013).  Nongenetic risk factors and congenital heart defects.  
Pediatric Cardiology, 34, 1535-1555.  doi: 10.1007/s00246-013-0775-4 
Patel, S., Burns, T., Botto, L., Riehle-Colarusso, T., Lin, A., Shaw, G., Romitti, P., & the 
National Birth Defects Prevention Study (2012).  Analysis of selected maternal 
exposures and non-syndromic atrioventricular septal defects in the National Birth 
Defects Prevention Study, 1997-2005.  American Journal of Medical Genetics 
(Part A), 158A, 2447-2455.  doi:  10.1002/ajmg.a.35555 
Peduzzi, P., Concato, J., Kemper, E., Holford, T. R., & Feinstein, A. R. (1996).  A 
simulation study of the number of events per variable in logistic regression 
analysis. Journal of Clinical Epidemiology, 49, 1373-1379 
Pollack, C. (1999).  Methodological considerations with secondary analysis. Outcomes 
Management for Nursing Practice, 3(4), 147-152.   
Polit, D. F., & Beck C. T. (2008). Nursing research: Generating and assessing evidence 
for nursing practice (8th ed.). Philadelphia, PA: Lippincott Williams & Wilkins. 
Pradat, P., Francannet, C., Harris, J.A., & Robert, E. (2003). The epidemiology of 
cardiovascular defects, part I: A study based on data from three large registries of 
congenital malformations.  Pediatric Cardiology, 24,195–221.  doi: 
10.1007/s00246-002-9401-6 
Reamon-Buettner, S. T., Spanel-Borowski, K., & Borlak, J. (2006).  Briding the gap 
between anatomy and molecular genetics for an improved understanding of 
154 
 
 11
9
 
congenital heart disease.  Annals of Anatomy, 188, 213-220.  doi:  
j.aanat.2005.10.007 
Reichman, N. E., Hamilton, E. R., Hummer, R. A., & Padilla, Y. C. (2008).  Racial and 
ethnic disparities in low birthweight among Urban unmarried mothers.  Maternal 
Child Health Journal, 12, 204-215.  doi:  10.1007/s10995-007-0240-1 
Rogers, J. (2009).  Tobacco and pregnancy.  Reproductive Toxicology, 28, 152-160.  doi:  
10.1016/j.reprotox.2009.03.012 
Romano-Zelekha, O., Hirsh, R., Blieden, L., Green, M. S., & Shohat, T. (2001).  The risk 
for congenital heart defects in offspring of individuals with congenital heart 
defects. Clinical Genetics, 59, 325-329.  
Sartiani, L., Stillitano, F., Luceri, C., Suffredini, S., Toti, S., De Filippo, C.,…& Cerbai, 
E. (2010).  Prenatal exposure to carbon monoxide delays postnatal cardiac 
maturation.  Laboratory Investigation, 20, 1582-1593.  doi: 
10.1038/labinvest.2010.122  
Seibert, D. C. (2010).  Genetics and disease prevention:  Commentary or contradictory?  
The Journal for Nurse Practitioners, 6(7), 507-516.   
Shaw, G. M., Nelson, V., Iovannisci, D. M., Finnell, R. H., & Lammer, E. J. (2003).  
Maternal occupational chemical exposures and biotransformation genotypes as 
risk factors for selected congenital anomalies.  American Journal of 
Epidemiology, 157(6), 475-484.   
Smith, A. K., Ayanian, J. Z., Covinsky, K. E., Landon, B. E., McCarthy, E. P., Wee, C. 
C., & Steinman, M.A. (2010).  Conducting high-value secondary dataset analysis:  
155 
 
 11
9
 
an introductory guide and resources.  Journal of General Internal Medicine, 
26(8), 920-929.  doi:  10.1007/sll606-010-1621-5   
Stodhard, K. J., Tennant, P. W. G., Bell, R., & Rankin, J. (2009). Maternal overweight 
and obesity and the risk of congenital anomalies. A systematic review and meta-
analysis. The Journal of American Medical Association, 301(6), 636-650. 
Strandberg-Larsen, K., Skov-Ettrup, L., Grønaek, M., Andersen, A., Olsen, J., & 
Tolstrup, J. (2011).  Maternal alcohol drinking pattern during pregnancy and the 
risk for an offspring with an isolated congenital heart defect and in particular a 
ventricular septal defect or an atrial septal defect.  Birth Defects Research (Part 
A), 91, 616-622.  doi: 10.1002/bdra.20818 
Teun van der Bom, A., Zomer, C., Zwinderman, A. H., Meijboom, F. J., Bouma, B. J., & 
Mulder, B. J. M. (2011).   The changing epidemiology of congenital heart disease.  
Nature Reviews-Cardiology, 8, 50-60. 
Thulstrup, A. M., & Bonde, J. P. (2006).  Maternal occupational exposure and risk of 
specific birth defects.  Occupational Medicine, 56, 532-543. doi:  
10.1093/occmed/kql115   
Tsikriktsis, N. (2005). A review of techniques for treating missing data in OM survey 
research. Journal of Operations Management, 24, 53-62.  DOI:  
10.1016/j.jom.2005.03.001 
United Nations Children’s Fund and World Health Organization, Low Birth weight: 
country, regional and global estimates. UNICEF, New York, 2004. 
U.S. Food and Drug Administration (2002).  Federal Food, Drug, and Cosmetic Act 
(FD&C Act).  Retrieved from 
156 
 
 11
9
 
http://www.fda.gov/regulatoryinformation/legislation/federalfooddrugandcosmeti
cactfdcact/default.htm 
Warnes, C. A., Liberthson, R., Danielson, G.K., Dore, A., Harris, L., Hoffman, J.I., 
Somerville, J....& Webb, G. D. (2001). Task force 1: the changing profile of 
congenital heart disease in adult life. Journal of the American College of 
Cardiology, 37(5), 1171-1175.   
Watson, R. E., Jacobson, C. F., Lavin Williams, A., Howard, W. B., & DeSesso, J.M. 
(2005).  Trichloroethylene-contaminated drinking water and congenital heart 
defects:  a critical analysis of the literature.  Reproductive Toxicology, 21, 117-
147.   doi:  10.1016/j.reprotox.2005.07.013 
Williams, R. V., Ravishankar, C., Zak, V., Evans, F., Atz, A.M., Border, W. L., Levine, 
J., …& Hsu, D. T. (2010).  Birth weight and prematurity in infants with single 
ventricle physiology:  Pediatric heart network infant single ventricle trial screened 
population.  Congenital Heart Disease, 5, 96-103. 
World Health Organization (2013). Fact sheet: Preterm birth. Retrieved from: 
http://www.who.int/mediacentre/factsheets/fs363/en/ 
Zen, T. D., Rosa, R., Zen, P., Trevisan, P, da Silva, A., Ricachinevsky, C., & Paskulin, G. 
(2011).  Gestational and family risk factors for carriers of congenital heart defects 
in southern Brazil.  Pediatrics International, 53, 551-557.  doi : 10.1111/j.1442-
200X.2011.03341x 
 
 
 
157 
 
 11
9
 
 
 
 
 
 
 
 
 
 
 
APPENDICES 
 
 
 
 
 
 
 
 
 
 
 
 
158 
 
 11
9
 
Appendix A 
 
 
159 
 
 11
9
 
Appendix B 
Wisconsin Pediatric Cardiac Registry 
Questionnaire (abbreviated) 
(Maternal and infant variables used in the study) 
 
INSTRUCTIONS: This comprehensive questionnaire is being given to the families of infants born with 
congenital heart defect in the state of Wisconsin.  The information is important to our continuing efforts to 
discover if there are identifiable causes of these defects.  All information is strictly confidential.  Prior to 
completing this questionnaire you must have agreed to participate in the study and completed the required 
consent form.  The questionnaire will take approximately 1 hour to complete. Completing this survey is 
voluntary.  You may skip questions or quit at any time. You do not need to complete the entire questionnaire at 
one session.  Please return both the consent form and the questionnaire to the address on the cover page.  Once 
we receive your questionnaire, if there are questions that are left unanswered, the Registry Coordinator will 
follow-up with a telephone call to obtain the information. If you have indicated that you decline to complete 
those questions, we will not contact you further.  
Medical terms are defined in a glossary at the back of this questionnaire.    
 
If you need help answering any of the questions, please call the Registry Coordinator at: 
(877) 809-9727 or 414-266-2325 
   
   2. Sex:   male  female 
   4. What is your child’s birth date?     ____ / ____ / ____  
           month   day      year 
   5. What was mother’s expected delivery date?    ____ / ____ / ____  
           month   day      year 
   6. When was mother’s last menstrual period prior to this pregnancy? ____ / ____ / ____   
           month   day      year 
Now we would like to ask you some questions about the baby’s mother and her health and family. 
8. Please circle mother’s race or ethnic group: 
(a) African-American 
(b) Asian 
(c) Caucasian 
(d) Hispanic 
(e) Native American 
(f) Other, please specify: ________________________________________________  
  
   9. What is mother’s date of birth? ____ / ____ / ____      
       month   day      year 
  10. What is mother’s marital status? 
(a) Single (never married) 
(b) Married    
(c) Divorced    
(d) Separated   
(e) Widowed 
 
  
  12. Did/does mother have a congenital heart defect, a heart condition that she was born with? 
   Yes*  No  Don't Know 
* If yes, please circle the correct answer below or write in the diagnosis. 
a) Ventricular septal defect   f)   Atrial septal defect 
b) Patent ductus arteriosus   g)   Coarctation of the aorta 
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c) Pulmonary valve stenosis   h)   Aortic valve stenosis 
d) Tetralogy of Fallot    i)   Transposition of the great arteries 
e) AV canal/endocardial cushion defect  j)   Bicuspid aortic valve 
k)  Other (please specify):
 ________________________
_ 
 
14. Did/does mother have any birth defect, malformation, or condition other than heart disease which was 
present from birth?          
Yes* No Don't Know 
*If yes, specify: ___________________________________________________________ 
 
Now we are going to ask about some illnesses that can last over a period of time and may sometimes have an 
effect on pregnancy. 
 
33. Has mother ever been told she has diabetes?      
Yes No* Don't Know 
a) Did mother have diabetes only during this pregnancy? Yes No Don't  Know 
b) During the 6 months before this pregnancy or during  
this pregnancy did mother take insulin?   Yes No Don't Know 
 c) During the 6 months before this pregnancy or during 
  this pregnancy did mother take oral hypoglycemic  
  pills or capsules?     Yes No Don't Know 
 
34.  Has mother ever been told that she has any of the following illnesses? 
 
Illness Has mother ever had:  
     Illness 
Yes *        No 
 Treatment 
Yes *        No 
Age at onset 
(year) 
Duration  
(years) 
a)  Asthma or allergies       
b)  Epilepsy (seizures)       
c)  Thyroid disease (specify)  
 
     
d)  Systemic lupus (SLE)       
e)  Peptic ulcer disease       
f)  Eating disorder       
g)  Cancer (specify)  
 
     
h)  Other (specify)  
 
     
 
35.  In the 6 months prior to or during this pregnancy did mother have any of the following illnesses or 
conditions? 
 Illness  Treatment 
 Yes No Yes* *If yes, please specify: 
a)  High blood pressure     
b)  Obesity (overweight)     
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c)  Bladder or kidney infections     
d)  Emotional (psychiatric) problems, 
including depression - please specify: 
___________________________ 
    
e)  Vaginal infection: 
           gonorrhea  
           syphilis 
           herpes 
           other, please specify: 
 
    
f)  Arthritis     
g)  Headaches     
h)  Colds, sinus infections,   bronchitis, 
pneumonia (please circle whichever 
apply) 
    
 
36. In the 6 months prior to or during this pregnancy did mother have or was mother exposed to anyone with the 
following infections (if yes, check the appropriate time period): 
    
         Infection 
 
 
Yes 
 
 
No 
Before 
pregnancy -  
Indicate 1-6 
months 
During pregnancy 
 
            (months) 
      1-3    4-6    7-9 
a)  Influenza (flu)       
b)  Mumps       
c)  Measles       
d)  Rubella       
e)  Chicken pox or shingles       
f)  Hepatitis       
g)  AIDS or HIV       
 
39. During this pregnancy did mother ever have a fever of 101F or higher?  
Yes* No Don't Know 
42. In the 6 months prior to or during this pregnancy did mother have any other serious health problem or 
was she hospitalized for any reason, excluding delivery?   
Yes* No Don't Know 
*If yes, please specify:          
           
 43. Did mother take vitamins or multi-vitamins during this pregnancy?   
Yes* No Don't Know 
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*If yes, please list the brand name:        
  
44. Did mother take any other “over-the-counter” health food or herbal supplements during this pregnancy? 
        
Yes* No Don't Know 
*If yes, please list the brand name:   ____________    
46. During this pregnancy, did mother regularly take any medication not mentioned above? 
 Yes* No Don't Know 
*If yes, please specify: __________________________________________________ 
47. What is mother's height?      _______ft.  ______in. 
48. What was mother's pre-pregnancy weight?   __________lbs. 
49. How much weight was gained during this pregnancy? __________lbs.
55. Did mother ever smoke cigarettes?     
Yes No* Don't Know 
a.)  Did mother smoke during the 6 month period prior to this pregnancy? 
Yes** No Don't Know  
 b.)  Did mother smoke during this pregnancy? 
        Yes** No Don't Know 
 
59. During the 6 months prior to this pregnancy or during this pregnancy, did mother drink 
 any alcoholic beverages (beer, wine, or liquor)? 
 Yes No* Don't Know 
64.  During this pregnancy, did mother use any of the following drugs? 
Drug Name Frequency 
 Never Rarely Less than 
once a 
week 
About 
once a 
week 
Almost 
daily 
Cocaine      
Marijuana      
Hash or Hashish      
Amphetamines (uppers, speed)      
Pain Killers (Percocet, Percodan, etc.)      
Glue Sniffing      
Crack      
Heroin      
Barbiturates (Downers)      
Valium      
Other Drugs (please 
specify)________________________ 
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69. In what type of house did mother live?  
a) Individual (unattached) house  
b) Row, duplex, or townhouse   
c) Apartment     
d) Trailer      
e) Other:________________________(specify) 
72. What was the source of mother's drinking water during this pregnancy? 
 a.)  City water 
 b.) Well water 
 c.) Bottled water 
 d.) Other, please specify: ______________________________________ 
75. Please look at the table and select the category that best represents the total annual family income (before 
taxes): 
 
77. What is the highest grade of schooling mother has completed? ________________ 
79. Was mother working during the 6 months before she became pregnant?  
Yes No* Don't Know* 
     
84. Was mother working during this pregnancy? 
 Yes No* Don't Know 
 
Now we would like to ask for some information about the baby. 
 
131. How much did he/she weigh at birth?  ___  ___  lbs.  ___  ___  oz.
        a.)   Less than $10,000   
        b.)   10,000 - 19,999   
        c.)  20,000 - 24,999   
        d.)  25,000 - 49,999   
        e.)  50,000 - 99,999   
        f.)  Greater than 100,000   
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